
<html lang="en"     class="pb-page"  data-request-id="d55db367-4fd6-4684-81f3-046958d23e2e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-9;article:article:10.1021/acs.jmedchem.7b01792;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="N-Substituted Prodrugs of Mebendazole Provide Improved Aqueous Solubility and Oral Bioavailability in Mice and Dogs" /></meta><meta name="dc.Creator" content="Sarah&#xA;C.  Zimmermann" /></meta><meta name="dc.Creator" content="Tomáš  Tichý" /></meta><meta name="dc.Creator" content="Jan  Vávra" /></meta><meta name="dc.Creator" content="Ranjeet P.  Dash" /></meta><meta name="dc.Creator" content="C. Ethan  Slusher" /></meta><meta name="dc.Creator" content="Alexandra J.  Gadiano" /></meta><meta name="dc.Creator" content="Ying  Wu" /></meta><meta name="dc.Creator" content="Andrej  Jančařík" /></meta><meta name="dc.Creator" content="Lukáš  Tenora" /></meta><meta name="dc.Creator" content="Lenka  Monincová" /></meta><meta name="dc.Creator" content="Eva  Prchalová" /></meta><meta name="dc.Creator" content="Gregory J.  Riggins" /></meta><meta name="dc.Creator" content="Pavel  Majer" /></meta><meta name="dc.Creator" content="Barbara S.  Slusher" /></meta><meta name="dc.Creator" content="Rana  Rais" /></meta><meta name="dc.Description" content="Mebendazole (MBZ) was developed as a broad-spectrum anthelmintic but has recently shown efficacy as an anticancer agent. The use of MBZ for cancer, however, is challenging due to its poor solubilit..." /></meta><meta name="Description" content="Mebendazole (MBZ) was developed as a broad-spectrum anthelmintic but has recently shown efficacy as an anticancer agent. The use of MBZ for cancer, however, is challenging due to its poor solubilit..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 12, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01792" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01792" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01792" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01792" /></link>
        
    
    

<title>N-Substituted Prodrugs of Mebendazole Provide Improved Aqueous Solubility and Oral Bioavailability in Mice and Dogs | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01792" /></meta><meta property="og:title" content="N-Substituted Prodrugs of Mebendazole Provide Improved Aqueous Solubility and Oral Bioavailability in Mice and Dogs" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0010.jpeg" /></meta><meta property="og:description" content="Mebendazole (MBZ) was developed as a broad-spectrum anthelmintic but has recently shown efficacy as an anticancer agent. The use of MBZ for cancer, however, is challenging due to its poor solubility leading to poor bioavailability. Herein, we developed a prodrug approach with various N-linked promoieties including acyloxymethyl, aminoacyloxymethyl, and substituted phosphonooxymethyl in attempt to improve these characteristics. Compound 12, containing an (((((isopropoxycarbonyl)oxy)methoxy)phosphoryl)oxy)methyl promoiety, showed a &gt;10 000-fold improvement in aqueous solubility. When evaluated in mice, 12 displayed a 2.2-fold higher plasma AUC0–t and a 1.7-fold improvement in brain AUC0–t with a calculated oral bioavailability of 52%, as compared to 24% for MBZ-polymorph C (MBZ-C), the most bioavailable polymorph. In dogs, 12 showed a 3.8-fold higher plasma AUC0–t with oral bioavailability of 41% compared to 11% for MBZ-C. In summary, we have identified a prodrug of MBZ with better physicochemical properties and enhanced bioavailability in both mice and dog." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01792"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01792">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01792&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01792&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01792&amp;href=/doi/10.1021/acs.jmedchem.7b01792" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3918-3929</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01745" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01809" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">N-Substituted Prodrugs of Mebendazole Provide Improved Aqueous Solubility and Oral Bioavailability in Mice and Dogs</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Sarah C. Zimmermann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah C. Zimmermann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery,  Departments of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah%0AC.++Zimmermann">Sarah C. Zimmermann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tomáš Tichý</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tomáš Tichý</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tom%C3%A1%C5%A1++Tich%C3%BD">Tomáš Tichý</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jan Vávra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jan Vávra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jan++V%C3%A1vra">Jan Vávra</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ranjeet P. Dash</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ranjeet P. Dash</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery,  Departments of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ranjeet+P.++Dash">Ranjeet P. Dash</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">C. Ethan Slusher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">C. Ethan Slusher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=C.+Ethan++Slusher">C. Ethan Slusher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexandra J. Gadiano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexandra J. Gadiano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexandra+J.++Gadiano">Alexandra J. Gadiano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ying Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ying Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Wu">Ying Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrej Jančařík</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrej Jančařík</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrej++Jan%C4%8Da%C5%99%C3%ADk">Andrej Jančařík</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lukáš Tenora</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lukáš Tenora</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luk%C3%A1%C5%A1++Tenora">Lukáš Tenora</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lenka Monincová</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lenka Monincová</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lenka++Monincov%C3%A1">Lenka Monincová</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eva Prchalová</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eva Prchalová</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery,  Departments of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eva++Prchalov%C3%A1">Eva Prchalová</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregory J. Riggins</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory J. Riggins</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Oncology,  Neurosurgery, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+J.++Riggins">Gregory J. Riggins</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pavel Majer</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pavel Majer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</div></div><span class="conrtib-corresp"><strong>*</strong>P.M.: phone, +420-220-183-125; e-mail, <a href="/cdn-cgi/l/email-protection#137e7279766153667c707b713d7072603d7069"><span class="__cf_email__" data-cfemail="eb868a818e99ab9e84888389c5888a98c58891">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pavel++Majer">Pavel Majer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Barbara S. Slusher</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Barbara S. Slusher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery,  Departments of Neurology,  Psychiatry and Behavioral Sciences,  Neuroscience,  Medicine,  Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</div></div><span class="conrtib-corresp"><strong>*</strong>B.S.S.: phone, 410-614-0662; fax, 410-614-0659; e-mail, <a href="/cdn-cgi/l/email-protection#3e5c4d524b4d565b4c7e54565357105b5a4b"><span class="__cf_email__" data-cfemail="e98b9a859c9a818c9ba983818480c78c8d9c">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Barbara+S.++Slusher">Barbara S. Slusher</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9814-4157" title="Orcid link">http://orcid.org/0000-0001-9814-4157</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Rana Rais</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rana Rais</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Johns Hopkins Drug Discovery,  Departments of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</div></div><span class="conrtib-corresp"><strong>*</strong>R.R.: phone, 410-502-0497; fax, 410-614-0659; e-mail, <a href="/cdn-cgi/l/email-protection#2d5f5f4c445e1f6d4745404403484958"><span class="__cf_email__" data-cfemail="a2d0d0c3cbd190e2c8cacfcb8cc7c6d7">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rana++Rais">Rana Rais</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4059-2453" title="Orcid link">http://orcid.org/0000-0003-4059-2453</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01792&amp;href=/doi/10.1021%2Facs.jmedchem.7b01792" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3918–3929</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 12, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 December 2017</li><li><span class="item_label"><b>Published</b> online</span>12 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 May 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01792" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01792</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3918%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSarah%250AC.%2BZimmermann%252C%2BTom%25C3%25A1%25C5%25A1%2BTich%25C3%25BD%252C%2BJan%2BV%25C3%25A1vra%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D9%26contentID%3Dacs.jmedchem.7b01792%26title%3DN-Substituted%2BProdrugs%2Bof%2BMebendazole%2BProvide%2BImproved%2BAqueous%2BSolubility%2Band%2BOral%2BBioavailability%2Bin%2BMice%2Band%2BDogs%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3929%26publicationDate%3DMay%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01792"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2401</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01792" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;N-Substituted Prodrugs of Mebendazole Provide Improved Aqueous Solubility and Oral Bioavailability in Mice and Dogs&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sarah\nC.&quot;,&quot;last_name&quot;:&quot;Zimmermann&quot;},{&quot;first_name&quot;:&quot;Tomáš&quot;,&quot;last_name&quot;:&quot;Tichý&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Vávra&quot;},{&quot;first_name&quot;:&quot;Ranjeet&quot;,&quot;last_name&quot;:&quot;P. Dash&quot;},{&quot;first_name&quot;:&quot;C.&quot;,&quot;last_name&quot;:&quot;Ethan Slusher&quot;},{&quot;first_name&quot;:&quot;Alexandra&quot;,&quot;last_name&quot;:&quot;J. Gadiano&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Andrej&quot;,&quot;last_name&quot;:&quot;Jančařík&quot;},{&quot;first_name&quot;:&quot;Lukáš&quot;,&quot;last_name&quot;:&quot;Tenora&quot;},{&quot;first_name&quot;:&quot;Lenka&quot;,&quot;last_name&quot;:&quot;Monincová&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Prchalová&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;J. Riggins&quot;},{&quot;first_name&quot;:&quot;Pavel&quot;,&quot;last_name&quot;:&quot;Majer&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;S. Slusher&quot;},{&quot;first_name&quot;:&quot;Rana&quot;,&quot;last_name&quot;:&quot;Rais&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3918-3929&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01792&quot;},&quot;abstract&quot;:&quot;Mebendazole (MBZ) was developed as a broad-spectrum anthelmintic but has recently shown efficacy as an anticancer agent. The use of MBZ for cancer, however, is challenging due to its poor solubility leading to poor bioavailability. Herein, we developed a prodrug approach with various N-linked promoieties including acyloxymethyl, aminoacyloxymethyl, and substituted phosphonooxymethyl in attempt to improve these characteristics. Compound 12, containing an (((((isopropoxycarbonyl)oxy)methoxy)phosphoryl)oxy)methyl promoiety, showed a &gt;10 000-fold improvement in aqueous solubility. When evaluated in mice, 12 displayed a 2.2-fold higher plasma AUC0–t and a 1.7-fold improvement in brain AUC0–t with a calculated oral bioavailability of 52%, as compared to 24% for MBZ-polymorph C (MBZ-C), the most bioavailable polymorph. In dogs, 12 showed a 3.8-fold higher plasma AUC0–t with oral bioavailability of 41% compared to 11% for MBZ-C. In summary, we have identified a prodrug of MBZ with better physicochemical properties an&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01792&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01792" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01792&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01792" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01792&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01792" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01792&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01792&amp;href=/doi/10.1021/acs.jmedchem.7b01792" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01792" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01792" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01792%26sid%3Dliteratum%253Aachs%26pmid%3D29648826%26genre%3Darticle%26aulast%3DZimmermann%26date%3D2018%26atitle%3DN-Substituted%2BProdrugs%2Bof%2BMebendazole%2BProvide%2BImproved%2BAqueous%2BSolubility%2Band%2BOral%2BBioavailability%2Bin%2BMice%2Band%2BDogs%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D9%26spage%3D3918%26epage%3D3929%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=291155" title="Bioavailability">Bioavailability</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/jmcmar.2018.61.issue-9/20180510/jmcmar.2018.61.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Mebendazole (MBZ) was developed as a broad-spectrum anthelmintic but has recently shown efficacy as an anticancer agent. The use of MBZ for cancer, however, is challenging due to its poor solubility leading to poor bioavailability. Herein, we developed a prodrug approach with various N-linked promoieties including acyloxymethyl, aminoacyloxymethyl, and substituted phosphonooxymethyl in attempt to improve these characteristics. Compound <b>12</b>, containing an (((((isopropoxycarbonyl)oxy)methoxy)phosphoryl)oxy)methyl promoiety, showed a >10 000-fold improvement in aqueous solubility. When evaluated in mice, <b>12</b> displayed a 2.2-fold higher plasma AUC<sub>0–<i>t</i></sub> and a 1.7-fold improvement in brain AUC<sub>0–<i>t</i></sub> with a calculated oral bioavailability of 52%, as compared to 24% for MBZ-polymorph C (MBZ-C), the most bioavailable polymorph. In dogs, <b>12</b> showed a 3.8-fold higher plasma AUC<sub>0–<i>t</i></sub> with oral bioavailability of 41% compared to 11% for MBZ-C. In summary, we have identified a prodrug of MBZ with better physicochemical properties and enhanced bioavailability in both mice and dog.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mebendazole (MBZ) was originally developed as a broad-spectrum anthelmintic for human and veterinary use more than 20 years ago.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> More recently, MBZ has been shown to possess anticancer properties in a broad range of preclinical studies across various cancer types such as adrenocortical carcinoma,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> non-small-cell lung cancer,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> gastric cancer,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> colon cancer,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> melanoma,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> glioblastoma,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> medulloblastoma,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and glioblastoma multiforme.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> MBZ’s anticancer efficacy is thought to be due to its polypharmacology, including its ability to inhibit microtubule formation,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> VEGFR2 kinase,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> the hedgehog pathway,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and other kinases implicated in cancers including BCR-ABL and BRAF.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Recently, MBZ-C, the most bioavailable MBZ polymorph, has been used in exploratory clinical studies for brain cancer.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12−15)</a></div><div class="NLM_p">Despite these encouraging results, the development of MBZ for indications requiring systemic availability remains challenging. MBZ is a Biopharmaceutics Classification System (BCS) class II drug<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> which displays poor physicochemical properties including low aqueous solubility and poor oral bioavailability,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> despite its optimal partition coefficient (cLogP = 3.1). MBZ’s low solubility is hypothesized to be due to its planar structure causing strong stacking interactions in the crystal lattice, which are reinforced by intermolecular hydrogen bonds.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In a pilot human pharmacokinetic study with one subject using intravenous and oral administration of [<sup>3</sup>H]-mebendazole, the oral bioavailability of MBZ was found to be 17%.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> A second study in five subjects confirmed these results, calculating the bioavailability as 22% with a variable range of 12–35%.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Multiple strategies have been investigated to improve the bioavailability of MBZ. MBZ exists in three polymorphic forms, A, B, and C (MBZ-A, MBZ-B, and MBZ-C, respectively), that have been investigated for their differences in physicochemical properties including solubility,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> dissolution rate, and therapeutic effects.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> MBZ-C is the clinically preferred polymorph<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> due to its improved solubility over MBZ-A.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> Furthermore, MBZ-C displayed less toxicity than MBZ-B<a onclick="showRef(event, 'ref22 ref26'); return false;" href="javascript:void(0);" class="ref ref22 ref26">(22,26)</a> and was found to exhibit higher plasma AUC levels and brain to plasma (B/P) ratios as compared to MBZ-A and MBZ-B.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In addition to characterization of the different polymorphic forms, salt forms and cosolvent strategies have been investigated for enhancing its solubility. Specifically, the MBZ mesylate salt was shown to improve solubility,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> whereas MBZ oil and cosolvent based formulations (e.g., with oleic acid, glycerol trioleate, span 80, Tween 80, soybean oil, olive oil, polyethylene glycol)<a onclick="showRef(event, 'ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31 ref32">(28−32)</a> were shown to improve MBZ’s plasma exposures following oral administration. These latter methods, however, were limited to administration as oral suspensions leading to increased variability in exposure.</div><div class="NLM_p">Prodrug approaches to improve MBZ’s aqueous solubility and oral bioavailability have also been investigated focusing on 4-amino-3-(3′-methoxycarbonyl-2′-thioureido)benzophonone<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf" class="ext-link">Figure S1A in Supporting Information</a>) and <i>N</i>-alkoxycarbonyl MBZ (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf" class="ext-link">Figure S1B</a>).<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> Although these prodrug strategies demonstrated feasibility, they profiled limited chemistry focusing on simple acylations of the benzimidazole nitrogens and a single 4-amino-3-(3′-methoxycarbonyl-2′-thioureido)benzophenone analog. The latter was evaluated in an oral pharmacokinetic study in rats and showed a 2-fold improvement in plasma exposure versus equimolar oral MBZ. Both intact prodrug and MBZ were observed in plasma, suggesting that the prodrug was likely stable in the gastrointestinal tract, undergoing conversion to MBZ in rat liver or plasma post absorption. There were similar findings with the <i>N</i>-alkoxycarbonyl prodrugs, showing rapid hydrolysis in human and rabbit plasma and liver homogenate in in vitro metabolic stability studies. When orally dosed to rabbits in vivo, the best <i>N</i>-methoxycarbonyl derivative exhibited a 13-fold improvement in MBZ plasma exposure compared to oral MBZ.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Oral bioavailability could not be calculated, however, as intravenous MBZ studies were not performed. In addition, no information regarding the identity of MBZ polymorph (A, B, or C) used for the comparative analysis was provided, which could have significantly impacted the PK parameter comparisons, as detailed by others.<a onclick="showRef(event, 'ref21 ref36'); return false;" href="javascript:void(0);" class="ref ref21 ref36">(21,36)</a></div><div class="NLM_p last">Herein, we strategized additional prodrug approaches to improve the aqueous solubility and oral bioavailability of MBZ by making <i>N</i>-acyloxymethyl and <i>N</i>-phosphonooxymethyl analogs. The selection of promoieties was made with the goal of disrupting the MBZ crystal packing by weakening intermolecular interactions (e.g., <i>N</i>-acyloxymethyl prodrugs) as well as imparting hydrophilicity by addition of charge (e.g., <i>N</i>-phosphonooxymethyl prodrugs) to obtain prodrugs with adequate solubility and lipophilicity for oral absorption. We describe eight MBZ prodrugs with improved aqueous solubility compared to MBZ-C, of which seven were evaluated in mice and showed increased plasma exposure following oral administration. When compared to equimolar MBZ-C, our best prodrug, with a phosphonooxymethyl alkyl promoiety, showed a >10 000-fold improvement in solubility and a 2.2- and 3.8-fold improvement in oral bioavailability in mice and dogs, respectively.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">A variety of known promoieties (employed in other FDA approved drugs) were used to derivatize MBZ. As detailed previously, MBZ’s low solubility is hypothesized to be due to its planar structure causing strong stacking interactions in the crystal lattice, which are reinforced by intermolecular hydrogen bonds. Promoieties were selected to improve solubility by disrupting the planar structure (e.g., <i>N</i>-acyloxymethyl prodrugs) and enhancing hydrophilicity (e.g., <i>N</i>-phosphonooxymethyl prodrugs) while retaining lipophilicity for effective oral absorption.</div><div class="NLM_p">Pivaloyloxymethyl (POM, <b>1</b>) and isopropyloxycarbonyloxymethyl (POC, <b>2</b>) promoieties, which have shown previous success for phosphate containing compounds,<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37−40)</a> were used to prepare prodrugs <b>1</b> and <b>2</b>. MBZ was alkylated (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) in DMSO with the requisite chlorides, chloromethyl pivalate for <b>1</b> and chloromethyl isopropyl carbonate for <b>2</b>, leading to final prodrugs with the POM (<b>1</b>) and POC (<b>2</b>) promoieties. To further increase solubility of MBZ prodrugs, the pivalic acid in <b>1</b> was replaced by several amino acids or dipeptides. Unfortunately, all prodrugs with a free amino group (e.g., <b>14</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) were too unstable in aqueous environment, even under neutral or mildly acidic conditions, making characterization and in vitro assessment challenging. However, when the free amino group was acetylated as in acetyl-<span class="smallcaps smallerCapital">l</span>-leucinylglycinyloxymethyl compound <b>7</b>, the prodrug was sufficiently stable to be tested. Prodrug <b>7</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) was prepared in a similar fashion as discussed above, by reacting MBZ with chloromethyl (<i>tert</i>-butoxycarbonyl)glycinate to yield <b>3</b>. Intermediate <b>3</b> was then deprotected under acidic conditions and its peptide chain extended by standard method using a BOC protection to form <b>6</b>. The amine was then deprotected and acetylated to obtain prodrug <b>7</b>, predominately composed of the <i>N</i><sup>1</sup> isomer. The succinyloxymethyl promoiety with a free carboxylate was used in prodrug <b>8</b>. The succinic acid was introduced in a similar manner by alkylating MBZ using <i>tert-</i>butyl (chloromethyl)succinate to produce intermediate <b>4</b>, which was hydrolyzed to <b>8</b> using TFA.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Prodrugs <b>1</b>, <b>2</b>, and <b>7</b>–<b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <i>t</i>-BuOK, DMSO, rt, 15 min; (ii) Cl-R, rt, 1 h; (b) (i) <b>3</b>, HCl, dioxane, 0 °C, 1 h; (ii) Boc-<span class="smallcaps smallerCapital">l</span>-Leu-OH, HOBt, EDC, DIPEA, DMF, rt, overnight; (c) (i) <b>6</b>, HCl, dioxane, 0 °C; (ii) AcOH, HOBt, EDC, DIPEA, DMF, 0 °C to rt, overnight; (d) <b>4</b> or <b>5</b>, TFA, DCM, 0 °C to rt, 3.5 or 2 h.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Prodrug <b>11</b>, <b>12</b>, and <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, DMF, 0 °C, 1 h; (ii) Cl-R, DMF, 0 °C to rt, 16 h; (b) <b>10</b> or <b>13,</b> TFA, DCM, rt, 16 h; (c) <b>11</b>, <i>N</i>,<i>N</i>′-dicyclohexyl-4-morpholinecarboxamidine, DMF, chloromethyl isopropyl carbonate, rt, 24 h.</p></p></figure><div class="NLM_p">Another strategy employed to increase the solubility of MBZ was to introduce a glucose moiety attached via the primary 6-hydroxy group (<b>9</b>), which could then be hydrolyzed in vivo to MBZ. Prodrug <b>9</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) was prepared by alkylation of MBZ with chloromethyl (((2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>,6<i>R</i>)-3,4,5,6-tetrakis((trimethylsilyl)oxy)tetrahydro-2<i>H</i>-pyran-2-yl)methyl) carbonate to yield intermediate <b>5</b>, which was hydrolyzed by TFA to <b>9</b>.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">The phosphonooxymethyl promoiety which has been successfully employed to improve aqueous solubility and bioavailability of water insoluble drugs<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> was used for the synthesis of compound <b>11</b>. Compound <b>11</b> was further modified with an additional POC by masking the phosphate to obtain <b>12</b>. The POC was found to compensate for the highly hydrophilic nature of the phosphonooxymethyl, which led to an increase in the cLogP to a more favorable value of 3.63 for <b>12</b>, as compared to a value of 0.80 for the free phosphate <b>11</b>. To prepare <b>11</b> and <b>12</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), MBZ was first reacted with di-<i>tert</i>-butyl (chloromethyl) phosphate to produce intermediate <b>10</b>. Prodrug <b>11</b> was then synthesized by deprotection of <b>10</b> with TFA to the free phosphate. <b>11</b> was then alkylated by chloromethyl isopropyl carbonate to yield <b>12</b>. Compound <b>14</b> was synthesized by reaction MBZ with <i>N</i>-Boc-glutamic acid α-<i>tert</i>-butyl-γ-chloromethyl ester and removal of the protecting groups from the intermediate <b>13</b> by TFA.</div><div class="NLM_p last">All prodrugs were obtained as a mixture of their <i>N</i><sup>1</sup> and <i>N</i><sup>3</sup> positional isomers resulting from the undifferentiated substitution of both benzimidazole nitrogen atoms. For simplicity, however, all figures are shown with promoieties on the <i>N</i><sup>1</sup> position. The formation of positional isomer (<i>N</i><sup>2</sup>) was not observed in any prodrug. The ratios of the positional isomers differed for individual prodrugs and are detailed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Since the hydrolysis of either <i>N</i><sup>1</sup> and <i>N</i><sup>3</sup> positional isomers results in the release of the same active product (i.e., MBZ), all the biological studies were performed on the mixtures. This is somewhat analogous to the situation of prodrugs containing chiral center in the promoiety (fosinopril, cefuroxime axetil, cefpodoxime proxetil)<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> that are marketed as mixtures of diastereomers.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Solubility and Chemical Stability Assessment</h3><div class="NLM_p">Eight prodrugs of MBZ were synthesized and evaluated in both in vitro and in vivo experiments. The in silico cLogP values were obtained from ChemDraw Professional 16.0 software and are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The prodrugs showed varying degree of lipophilicity (cLogP from 0.4 to 4.23) compared to MBZ (cLogP = 3.08).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Metabolic Stability of MBZ Prodrugs<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Footnote #: n/a indicates that data were not attainable due to chemical instability.</p></div></div><div></div></div><div class="NLM_p">The prodrugs were screened for aqueous solubility in 0.01 M PBS using a modified form of the shake flask method.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> All of the prodrugs displayed increased solubility (as shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) compared to MBZ-C, with <b>7</b>, <b>8</b>, and <b>9</b> with a methyl acetyl-<span class="smallcaps smallerCapital">l</span>-leucylglycinate, methyl 4-oxobutanoic acid, and methylglucosyl promoieties, respectively, all imparting a greater than 200-fold improvement, although cLogP values varied 0.62–3. Compounds <b>11</b> and <b>12</b> with the charged phosphonooxymethyl and POC substituted phosphonooxymethyl promoiety respectively showed the highest increase, with <b>12</b> displaying a >10 000-fold improvement over MBZ-C (solubility of 0.4 μg/mL versus 14 000 μg/mL, respectively).</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Aqueous solubility of MBZ and MBZ prodrugs <b>1</b>, <b>2</b>, <b>7</b>–<b>9</b>, <b>11</b>, and <b>12</b> in 0.01 M PBS determined using equilibrium solubility methods. Data are expressed as the mean ± SEM (<i>n</i> = 3). The dotted line represents the solubility of MBZ-C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Prodrugs were also tested for chemical stability in 0.01 M PBS for 60 min at 37 °C by monitoring intact prodrug using LC–MS. All prodrugs were stable over the assay conditions except <b>14</b> which showed high instability with 0% remaining at 60 min, respectively. Thus, prodrug <b>14</b> was not assessed in assays due to its significant instability in PBS at pH 7.4.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Metabolic Stability Assessment</h3><div class="NLM_p last">In addition to solubility, all prodrugs were screened for in vitro metabolic stability in mouse jejunum homogenate, liver microsomes, and plasma (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) to characterize their bioconversion to MBZ. The screening paradigm was designed to confirm activation of prodrugs to MBZ following oral administration in these highly metabolic sites. Initial screening was done in mouse jejunum homogenate by incubating the compounds for 60 min. The results showed that <b>2</b>, <b>9</b>, and <b>12</b> were completely metabolized (>95%) and <b>1</b>, <b>7</b>, <b>11</b>, and <b>8</b> were highly metabolized (63–82%). Following jejunum stability, the prodrugs were screened in mouse liver microsomes. After a 60 min incubation, <b>1</b> and <b>2</b> showed complete metabolism (>95%) and <b>7</b>, <b>8</b>, <b>9</b>, and <b>12</b> were highly metabolized (71–86%). Interestingly, <b>11</b> with a phosphonooxymethyl was metabolically stable in liver microsomes but when retested in liver tissue homogenate showed instability (65 ± 3%, remaining at 1 h; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf" class="ext-link">Figure S2</a>). Lastly, screening in mouse plasma showed that after a 60 min incubation, prodrugs containing the POM (<b>1</b>), the POC (<b>2</b>), and the methyl acetyl-<span class="smallcaps smallerCapital">l</span>-leucylglycinate (<b>7</b>) promoieties were completely metabolized (>95%), prodrug <b>9</b>, containing a methyl (glucosyl)methyl carbonate promoiety was highly metabolized (82%), while prodrugs containing the methyl 4-oxobutanoic acid (<b>8</b>) and methyl (isopropoxycarbonyloxy)methyl phosphate (<b>12</b>) promoieties showed the least metabolism (<30%) in mouse plasma.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Single Time-Point Oral Pharmacokinetic Comparison of MBZ-C and Prodrugs in Mice</h3><div class="NLM_p">All prodrugs were screened in a single time-point mouse pharmacokinetic study in comparison to MBZ-C (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). MBZ-C and the prodrugs were administered via oral gavage at equivalent doses, and MBZ levels in plasma were analyzed by LC–MS at 1 h postdrug administration. When directly compared to MBZ-C (2.86 ± 0.25 nmol/mL), oral administration of <b>7</b> (8.72 ± 0.63 nmol/mL), <b>11</b> (8.53 ± 2.33 nmol/mL), and <b>12</b> (10.35 ± 2.57 nmol/mL) showed statistically significant improvement in the exposure of plasma MBZ, with <b>12</b> showing the best profile with a 3.6-fold improvement over MBZ-C. Given this, <b>12</b> was further characterized for full pharmacokinetic time course studies in both mice and dogs as described.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. MBZ plasma concentration at 1 h after oral administration of MBZ-C or prodrug administration. MBZ-C or <b>1</b>, <b>2</b>, <b>7</b>, <b>8</b>, <b>9</b>, <b>11</b>, <b>12</b> were administered to male CD-1 mice as a single dose by oral gavage at 30 mg/kg MBZ equivalent dose. Data are expressed as the mean ± SEM (<i>n</i> = 3), with statistics quantified using one-way ANOVA with Dunnett’s multiple comparison test: (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Pharmacokinetic Profile of Intravenous MBZ-C in Mice and Dogs</h3><div class="NLM_p">In order to calculate exact pharmacokinetic parameters (specifically oral bioavailability) of MBZ from <b>12</b>, it was imperative to conduct intravenous (iv) pharmacokinetic analysis of MBZ. To our knowledge, iv pharmacokinetics of MBZ in preclinical studies has not been previously reported, likely due to its poor aqueous solubility. Using a cosolvent system comprising 1% DMSO and 10% Cremophor EL formulation, however, we successfully administered iv MBZ at a dose of 1.5 mg/kg in mice (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A) and a dose of 0.3 mg/kg in dog (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). In mice, iv MBZ-C administration at 1.5 mg/kg led to a <i>C</i><sub>max</sub> of 5.3 nmol/mL at 5 min postdose, with an AUC<sub>0–<i>t</i></sub> of 2.7 nmol·h/mL. In beagle dogs, iv MBZ-C administration at 0.3 mg/kg with the same formulation resulted in a <i>C</i><sub>max</sub> of 2.2 nmol/mL at 5 min and an AUC<sub>0–<i>t</i></sub> of 0.9 nmol·h/mL. The half-lives for MBZ-C were short following iv administration with a value of 0.73 and 0.72 h in mice and dog, respectively. The volume of distribution (Vd) in mice was calculated to be 1.4 L/kg and in dog 1.3 L/kg, suggesting moderate distribution to tissue components. Lastly, the clearance values were 27 mL/min/kg and 22 mL min<sup>–1</sup> kg<sup>–1</sup> in mice and dog, respectively, suggesting moderate to high systemic clearance.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. MBZ pharmacokinetics in mice and dogs following iv administration. (A) MBZ-C was administered to male CD-1 mice as a single iv dose at 1.5 mg/kg, and plasma concentrations were determined over time. (B) MBZ-C was administered to male beagle dogs as a single iv dose of 0.3 mg/kg, and plasma concentrations were determined over time. (C) Pharmacokinetic parameters were calculated using noncompartmental analysis in WinNonlin. Data are expressed as the mean ± SEM for mouse (<i>n</i> = 3/time-point) and as the mean for dog (<i>n</i> = 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Pharmacokinetic Profile of Oral MBZ-C and Prodrug <b>12</b> in Mice and Dog</h3><div class="NLM_p">To determine the oral bioavailability in mice, MBZ-C and <b>12</b> were dosed at an equivalent 30 mg/kg peroral (po) dose in 5% ethanol, 5% polysorbate 80 in 90% saline. <b>12</b> showed a 2.4-fold enhancement in <i>C</i><sub>max</sub> compared to MBZ-C (12.2 nmol/mL at 0.5 h for <b>12</b> versus 5.1 nmol/mL at 1 h for MBZ-C). Prodrug <b>12</b> also displayed a 2.2-fold enhanced AUC<sub>0–<i>t</i></sub> (27.9 nmol·h/mL for <b>12</b> versus 12.9 nmol·h/mL for MBZ-C), with calculated oral bioavailability (% <i>F</i>) of 24% and 52% of MBZ from MBZ-C or <b>12</b> administrations, respectively (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Brain concentrations of MBZ were also measured in tandem. In mouse brain (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), <b>12</b> showed a 2.3-fold improvement in <i>C</i><sub>max</sub> over MBZ-C (11.7 nmol/mL at 0.5 h for <b>12</b> versus 5.1 nmol/mL at 1 h for MBZ-C) and a 1.7-fold increase in brain AUC<sub>0–<i>t</i></sub> (21.9 nmol·h/mL for <b>12</b> versus 13.1 nmol·h/mL for MBZ-C). The brain to plasma (<i>B</i>/<i>P</i>) ratio of MBZ stayed consistent with a <i>B</i>/<i>P</i> ratio of 1 for MBZ-C and 0.8 for <b>12</b> as shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C. Further, no intact prodrug was detected in either brain or plasma samples at any time point, suggesting complete conversion to MBZ prior to systemic absorption. These pharmacokinetic results also corroborated the in vitro metabolism studies given the instability of <b>12</b> in intestinal tissue homogenate.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) MBZ plasma and (B) brain pharmacokinetics in mice after oral administration of MBZ-C or <b>12</b>. MBZ-C and <b>12</b> were administered to mice as a single po dose of 30 mg/kg equivalent for <b>12</b>. (C) Pharmacokinetic parameters were calculated using noncompartmental analysis in WinNonlin, with data expressed as the mean ± SEM (<i>n</i> = 3 mice/time-point).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">MBZ-C and <b>12</b> were also administered to male beagle dogs (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) as a single po dose of 2.5 mg/kg equivalent MBZ in a formulation of 5% ethanol, 5% polysorbate 80 in 90% saline. Compared to MBZ-C, <b>12</b> showed a 3.5-fold higher <i>C</i><sub>max</sub> (0.7 nmol/mL at 2 h for <b>12</b> versus 0.2 nmol/mL at 2 h for MBZ-C) and 3.8-fold higher AUC<sub>0–<i>t</i></sub> (3.0 nmol·.h/mL for <b>12</b> versus 0.8 nmol·h/mL for MBZ-C). The calculated oral bioavailability was 11% and 41% of MBZ from MBZ-C or <b>12</b> administrations, respectively, suggesting almost a 4-fold improvement in dogs from <b>12</b>. Similar to mouse no intact prodrug was observed in dog plasma following oral administration of <b>12</b>.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) MBZ plasma exposure in male beagle dogs after oral administration of MBZ-C or <b>12</b>. MBZ-C and prodrug <b>12</b> were administered to male beagle dogs (<i>n</i> = 2 per group) as a single po dose of 2.5 mg/kg or equivalent for <b>12</b>. (B) Pharmacokinetic parameters were calculated using noncompartmental analysis in WinNonlin, with data expressed as the mean.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The anthelmintic MBZ has been used since the 1970s for the treatment of parasitic worm infections and has more recently shown potential for strong effectiveness against a variety of cancers supported by both preclinical and clinical studies. The main challenge with MBZ has been its limited and variable oral bioavailability. MBZ is a Biopharmaceutics Classification System (BCS) class II drug<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> that displays poor physicochemical properties including low aqueous solubility and poor oral bioavailability,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> despite its optimal partition coefficient (cLogP = 3.1). MBZ’s low solubility is hypothesized to be due, at least in part, to its planar structure causing strong stacking interactions in the crystal lattice, which are reinforced by intermolecular hydrogen bonds.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Previous studies have attempted to increase MBZ’s bioavailability using oil-based formulations,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> nanoformulations,<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> and prodrug strategies,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> although with varied success. Our work extends and improves upon prior MBZ prodrug efforts by exploring alternative N-linked substituents including acyloxymethyl, aminoacyloxymethyl, and substituted phosphonooxymethyl promoieties. These promoieties were selected based on the fact that they have been previously employed in FDA approved drugs, with proven low toxicity potential upon release. In addition, the promoieties afforded varying degrees of lipophilicity (cLogP of 0.4–4.23), providing prodrugs spanning a wide range physicochemical properties.</div><div class="NLM_p">A comprehensive evaluation paradigm with chemical stability, aqueous solubility, jejunum, liver, and plasma stability, and oral and iv in vivo pharmacokinetic analyses in two species was employed with the goal of obtaining an orally bioavailable prodrug capable of delivering efficacious plasma exposures. With the exception of <b>14</b>, all of the prodrugs showed good chemical stability and improved solubility versus the most soluble polymorph, MBZ-C. The prodrugs <b>11</b> and <b>12</b> with the charged phosphonooxymethyl and POC substituted phosphonooxymethyl promoieties, respectively showed solubility improvement of >1000-fold. The relative enhanced solubility of <b>12</b> versus <b>11</b>, however, was unexpected. As discussed earlier, the poor solubility of MBZ not only comes from its hydrophobicity but also is due to its planar structure, and thus the higher solubility afforded by <b>12</b> may be in part explained by its higher efficiency in disrupting the intermolecular interactions.</div><div class="NLM_p">In vitro studies evaluating prodrug hydrolysis in intestinal homogenates and liver microsomes showed that <b>12</b> was rapidly metabolized in both the gastrointestinal tract (GIT) and liver, suggesting compound bioactivation to occur prior to reaching the systemic circulation. Interestingly <b>11</b> was also metabolized in GIT but was found to be stable in liver microsomes. With its charged phosphonooxymethyl promoiety, <b>11</b> is likely cleaved by alkaline phosphatases which are known to be highly abundant in liver.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> This is analogous to other phosphate-based prodrugs that have been reported to be stable in liver microsomes but metabolized when incubated with S9 fractions.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Given this, we reanalyzed <b>11</b> using liver tissue homogenate as a more relevant in vitro system. Indeed, when incubated in mouse liver homogenate, <b>11</b> was readily metabolized (65 ± 3% remaining after 1 h; see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf" class="ext-link">Supporting Information Figure S2</a>).</div><div class="NLM_p">Following the in vitro metabolism studies, we conducted iv studies of MBZ-C in both mouse and dog so that the absolute oral bioavailability could be determined for the prodrugs. Given MBZ-C’s poor solubility, we used a cosolvent based formulation (1% DMSO and 10% Cremophor EL) to achieve a dose of 1.5 mg/kg in mice and a dose of 0.3 mg/kg in dog. To our knowledge, this is the first report of iv pharmacokinetics of MBZ-C in preclinical models. By use of these data, the absolute oral bioavailability (% <i>F</i>) of MBZ-C in mice and dog was observed to be 22% and 11%, respectively. These data are in the range for those reported previously from the pilot human studies using intravenous and oral administration of [<sup>3</sup>H]-mebendazole, with an average value of 22% and a variable range of 12–35%.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a></div><div class="NLM_p">In a single time-point mouse pharmacokinetic study, compounds <b>7</b>, <b>11</b>, and <b>12</b> displayed a statistically significant improvement in the exposure of plasma MBZ in comparison to MBZ-C, with <b>12</b> showing the best profile. Notably, as mentioned earlier, these prodrugs, specifically <b>11</b> and <b>12</b>, also exhibited the highest aqueous solubility, confirming MBZ oral absorption is indeed dissolution rate limited. Given this, <b>12</b> was further characterized for full pharmacokinetic time course studies in both mice and dogs. Prodrug <b>12</b> caused a significant improvement in MBZ plasma exposure following oral administration in both mouse and dog (2.2-fold and 3.8 higher plasma AUC<sub>0–<i>t</i></sub>, respectively). No intact prodrug was quantifiable in plasma, suggesting rapid presystemic enzymatic activation, corroborating the in vitro data. Overall, these findings are consistent with other prodrugs containing <i>N</i>-phosphonooxymethyl promoieties that have also shown enhanced solubility and bioavailability.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a></div><div class="NLM_p last">Future efforts will focus on obtaining and characterizing the <i>N</i><sup>1</sup> and <i>N</i><sup>3</sup> positional isomers of <b>12</b> to evaluate any differences in their metabolic rate of MBZ liberation. However, because no intact <b>12</b> was observed in plasma, it is likely that both isomers underwent complete hydrolysis prior to systemic absorption. Given this, the two isomers may not have differential impact on MBZ bioavailability and distribution. Overall our findings show that a prodrug approach can improve the solubility and pharmacokinetic parameters of MBZ, improving MBZ as a therapeutic agent for systemic applications.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Information</h3><div class="NLM_p last">The <sup>1</sup>H NMR spectra were measured at 400.1 or 500.1 MHz and <sup>13</sup>C NMR spectra at 100.8 or 125.7 MHz (as specified in the individual compound characterization) in CDCl<sub>3</sub>, acetone-<i>d</i><sub>6</sub>, DMSO-<i>d</i><sub>6</sub>, or MeOD-<i>d</i><sub>4</sub> as indicated in 5 mm PFG probe (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf" class="ext-link">Supporting Information pages S12–S24</a>). For standardization of <sup>1</sup>H NMR spectra the internal signal of TMS (δ 0.0, CDCl<sub>3</sub>) or residual signals of solvents (δ 7.26 for CDCl<sub>3</sub>, δ 2.05 for CD<sub>3</sub>COCD<sub>3</sub>, δ 2.50 for CD<sub>3</sub>SOCD<sub>3</sub>, and δ 3.31 for CD<sub>3</sub>OD) were used. In the case of <sup>13</sup>C NMR spectra (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf" class="ext-link">Supporting Information pages S25–S36</a>) the residual signals of solvents (δ 77.0 for CDCl<sub>3</sub>, δ 29.8 and δ 206.3 for CD<sub>3</sub>COCD<sub>3</sub>, δ 39.5 for CD<sub>3</sub>SOCD<sub>3</sub>, and δ 49.0 for CD<sub>3</sub>OD) were used. The chemical shifts are given in δ-scale, and the coupling constants <i>J</i> are given in Hz. Low and high resolution CI mass spectra were measured using an orthogonal acceleration time-of-flight (OA-TOF) mass spectrometer (GCT premier, Waters) at an ionizing voltage of 70 eV, and the <i>m</i>/<i>z</i> values are given with their relative intensities (%). The spectra were recorded in positive mode, and the source temperature was 150 °C. Methane was present as a reagent gas in the CI source. For exact measurements, the spectra were internally calibrated using Heptacosa or 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (Metri). The ESI mass spectra were recorded with a ZQ micromass mass spectrometer (Waters) equipped with an ESCi multimode ion source and controlled by MassLynx software. THF was freshly distilled from sodium/benzophenone under nitrogen. The flash chromatography was performed on silica gel 60 (0.040–0.063 mm, Fluka). All chemicals were purchased from Sigma-Aldrich. Dichloromethane was freshly distilled from calcium hydride under nitrogen. YMC-Pack, ODS-AM column 250 mm × 20 mm, 5 μm was used for RP-HPLC purifications. Purity of all final compounds was assessed by RP-HPLC (UV detector, 210 nm) and found to be over 95% unless otherwise noted (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf" class="ext-link">Supporting Information pages S4–S11</a>). MBZ was supplied from TCI Europe.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (5-Benzoyl-2-((methoxycarbonyl)amino)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)methyl Pivalate (<b>1</b>)</h3><div class="NLM_p last">A suspension of MBZ (590 mg, 2.0 mmol, 1 equiv) and <i>t</i>-BuOK (495 mg, 4.4 mmol, 2.2 equiv) in anhydrous DMSO (10 mL) was sonicated until complete dissolution and then the solution was stirred for 15 min at rt. Chloromethyl pivalate (288 μL, 2.0 mmol, 1 equiv) was added, the solution was stirred for 1 h at rt, and the solvent was evaporated (60 °C). The residue was chromatographed on a silica gel column (acetone/hexanes 2:3). The product <b>1</b> was finally crystallized from EtOAc/hexane mixture and gave 410 mg of colorless solid (50% yield, mixture of <i>N</i><sup>1</sup> and <i>N</i><sup>3</sup> isomers). <sup>1</sup>H NMR (500.1 MHz, DMSO<i>-d</i><sub>6</sub>): δ 1.11, 1.13 (2 × s, 9H), 3.67, 3.68 (2 × s, 3H), 6.11 (bs, 2H), 7.53–7.87 (m, 8H), 12.32 (bs, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO<i>-d</i><sub>6</sub>): δ 26.6, 26.6, 38.3, 38.3, 52.0, 64.9 (bs), 109.6, 111.5, 125.1, 125.7, 128.4, 129.3, 129.4, 131.5, 132.0, 132.1, 132.2, 137.6, 137.7, 163.2, 176.7, 176.7, 194.8, 194.9. MS (ESI) <i>m</i>/<i>z</i> (%): 410 (100, [M + H]<sup>+</sup>), 432 (44, [M + Na]<sup>+</sup>), 841 (25, [2M + Na]<sup>+</sup>). HRMS (ESI): [M + H] (C<sub>22</sub>H<sub>24</sub>O<sub>5</sub>N<sub>3</sub>) calcd 410.17105, found 410.17120.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Methyl (5-Benzoyl-1-(((isopropoxycarbonyl)oxy)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)carbamate (<b>2</b>)</h3><div class="NLM_p last">A suspension of MBZ (295 mg, 1.0 mmol, 1 equiv) and <i>t</i>-BuOK (123 mg, 1.1 mmol, 1.1 equiv) in anhydrous DMSO (5 mL) was sonicated until complete dissolution, and then the solution was stirred for 15 min at rt. Chloromethyl isopropyl carbonate (268 μL, 2.0 mmol, 2 equiv) was added, and the resulting solution was stirred for further 1 h at rt. Solvent was evaporated (60 °C), and the residue was chromatographed repeatedly (2×) on a silica gel column (acetone/hexanes 2:3) giving 180 mg of colorless solid (44% yield, mixture of <i>N</i><sup>1</sup> and <i>N</i><sup>3</sup> isomers). <sup>1</sup>H NMR (500.1 MHz, DMSO<i>-d</i><sub>6</sub>): δ 1.20–1.23 (m, 6H), 3.65 and 3.66 (2 × s, 3H), 4.75–4.84 (m, 1H), 6.10 (bs, 2H), 7.53–7.99 (m, 8H), 12.35 and 12.50 (2 × bs, 1H). <sup>13</sup>C NMR (125.7 MHz, DMSO<i>-d</i><sub>6</sub>): δ 21.5, 21.6, 52.3, 67.2, 67.4, 72.7, 72.7, 110.0, 111.4, 111.8, 113.5, 125.5, 126.4, 128.7, 129.7, 129.8, 131.7, 132.2, 132.5, 132.6, 137.7, 137.8, 153.2, 153.3, 154.5 (bs), 162.4 (bs), 195.0, 195.1. MS (ESI) <i>m</i>/<i>z</i> (%): 412 (100, [M + H]<sup>+</sup>), 434 (32, [M + Na]<sup>+</sup>), 845 (27, [2M+Na]<sup>+</sup>). HRMS (ESI): [M + H] (C<sub>21</sub>H<sub>22</sub>O<sub>6</sub>N<sub>3</sub>) calcd 412.15031, found 412.15045.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> (5-Benzoyl-2-((methoxycarbonyl)amino)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)methyl (<i>tert</i>-Butoxycarbonyl)glycinate (<b>3</b>)</h3><div class="NLM_p last">MBZ (832 mg, 2.82 mmol, 1 equiv) and <i>t</i>-BuOK (364 mg, 3.24 mmol, 1.15 equiv) were suspended in anhydrous DMSO (10 mL), and the mixture was sonicated until complete dissolution occurred. Finally, chloromethyl (<i>tert</i>-butoxycarbonyl)glycinate (630 mg, 2.82 mmol, 1 equiv) in DMSO (5 mL) was added. The resulting solution was stirred for 1 h at rt, and the solvent was evaporated (60 °C). The residue was chromatographed on a silica gel column (acetone/hexanes 2:3) giving 570 mg of mixture of desired product (42% yield) contaminated with MBZ. The product was used for the next step without further purification. MS (ESI) <i>m</i>/<i>z</i> (%): 483 (40, [M + H]<sup>+</sup>), 505 (100, [M + Na]<sup>+</sup>). HRMS (ESI): [M + H] (C<sub>24</sub>H<sub>27</sub>O<sub>7</sub>N<sub>4</sub>) calcd 483.18743, found 483.18761; [M + Na] (C<sub>24</sub>H<sub>26</sub>O<sub>7</sub>N<sub>4</sub>Na) calcd 505.16937, found 505.16942.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (5-Benzoyl-2-((methoxycarbonyl)amino)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)methyl <i>tert</i>-Butyl Succinate (<b>4</b>)</h3><div class="NLM_p last">MBZ (2.07 g, 7.00 mmol, 1 equiv) and <i>t</i>-BuOK (903 mg, 8.05 mmol) were suspended in anhydrous DMSO (15 mL), and the suspension was sonicated until complete dissolution of both compounds. The resulting solution was stirred for 15 min at rt. Finally, a solution of <i>tert</i>-butyl (chloromethyl) succinate (1.56 g, 7.0 mmol, 1 equiv) in DMSO (15 mL) was added dropwise, and the mixture was stirred for 1 h at rt. Solvent was evaporated (60 °C). The residue was chromatographed repeatedly (2×) on a silica gel column (acetone/hexanes 2:3) giving 1.20 g (36% yield, mixture of <i>N</i><sup>1</sup> and <i>N</i><sup>3</sup> isomers) of amorphous solid. <sup>1</sup>H NMR (500.1 MHz, CDCl<sub>3</sub>): δ 1.37, 1.39 (2 × s, 9H), 2.52–2.63 (m, 4H), 3.81, 3.82 (2 × s, 3H), 6.13–6.18 (2 × s, 2H), 7.30 (m, 1/2 H), 7.48–7.56 (m, 2 1/2 H), 7.61 (m, 1H), 7.72–7.81 (m, 3 1/2 H), 7.97 (d, 1/2 H, <i>J</i> = 1.6), 11.29, 11.41 (2 × bs, 1H). <sup>13</sup>C NMR (125.7 MHz, CDCl<sub>3</sub>): δ 27.9, 28.0, 28.9, 29.0, 29.9, 52.9, 52.9, 63.6, 63.8, 80.9, 80.9, 109.7, 109.9, 112.2, 112.3, 126.5, 126.8, 128.3, 129.9, 130.0, 132.4, 133.0, 133.3, 137.5, 137.6, 155.8, 164.3, 171.0–172.1 (m), 195.2, 195.4. MS (ESI) <i>m</i>/<i>z</i> (%): 482 (58, [M + H]<sup>+</sup>), 504 (100, [M + Na]<sup>+</sup>). HRMS (ESI): [M + H] (C<sub>25</sub>H<sub>28</sub>O<sub>7</sub>N<sub>3</sub>) calcd 482.19218, found 482.19222; [M + Na] (C<sub>25</sub>H<sub>27</sub>O<sub>7</sub>N<sub>3</sub>Na) calcd 504.17412, found 504.17413.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chloromethyl (((2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>,6<i>R</i>)-3,4,5,6-Tetrakis((trimethylsilyl)oxy)tetrahydro-2<i>H</i>-pyran-2-yl)methyl)carbonate (<b>5a</b>)</h3><div class="NLM_p last">A solution of 1,2,3,4-tetra-OTMS-<span class="smallcaps smallerCapital">d</span>-glucose (1.41 g, 3.0 mmol, 1 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was cooled to 0 °C, pyridine (290 μL, 3.6 mmol, 1.2 equiv) was added, and finally chloromethyl chloroformate (293 μL, 3.3 mmol, 1.1 equiv) was added dropwise during 5 min. The resulting mixture was stirred for 1.5 h at rt, then quenched by addition of 5% aq NH<sub>4</sub>Cl (20 mL). Aqueous phase was extracted with further CH<sub>2</sub>Cl<sub>2</sub> (15 mL), and combined organic phases were dried over MgSO<sub>4</sub> and concentrated. The crude product was obtained as syrup (1.64 g), and it was used to the following step without further purification. <sup>1</sup>H NMR (500.1 MHz, CDCl<sub>3</sub>): δ 0.13 (s, 9H), 0.14 (2 × s, 18H), 0.16 (s, 9H), 3.37 (dd, 1H, <i>J</i> = 9.0, 3.0), 3.46 (dd, 1H, <i>J</i> = 9.8, 8.6), 3.78 (t, 1H, <i>J</i> = 8.9), 3.90–3.95 (m, 1H), 4.28 (dd, 1H, <i>J</i> = 11.4, 4.5), 4.42 (dd, 1H, <i>J</i> = 11.4, 2.3), 5.03 (d, 1H, <i>J</i> = 3.0), 5.72 (d, 1H, <i>J</i> = 6.3), 5.79 (d, 1H, 6.3). <sup>13</sup>C NMR (125.7 MHz, CDCl<sub>3</sub>): δ 0.3, 0.6, 1.0, 1.4, 68.1, 69.8, 72.0, 72.3, 73.8, 73.9, 94.1, 153.5. MS (ESI) <i>m</i>/<i>z</i> (%): 583 (100, [M + Na]<sup>+</sup>), 585 (57, [M + Na]<sup>+</sup>). HRMS (ESI): [M + Na] (C<sub>20</sub>H<sub>45</sub>O<sub>8</sub>ClNaSi<sub>4</sub>) calcd 583.17722, found 583.17738.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Methyl (5-Benzoyl-1-((((((2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>,6<i>R</i>)-3,4,5,6-tetrakis((trimethylsilyl)oxy)tetrahydro-2<i>H</i>-pyran-2-yl)methoxy)carbonyl)oxy)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)carbamate (<b>5</b>)</h3><div class="NLM_p last">MBZ (703 mg, 2.38 mmol, 1 equiv) and <i>t</i>-BuOK (294 mg, 2.62 mmol, 1.1 equiv) were suspended in anhydrous DMSO (5 mL), and the mixture was sonicated until complete dissolution, and then the solution was stirred for 15 min at rt. Then, a solution of chloromethyl (((2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>,6<i>R</i>)-3,4,5,6-tetrakis((trimethylsilyl)oxy)tetrahydro-2<i>H</i>-pyran-2-yl)methyl) carbonate (1.67 g, 2.97 mmol, 1.25 equiv) in DMSO (5 mL) was slowly added and the resulting solution was stirred for 1 h at rt. Solvent was evaporated (60 °C), and chromatography of the residue on a silica gel column (acetone/hexanes 1:9 to 3:7) furnished 495 mg of the desired compound (25% yield, <i>N</i><sup>1</sup> predominate positional isomer). <sup>1</sup>H NMR (500.1 MHz, CDCl<sub>3</sub>): δ 0.13–0.19 (4 × s, 36 H), 3.45 (dd, <i>J</i> = 9.2, 3.0, 1H), 3.62 (t, <i>J</i> = 9.1 Hz, 1H), 3.79–3.84 (m, 4H), 3.95–4.00 (m, 1H), 4.26 (dd, <i>J</i> = 11.7, 4.5, 1H), 4.30–4.36 (m, 1H), 5.05 (d, <i>J</i> = 3.0, 1H), 6.11–6.23 (m, 2H), 7.47–7.54 (m, 2H), 7.58–7.64 (m, 1H), 7.68–7.81 (m, 4H), 7.94–7.96 (m, 1H). <sup>13</sup>C NMR (125.7 MHz, CDCl<sub>3</sub>): δ 0.3, 0.6, 1.1, 1.4, 55.6, 65.2, 67.2, 70.2, 72.3, 74.0, 74.1, 94.1, 109.7, 112.1, 126.6, 127.2, 128.5, 130.1, 132.6, 133.1, 133.5, 137.8, 154.9, 155.2, 195.5. MS (ESI) <i>m</i>/<i>z</i> (%): 820 (38, [M + H]<sup>+</sup>), 842 (100, [M + Na]<sup>+</sup>). HRMS (ESI): [M + H] (C<sub>36</sub>H<sub>58</sub>O<sub>11</sub>N<sub>3</sub>Si<sub>4</sub>) calcd 820.31429, found 820.31470; [M + Na] (C<sub>36</sub>H<sub>57</sub>O<sub>11</sub>N<sub>3</sub>NaSi<sub>4</sub>) calcd 842.29624, found 842.29653.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (5-Benzoyl-2-((methoxycarbonyl)amino)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)methyl (<i>tert</i>-Butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-leucylglycinate (<b>6</b>)</h3><div class="NLM_p last">The crude compound <b>3</b> (907 mg, ≤1.88 mmol, 1 equiv) was treated with 2 M HCl in dioxane (10 mL) at 0 °C, and the solution was stirred for 1 h, solvent was evaporated, and residue was codistilled with toluene (10 mL). The residue was dissolved in DMF (10 mL), and the solution was used immediately in subsequent reaction with Boc-<span class="smallcaps smallerCapital">l</span>-Leu-OH. In the meantime, a mixture of Boc-<span class="smallcaps smallerCapital">l</span>-Leu-OH·H<sub>2</sub>O (469 mg, 1.88 mmol, 1 equiv), HOBt (270 mg, 2.06 mmol, 1.1 equiv), and EDC·HCl (383 mg, 2.06 mmol, 1.1 equiv) in DMF (2 mL) was treated with DIPEA (675 μL, 3.88 mmol, 2.1 equiv) at 0 °C. The mixture was stirred for 10 min at 0 °C and then a freshly prepared DMF solution of intermediate (5-benzoyl-2-((methoxycarbonyl)amino)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)methyl glycinate hydrochloride was added. The mixture was stirred at rt overnight, the solvent was evaporated, and the residue was suspended in EtOAc (20 mL) using ultrasound. Crystals of MBZ were filtered off and the crude product was chromatographed on a silica gel column (MeOH/CHCl<sub>3</sub> 3:97). Yield 660 mg of syrup (59% yield, <i>N</i><sup>1</sup> predominate positional isomer). <sup>1</sup>H NMR (500.1 MHz, CDCl<sub>3</sub>): δ 0.96 (m, 6H), 1.45 (s, 9H), 1.51–1.79 (m, 3H), 3.81 (s, 3H), 4.02–4.08 (m, 2H), 4.32 (m, 1H), 4.95 (bs, 1H), 6.17 (s, 2H), 6.83 (bs, 1H), 7.35 (d, 1H, <i>J</i> = 8.3), 7.51 (m, 2H), 7.62 (m, 1H), 7.72 (m, 1H), 7.80 (m, 2H), 7.95 (d, 1H, <i>J</i> = 1.5). <sup>13</sup>C NMR (125.7 MHz, CD<sub>3</sub>OD): δ 21.8, 22.9, 24.7, 28.3, 41.0, 41.6, 52.0, 53.0, 64.5, 79.9, 110.5, 111.8, 127.1, 128.4, 128.9, 130.0, 132.5, 133.0, 137.5, 155.2, 155.6, 155.8, 163.6, 169.1, 176.6, 195.3. MS (ESI) <i>m</i>/<i>z</i> (%): 596 (28, [M + H]<sup>+</sup>), 618 [M + Na]<sup>+</sup>. HRMS (ESI): [M + H] (C<sub>30</sub>H<sub>38</sub>O<sub>8</sub>N<sub>5</sub>) calcd 596.27149, found 596.27153; [M + Na] (C<sub>24</sub>H<sub>37</sub>O<sub>8</sub>N<sub>5</sub>Na) calcd 618.25343, found 618.25349.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (5-Benzoyl-2-((methoxycarbonyl)amino)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)methyl Acetyl-<span class="smallcaps smallerCapital">l</span>-leucylglycinate (<b>7</b>)</h3><div class="NLM_p last">The crude compound <b>6</b> (623 mg, 1.05 mmol, 1 equiv) was treated with 2 M HCl in dioxane (10 mL) at 0 °C and the solution was stirred for 1 h at rt, then solvent was evaporated and the residue was codistilled with toluene (10 mL). The Boc-deprotected intermediate was dissolved in DMF (10 mL), and the solution was used immediately in subsequent reaction with AcOH. In the meantime a mixture of AcOH (54 μL, 1.05 mmol, 1 equiv), HOBt (149 mg, 1.10 mmol, 1.05 equiv), and EDC·HCl (211 mg, 1.10 mmol, 1.05 equiv) in DMF (1 mL) was treated with diisopropylethylamine (374 μL, 2.15 mmol, 2.05 equiv) at 0 °C. The mixture was stirred for 10 min at 0 °C and then a freshly prepared DMF solution of (5-benzoyl-2-((methoxycarbonyl)amino)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)methyl <span class="smallcaps smallerCapital">l</span>-leucylglycinate hydrochloride was added. The mixture was stirred at rt overnight, solvent was evaporated, and the residue was suspended in EtOAc (20 mL) using sonication. Crystals of MBZ were filtered off and the crude product was chromatographed on a silica gel column MeOH/EtOAc (3:97 to 1:19); subsequent purification on 50 g C18 Aq column (from 20% to 75% ACN/H<sub>2</sub>O) gave 62 mg (11% yield, <i>N</i><sup>1</sup> predominant positional isomer). <sup>1</sup>H NMR (500.1 MHz, CDCl<sub>3</sub>): δ 0.87 (d, 3H, <i>J</i> = 6.1), 0.89 (d, 3H, <i>J</i> = 6.3), 1.43–1.66 (m, 3H), 1.99 (s, 3H), 3.79 (s, 3H), 3.95 (dd, 1H, <i>J</i> = 18.2, 5.3), 4.06 (dd, 1H, <i>J</i> = 18.2, 5.9), 4.53 (m, 1H), 6.12–6.17 (m, 2H), 6.53 (m, 1H), 7.11 (bs, 1H), 7.31 (d, 1H, <i>J</i> = 8.2), 7.50 (m, 2H), 7.61 (m, 1H), 7.67 (dd, 1H, <i>J</i> = 8.3, 1.4), 7.78 (m, 2H), 7.95 (d, 1H, <i>J</i> = 1.5). <sup>13</sup>C NMR (125.7 MHz, CDCl<sub>3</sub>): δ 22.0, 22.8, 23.0, 24.6, 40.1, 41.2, 51.1, 52.9. 64.3, 109.5, 111.9, 127.1, 128.4, 128.9, 130.0, 132.5, 132.9, 137.4, 155.4, 163.8, 169.1, 170.8, 172.7, 195.5. MS (ESI) <i>m</i>/<i>z</i> (%): 538 (38, [M + H]<sup>+</sup>), 560 [M + Na]<sup>+</sup>. HRMS (ESI): [M + Na] (C<sub>27</sub>H<sub>31</sub>O<sub>7</sub>N<sub>5</sub>Na) calcd 560.21157, found 560.21161.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-((5-Benzoyl-2-((methoxycarbonyl)amino)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)methoxy)-4-oxobutanoic Acid (<b>8</b>)</h3><div class="NLM_p last">A suspension of compound <b>4</b> (1.15 g, 2.39 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was cooled to 0 °C and then treated with TFA (10 mL). The resulting solution was stirred for 3.5 h at rt. The volatiles were distilled off, and the residue was codistilled with toluene (30 mL). The product and MBZ as a major contaminant were separated by repeated RP flash chromatography (C18 Aqua column, 50 g, H<sub>2</sub>O to 80% ACN/H<sub>2</sub>O, 20 min). Yield 375 mg (37% yield, <i>N</i><sup>1</sup> predominant positional isomer, 3:1 mixture) of solid compound. <sup>1</sup>H NMR (500.1 MHz, CD<sub>3</sub>COCD<sub>3</sub>): δ 4.61–4.69 (m, 4H), 3.68 (s, 3H), 6.21 (s, 2H), 7.54–7.60 (m, 2H), 7.63–7.69 (m, 2H), 7.71–7.76 (m, 1H), 7.78–7.84 (m, 2H), 7.97 (dd, 1H, <i>J</i> = 1.6, 0.6). <sup>13</sup>C NMR (125.7 MHz, DMSO<i>-d</i><sub>6</sub>): δ 28.5 (bs), 52.1, 64.6, 109.8, 113.3, 125.4, 128.5, 129.5, 129.7, 131.3, 131.9, 132.4, 137.6, 154.3, 162.4, 171.8, 173.3, 195.0. MS (ESI) <i>m</i>/<i>z</i> (%): 424 (4, [M – H]<sup>+</sup>), 849 (6, [2M – H]). HRMS (ESI): [M – H] (C<sub>21</sub>H<sub>18</sub>O<sub>7</sub>N<sub>3</sub>) calcd 424.11502, found 424.11471.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Methyl (5-Benzoyl-1-((((((2<i>R</i>,3<i>S</i>,4<i>S</i>,5<i>R</i>)-3,4,5,6-tetrahydroxytetrahydro-2<i>H</i>-pyran-2-yl)methoxy)carbonyl)oxy)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)carbamate (<b>9</b>)</h3><div class="NLM_p last">A solution of compound <b>5</b> (470 mg, 0.57 mmol, 1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was cooled to 0 °C, and TFA (3 mL) was slowly added. The solution was stirred for 2 h at rt, the volatiles were then evaporated, and the residue was codistilled with toluene (15 mL). The crude product was purified by RP flash chromatography (C18 Aqua column, 50 g, H<sub>2</sub>O → MeOH, 20 min) yield 188 mg. Recrystallization from EtOH/Et<sub>2</sub>O afforded 122 mg of colorless solid (40% yield, mixture of <i>N</i><sup>1</sup> and <i>N</i><sup>3</sup> isomers). <sup>1</sup>H NMR (500.1 MHz, MeOD-<i>d</i><sub>4</sub>): δ 3.14–3.20 (m, 1/2 H), 3.35–3.42 (m, 2H), 3.53–3.58 (m, 1/2 H), 3.71 (t, <i>J</i> = 9.3, 1/2 H), 3.79, 3.80 (2 × s, 3H), 4.00–4.07 (m, 1/2 H), 4.27–4.48 (m, 11/2 H), 4.51 (dd, <i>J</i> = 7.8, 1.9, 1H), 5.11 (d, <i>J</i> = 3.7, 1/2 H), 6.16, 6.18 (2 × bs, 2H), 7.51–7.57 (m, 21/2 H), 7.61–7.68 (m, 11/2 H), 7.69–7.86 (m, 31/2 H). <sup>13</sup>C NMR (125.7 MHz, DMSO-<i>d</i><sub>6</sub>) δ 55.2, 55.2, 64.9, 65.1, 67.4, 67.6, 69.4, 70.4, 72.3, 73.0, 73.8, 74.7, 76.6, 76.8, 92.3, 96.9, 109.9, 111.2, 111.7, 113.3, 125.4, 126.3, 128.5, 128.5, 129.5, 129.7, 131.5, 132.0, 132.4, 132.5, 137.5, 137.6, 154.2, 154.3, 154.3 (bs), 162.0 (bs), 194.9, 195.0. MS (ESI) <i>m</i>/<i>z</i> (%): 532 (5, [M + H]<sup>+</sup>), 554 (100, [M + Na]<sup>+</sup>), 1085 (6, [2M+Na]<sup>+</sup>). HRMS (ESI): [M + Na] (C<sub>24</sub>H<sub>25</sub>O<sub>11</sub>N<sub>3</sub>Na) calcd 554.13813, found 554.13830.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Methyl (5-Benzoyl-1-(((di-<i>tert</i>-butoxyphosphoryl)oxy)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)carbamate (<b>10</b>)</h3><div class="NLM_p last">MBZ (2.00 g, 6.64 mmol, 1 equiv) and NaH (796 mg, 19.9 mmol, 3 equiv) were placed in a Schlenk flask under inert atmosphere with argon. DMF (40 mL) was slowly added while stirring. The mixture was stirred at rt for 1 h, resulting in homogeneous yellow mixture. Di-<i>tert</i>-butyl (chloromethyl) phosphate<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> (2.06 g, 7.96 mmol, 1.2 equiv) in DMF (10 mL) was added dropwise over 2 min and the mixture was stirred overnight (16 h). Saturated aq NaHCO<sub>3</sub> solution (100 mL) was added, and the reaction mixture was extracted with EtOAc (4 × 180 mL), dried over MgSO<sub>4</sub>, filtered, and volatiles were evaporated. The residue was used without further purification to the following step.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Methyl (5-Benzoyl-1-((phosphonooxy)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)carbamate (<b>11</b>)</h3><div class="NLM_p last">The crude compound <b>10</b> was placed in a Schlenk flask under inert atmosphere in argon. DCM (25 mL) was added followed by dropwise addition of TFA (10 mL). The mixture was stirred at rt overnight (16 h). Volatiles were removed on rotavap and residue was purified on reverse phase C18 column (100 g, eluent H<sub>2</sub>O + 0.1% TFA to 70% MeCN, 20 min) to obtain 562 mg (21% yield, 1.39 mmol) of colorless solid after lyophilization. <sup>1</sup>H NMR (400.1 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.67 (s), 3.68 (s, 3H), 5.85 (s), 5.87 (s, 2H), 7.54–7.71 (m, 5H), 7.72–7.78 (m, 2H), 7.85–7.97 (m, 1H). <sup>13</sup>C NMR (100.8 MHz, DMSO-<i>d</i><sub>6</sub>): δ 52.2, 52.2, 66.3, 66.4, 109.9, 111.6, 111.9, 114.0, 125.2, 126.1, 128.5, 128.5, 129.3, 129.3, 129.5, 129.7, 131.4, 131.9, 132.4, 132.4, 132.6, 132.7, 137.4, 137.6, 153.2, 153.2, 161.1, 161.2, 194.9, 195.0. MS (ESI) <i>m</i>/<i>z</i> (%): 406 (100, [M + H]<sup>+</sup>). HRMS (ESI): [M + H] (C<sub>17</sub>H<sub>17</sub>O<sub>7</sub>N<sub>3</sub>P) calcd 406.07986, found 406.07991.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Methyl (5-Benzoyl-1-(((hydroxy(((isopropoxycarbonyl)oxy)methoxy)phosphoryl)oxy)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)carbamate, Sodium Salt (<b>12</b>)</h3><div class="NLM_p last">To a solution of compound <b>11</b> (600 mg, 1.48 mmol, 1 equiv) and <i>N</i>,<i>N</i>′-dicyclohexyl-4-morpholinecarboxamidine (1.74 g, 5.92 mmol, 4 equiv) in anhydrous DMF (25 mL) chloromethyl isopropyl carbonate (1.3 mL, 8.88 mmol, 6 equiv) was added. The mixture was stirred for 24 h at rt. Solvent was evaporated and the residue was purified by RP flash chromatography (C18 Aqua column, 100 g, H<sub>2</sub>O to 70% MeCN/H<sub>2</sub>O, 20 min) to yield 536 mg of <i>N</i>,<i>N</i>′-dicyclohexyl-4-morpholinecarboxamidine salt. The salt was put on a DOWEX 50X8 (Na<sup>+</sup>) column, and the product was eluted with 10% aq methanol. UV absorbing fractions were concentrated, and the product was precipitated by means of addition of several drops of EtOH, sonication, and addition of excess of EtOAc. Yield 340 mg (42%, mixture of <i>N</i><sup>1</sup> and <i>N</i><sup>3</sup> isomers). <sup>1</sup>H NMR (500.1 MHz, CD<sub>3</sub>OD): δ 1.20, 1.24 (2 × d, 6H, <i>J</i> = 6.3), 3.78, 3.84 (2 × bs, 3H), 4.72–4.83 (m, 1H), 5.42–5.49 (m, 2H), 5.88–5.94 (m, 2H), 7.53–7.56 (m, 2H), 7.62–7.67 (m, 1H), 7.77–7.82 (m, 2H), 7.47–8.08 (m, 3H). <sup>13</sup>C NMR (125.7 MHz, CD<sub>3</sub>OD): δ 21.9, 21.9, 53.5, 67.9, 68.8, 73.6, 86.8, 111.3, 113.6, 129.5, 129.5, 130.9, 131.1, 133.5, 133.9, 139.6, 154.9, 155.0, 197.8, 198.9. MS (ESI) <i>m</i>/<i>z</i> (%): 520 (72, [M-H]<sup>−</sup>). HRMS (ESI): [M – H] (C<sub>22</sub>H<sub>23</sub>O<sub>10</sub>N<sub>3</sub>P) calcd 520.11265, found 520.11230.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-(<i>tert</i>-Butyl) 5-(Chloromethyl) (<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-glutamate<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></h3><div class="NLM_p last">(<i>S</i>)-5-(<i>tert</i>-Butoxy)-4-((<i>tert</i>-butoxycarbonyl)amino)-5-oxopentanoic acid (2.00 g, 6.46 mmol, 1 equiv) was placed in a round-bottom flask, and water (80 mL) was added followed by Bu<sub>4</sub>NHSO<sub>4</sub> (448 mg, 1.29 mmol, 0.2 equiv) and portionwise addition of NaHCO<sub>3</sub> (2.19 g, 25.8 mmol, 4 equiv). The mixture was stirred for 15 min at rt, cooled to 0 °C, and dichloromethane (80 mL) was added followed by dropwise (5 min) addition of chloromethyl chlorosulfate (989 μL, 9.69 mmol, 1.5 equiv). The mixture was warmed to rt and stirred overnight (16 h). The layers were separated, the aqueous one was washed once with dichloromethane (80 mL), and combined organic layers were dried with MgSO<sub>4</sub>, filtered, and after volatiles removal the oily residue was purified by column chromatography on silica (hexanes/EtOAc 7:3) affording 2.07 g (91%, 5.88 mmol) of yellowish oil. <sup>1</sup>H NMR (400.1 MHz, CDCl<sub>3</sub>): δ 1.43 (s, 9H), 1.46 (s, 9H), 1.86–1.98 (m, 1H), 2.11–2.25 (m, 1H), 2.37–2.56 (m, 2H), 3.96–4.35 (m, 1H), 4.71–5.25 (m, 1H), 5.65–5.73 (m, 2H). <sup>13</sup>C NMR (100.8 MHz, CDCl<sub>3</sub>): δ 27.9, 28.1, 28.4, 30.3, 53.3, 68.8, 80.0, 82.6, 155.5, 171.1, 171.2. MS (ESI) <i>m</i>/<i>z</i> (%): 374 (100, [M + Na]<sup>+</sup>); HRMS (ESI): [M + Na] (C<sub>15</sub>H<sub>26</sub>O<sub>6</sub>NClNa) calcd 374.13409, found 374.13419.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 5-((5-Benzoyl-2-((methoxycarbonyl)amino)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)methyl) 1-(<i>tert</i>-Butyl)(<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-glutamate (<b>13</b>)</h3><div class="NLM_p last">MBZ (1.00 g, 3.32 mmol, 1 equiv) and NaH (146 mg, 3.65 mmol, 1.1 equiv) were placed in a Schlenk flask under an argon atmosphere. The flask was cooled to 0 °C, and DMF (30 mL) was added while stirring. The mixture was stirred for 1 h at rt, resulting in homogeneous yellow mixture. 1-(<i>tert</i>-Butyl) 5-(chloromethyl) (<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-glutamate, synthesis shown above (1.40 g, 3.98 mmol, 1.2 equiv), in DMF (10 mL) was added dropwise over 2 min. The resulting mixture was allowed to warm up to rt and stirred overnight (16 h). After DMF removal, water (100 mL) was added and the mixture was extracted with EtOAc (3 × 150 mL) and combined organic layers were dried with MgSO<sub>4</sub>, filtered, and volatiles were removed using rotary evaporation. The resulting mixture was sonicated in CHCl<sub>3</sub> (10 mL), and crystals were filtered off and washed with additional CHCl<sub>3</sub> (10 mL). Solvent was evaporated and the residue was purified on HPLC giving 648 mg (32% yield, 1.06 mmol) of a white solid. <sup>1</sup>H NMR (400.1 MHz, CDCl<sub>3</sub>): δ 1.37, 1.39 (s, 9H), 1.43, 1.44 (s, 9H), 1.74–2.01 (m, 1H), 2.06–2.23 (m, 1H), 2.35–2.54 (m, 2H), 3.83, 3.83 (s, 3H), 3.97–4.26 (m, 1H), 6.17 (d, <i>J</i> = 4.9, 1H), 6.21 (s, 1H), 7.41–7.65 (m, 4H), 7.73–8.03 (m, 4H). <sup>13</sup>C NMR (100.8 MHz, CDCl<sub>3</sub>): δ 28.0, 28.0, 28.1, 28.1, 28.4, 28.4, 29.9, 29.9, 53.1, 53.1, 53.3, 53.4, 64.2, 64.4, 80.0, 80.1, 82.6, 82.6, 110.0, 111.2, 112.5, 113.5, 126.8, 127.2, 128.5, 128.5, 129.0, 129.3, 130.0, 130.2, 132.3, 132.5, 132.7, 132.7, 133.4, 133.8, 137.6, 137.6, 154.3, 154.6, 162.3, 162.3, 162.8, 162.8, 171.3, 171.3, 172.2, 172.4, 195.4, 195.5. MS (ESI) <i>m</i>/<i>z</i> (%): 633 (100, [M + Na]<sup>+</sup>). HRMS (ESI): [M + Na] (C<sub>31</sub>H<sub>38</sub>O<sub>9</sub>N<sub>4</sub>Na) calcd 633.25310, found 633.25321.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>S</i>)-2-Amino-5-((5-benzoyl-2-((methoxycarbonyl)amino)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)methoxy)-5-oxopentanoic Acid (<b>14</b>)</h3><div class="NLM_p last">Compound <b>13</b> (106 mg, 0.17 mmol, 1 equiv) was placed in a Schlenk flask and put under an argon atmosphere. Dichloromethane (5 mL) was added followed by dropwise addition of trifluoroacetic acid (1 mL). The mixture was stirred at rt overnight (16 h). Volatiles were removed on rotavap, and trifluoroacetic acid residue was removed by codistillation with toluene (3 × 5 mL). The residual MBZ trifluoroacetate, which is soluble in CHCl<sub>3</sub>, was removed by sonicating the mixture in CHCl<sub>3</sub> (2 × 5 mL), centrifugation and supernatant removal. Acetonitrile (1 mL) and Et<sub>2</sub>O (2 mL) were then added, and the mixture was sonicated shortly causing a precipitate formation. After centrifugation, supernatant removal, and final washing with CHCl<sub>3</sub> (5 mL) a white solid was obtained. The HPLC purity was 94% (50 mg, 0.09 mmol, 51% yield). The NMR spectra could not be obtained due to instability of the product in solution. MS (ESI) <i>m</i>/<i>z</i> (%): 455 (100, [M + H]<sup>+</sup>). HRMS (ESI): [M + H] (C<sub>22</sub>H<sub>23</sub>O<sub>7</sub>N<sub>4</sub>) calcd 455.15613, found 455.15623.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Solubility and Stability Assessment</h3><div class="NLM_p">The aqueous solubility was determined as previously reported using the shake-flask procedure published by Zhou et al.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The compound was added to PBS buffer (0.01 M) and shaken for 24 h at 37 °C to ensure saturation. After 24 h, the solution was centrifuged (10 621<i>g</i> for 2 min, rt), filtered (0.45 μm PTFE) and the filtrate was diluted appropriately and the concentration of compound was determined using LC–MS/MS.</div><div class="NLM_p last">Prodrug chemical stability was measured by the addition of 1 μL of 10 mM DMSO stock solution to 1 mL of preheated (37 °C) 0.01 M PBS, resulting in a final concentration of 10 μM. The mixture was vortex-mixed for 30 s and then incubated at 37 °C. At specified time points 100 μL of the mixture was removed and extracted with 300 μL of cold acetonitrile (0 °C) with internal standard (losartan, 0.5 μM, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf" class="ext-link">Supporting Information page S38</a>). This mixture was further diluted with 400 μL of water, and the resulting solution was analyzed by LC–MS/MS.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> In Vitro Stability Assessment</h3><div class="NLM_p last">In vitro stability studies were done using mouse jejunum homogenate, mouse liver microsomes (purchased from Corning Gentest, USA), or naive mouse plasma. For mouse jejunum homogenate stability study, washed mouse jejunum was diluted 10-fold in 0.1 M potassium phosphate buffer and homogenized using probe sonication. Crude homogenate was then aliquoted to 1 mL, and the homogenate was spiked with 10 μM compound. Liver stability assay was performed in 100 mM potassium phosphate buffer, pH 7.4, and reactions were initiated by addition of the liver microsomes to the incubation mixture (compound final concentration was 10 μM; 0.5 mg/mL microsomes). The plasma stability of the prodrugs was determined by spiking (10 μM) of prodrugs in 1 mL of plasma and incubating in an orbital shaker at 37 °C. All the stability studies were conducted at predetermined times (0 and 60 min), where 100 μL aliquots of the mixture in triplicate were removed and the reaction was quenched by addition of 3 times the volume of ice cold acetonitrile spiked with the internal standard (losartan: 0.5 μM). The samples were vortex-mixed for 30 s and centrifuged at 10 000<i>g</i> for 10 min at 4 °C. An amount of 50 μL of the supernatant was diluted with 50 μL of water and transferred to a 250 μL polypropylene vial sealed with a Teflon cap. Prodrug disappearance was monitored over time using liquid chromatography and tandem mass spectrometry (LC–MS/MS).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Bioanalysis of Prodrugs</h3><div class="NLM_p last">Briefly, prodrugs were analyzed on a Thermo Scientific Accela UPLC system coupled to Accela open autosampler at ambient temperature with an Agilent Eclipse Plus column (100 mm × 2.1 mm i.d.) packed with a 1.8 μm C18 stationary phase. The autosampler was temperature controlled and operated at 10 °C. The mobile phase used for the chromatographic separation was composed of acetonitrile/water containing 0.1% formic acid and with a flow rate of 0.4 mL/min for 4.5 min using gradient elution. The column effluent was monitored using TSQ Vantage triple-quadrupole mass-spectrometric detector, equipped with an electrospray probe set in the positive ionization mode. Samples were introduced into the ionization source through a heated nebulized probe (350 °C). Disappearance of prodrugs was measured from ratio of peak areas of analyte to IS. Intact prodrug mass transitions can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf" class="ext-link">Table S1 (see Supporting Information page S37)</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Pharmacokinetic Studies in Mice</h3><div class="NLM_p last">All pharmacokinetic studies in mice were conducted according to protocols approved by the Animal Care and Use Committee at Johns Hopkins University. Male CD-1 mice between 25 and 30 g were obtained from Harlan and maintained on a 12 h light–dark cycle with ad libitum access to food and water. For po administration, prodrugs or MBZ-C was prepared immediately prior to dosing in 5% ethanol, 5% polysorbate 80, 90% water and administered to male mice as a single po dose by oral gavage of 30 mg/kg MBZ equivalent. For iv administration, MBZ-C was dissolved immediately prior to dosing in 1% DMSO, 10% Cremophor EL, 89% saline and was administered to mice as a single iv dose of 1.5 mg/kg. The mice were sacrificed at specified time points postdrug administration. For collection of plasma and brain tissue, animals were euthanized with CO<sub>2</sub>, and blood samples were collected in heparinized microtubes by cardiac puncture. Tissues were dissected and immediately flash frozen (−80 °C). Blood samples were spun at 2000<i>g</i> for 15 min, and plasma was removed and stored at −80 °C until LC-MS analysis. Prior to extraction, frozen samples were thawed on ice. The calibration curves were developed using plasma and brain from naive animals as a matrix. Plasma samples (50 μL), were processed using a single liquid extraction method by addition of 300 μL of acetonitrile as with internal standard (losartan: 0.5 μM), followed by vortex mixing for 30 s and then centrifugation at 10 000<i>g</i> for 10 min at 4 °C. For brain tissue, homogenized samples were vortex-mixed and centrifuged as above. A 10 μL aliquot of supernatant was diluted with 35 μL of acetonitrile and mixed with 50 μL of water containing 0.5 μM losartan as internal standard. Extracts were centrifuged at 10 000<i>g</i> for 10 min at 4 °C. Supernatants were transferred to 250 μL polypropylene autosampler vials sealed with a Teflon cap. A volume of 3 μL was injected onto the ultraperformance liquid chromatography (UPLC) instrument for quantitative analysis by LC–MS/MS.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Pharmacokinetics Studies in Beagle Dogs</h3><div class="NLM_p last">The dog pharmacokinetic study was conducted in accordance with the guidelines recommended in Guide for the Care and Use of Laboratory Animals and was approved by the Absorption Systems (San Diego, CA) Institutional Animal Care and Use Committee. MBZ-C and <b>12</b> were administered to male beagle dogs (<i>n</i> = 2 per group) as a single po dose of 2.5 mg/kg equivalent (5.4 mg/kg for <b>12</b>). Additionally, MBZ-C was administered to male beagle dogs (<i>n</i> = 2) as a single iv dose at 0.3 mg/kg. Blood samples were collected from the jugular vein (∼1 mL) via direct vein puncture at specified time points, placed into sodium heparin tubes, and maintained on wet ice until processing. Blood samples were centrifuged at 3000<i>g</i> for 5 min at 4 °C. Plasma samples were collected in tubes and stored at −80 °C until bioanalysis.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Bioanalysis of MBZ</h3><div class="NLM_p">Calibration curves over the range 0.001–50 nmol/g [MBZ] in plasma and brain were constructed from the peak area ratio of the analyte to the internal standard using linear regression with a weighting factor of 1/(nominal concentration). Correlation coefficient of greater than 0.99 was considered to be acceptable in the analytical runs for all analytes.</div><div class="NLM_p last">Briefly, chromatographic analysis was performed using an Accela ultrahigh performance system consisting of an analytical pump, and an autosampler coupled with TSQ Vantage mass spectrometer (Thermo Fisher Scientific Inc., Waltham, MA). Separation of the analyte was achieved using Agilent Eclipse Plus column (100 mm × 2.1 mm i.d.) packed with a 1.8 μm C18 stationary phase. The mobile phase consisted of 0.1% formic acid in acetonitrile and 0.1% formic acid in water with gradient elution, starting with 10% (acetonitrile) linearly increasing to 99% up to 2.5 min, maintaining at 99% (2.5–3.5 min) and re-equilibrating to 10% by 4.5 min. The [M + H]<sup>+</sup> ion transition of MBZ (<i>m</i>/<i>z</i> 295.966 → 264.096) and losartan (IS) (<i>m</i>/<i>z</i> 423.200 → 207.107, 180.880).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Pharmacokinetic Analysis of MBZ</h3><div class="NLM_p last">The pharmacokinetic parameters of MBZ were calculated using noncompartmental method as implemented in the computer software program Phoenix WinNonlin version 6.4 (Certara USA, Inc., Princeton, NJ). The maximum plasma concentration (<i>C</i><sub>max</sub>) and time to <i>C</i><sub>max</sub> (<i>T</i><sub>max</sub>) were the observed values. The area under the plasma concentration time curve (AUC) value was calculated to the last quantifiable sample (AUC<sub>last</sub>) by use of the log–linear trapezoidal rule. The brain to plasma partition coefficients were calculated as a ratio of mean AUCs (AUC<sub>0–<i>t</i>,brain</sub>/AUC<sub>0–<i>t</i>,plasma</sub>).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Statistical Analysis</h3><div class="NLM_p last">For single time point study where mice were dosed with either MBZ-C or other prodrugs, MBZ plasma concentrations were statistically compared by one-way ANOVA with Dunnett’s post hoc test. The a priori level of significance for all analyses was defined as <i>p</i> < 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01792" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01792" class="ext-link">10.1021/acs.jmedchem.7b01792</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Structures for previously reported prodrugs (Figure S1), liver homogenate stability of compound <b>11</b> (Figure S2), HPLC traces, <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra, LC–MS parameters (Table S1), structure of losartan internal standard, and molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf">jm7b01792_si_001.pdf (1.17 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_002.csv">jm7b01792_si_002.csv (0.9 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01792" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pavel Majer</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c2afa3a8a7b082b7ada1aaa0eca1a3b1eca1b8"><span class="__cf_email__" data-cfemail="573a363d3225172238343f357934362479342d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara S. Slusher</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery, 
    Departments
of Neurology, 
    Psychiatry and Behavioral Sciences, 
    Neuroscience, 
    Medicine, 
    Oncology, 
     and , , , , ,
and , Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9814-4157" title="Orcid link">http://orcid.org/0000-0001-9814-4157</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6406170811170c0116240e0c090d4a010011"><span class="__cf_email__" data-cfemail="395b4a554c4a515c4b7953515450175c5d4c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rana Rais</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery, 
    Departments
of Neurology, 
     and , , , , ,
and , Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4059-2453" title="Orcid link">http://orcid.org/0000-0003-4059-2453</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c7b5b5a6aeb4f587adafaaaee9a2a3b2"><span class="__cf_email__" data-cfemail="c0b2b2a1a9b3f280aaa8ada9eea5a4b5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah
C. Zimmermann</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery, 
    Departments
of Neurology, 
     and , , , , ,
and , Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomáš Tichý</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Vávra</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ranjeet P. Dash</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery, 
    Departments
of Neurology, 
     and , , , , ,
and , Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">C. Ethan Slusher</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery and , , , , ,
and , Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandra J. Gadiano</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery and , , , , ,
and , Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Wu</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery and , , , , ,
and , Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrej Jančařík</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lukáš Tenora</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lenka Monincová</span> - <span class="hlFld-Affiliation affiliation">Institute
of Organic Chemistry and Biochemistry v.v.i , Czech Academy of Sciences, Prague 166 10, Czech Republic</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Prchalová</span> - <span class="hlFld-Affiliation affiliation">Johns
Hopkins Drug Discovery, 
    Departments
of Neurology, 
     and , , , , ,
and , Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory J. Riggins</span> - <span class="hlFld-Affiliation affiliation">Oncology, 
    Neurosurgery, 
     and , , , , ,
and , Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d25e3003-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by NIH Grants RO1CA161056, UL1 TR001079, R01 CA193895 (B.S.S.), F32CA200275 (S.C.Z.) and the Institute of Organic Chemistry and Biochemistry v.v.i., Czech Academy of Sciences, (RVO 61388963).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">MBZ</td><td class="NLM_def"><p class="first last">mebendazole</p></td></tr><tr><td class="NLM_term">MBZ-A</td><td class="NLM_def"><p class="first last">mebendazole polymorph A</p></td></tr><tr><td class="NLM_term">MBZ-B</td><td class="NLM_def"><p class="first last">mebendazole polymorph B</p></td></tr><tr><td class="NLM_term">MBZ-C</td><td class="NLM_def"><p class="first last">mebendazole polymorph C</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">peroral</p></td></tr><tr><td class="NLM_term">POC</td><td class="NLM_def"><p class="first last">isopropyloxycarbonyloxymethyl</p></td></tr><tr><td class="NLM_term">POM</td><td class="NLM_def"><p class="first last">pivaloyloxymethyl</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14305" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14305" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 53 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dayan, A. D.</span></span> <span> </span><span class="NLM_article-title">Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/S0001-706X(03)00031-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2FS0001-706X%2803%2900031-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=12745134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1CksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2003&pages=141-159&author=A.+D.+Dayan&title=Albendazole%2C+mebendazole+and+praziquantel.+Review+of+non-clinical+toxicity+and+pharmacokinetics&doi=10.1016%2FS0001-706X%2803%2900031-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics</span></div><div class="casAuthors">Dayan, A. D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Tropica</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">141-159</span>CODEN:
                <span class="NLM_cas:coden">ACTRAQ</span>;
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The pharmacokinetics and toxicity of albendazole, mebendazole and praziquantel are extensively reviewed, drawing on original published work and reviews in the open scientific literature and on assessments by international agencies and official regulatory bodies in Europe and the USA.  Information about human and veterinary medical uses and adverse reactions is evaluated.  The totality of the non-clin. information available about these long-established drugs may not comply with current official guidelines for new medicines but reasons are given why the "deficiencies" are only apparent and the data gaps can be replaced by other results, largely obtained from the target species and the many years of clin. experience of safe use of these drugs in humans and animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1UR0n6yDH-7Vg90H21EOLACvtfcHk0lhrJNxh6_JnBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1CksLc%253D&md5=2a4a89437c43489535f81a0af4451bc3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0001-706X%2803%2900031-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0001-706X%252803%252900031-7%26sid%3Dliteratum%253Aachs%26aulast%3DDayan%26aufirst%3DA.%2BD.%26atitle%3DAlbendazole%252C%2520mebendazole%2520and%2520praziquantel.%2520Review%2520of%2520non-clinical%2520toxicity%2520and%2520pharmacokinetics%26jtitle%3DActa%2520Trop.%26date%3D2003%26volume%3D86%26spage%3D141%26epage%3D159%26doi%3D10.1016%2FS0001-706X%2803%2900031-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martarelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzoni, G.</span></span> <span> </span><span class="NLM_article-title">Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">817</span>, <span class="refDoi"> DOI: 10.1007/s00280-007-0538-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1007%2Fs00280-007-0538-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=17581752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitleru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=809-817&author=D.+Martarelliauthor=P.+Pompeiauthor=C.+Baldiauthor=G.+Mazzoni&title=Mebendazole+inhibits+growth+of+human+adrenocortical+carcinoma+cell+lines+implanted+in+nude+mice&doi=10.1007%2Fs00280-007-0538-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice</span></div><div class="casAuthors">Martarelli, Daniele; Pompei, Pierluigi; Baldi, Caterina; Mazzoni, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">809-817</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Adrenocortical carcinoma is a rare tumor of the adrenal gland which requires new therapeutic approaches as its early diagnosis is difficult and prognosis poor despite therapies used.  Recently, mebendazole has been proved to be effective against different cancers.  The aim of our study was to evaluate whether mebendazole may result therapeutically useful in the treatment of human adrenocortical carcinoma.  We analyzed the effect of mebendazole on human adrenocortical carcinoma cells in vitro and after implantation in nude mice.  In order to clarify mechanisms of mebendazole action, metastases formation, apoptosis and angiogenesis were also investigated.  Mebendazole significantly inhibited cancer cells growth, both in vitro and in vivo, the effects being due to the induction of apoptosis.  Moreover, mebendazole inhibited invasion and migration of cancer cells in vitro, and metastases formation in vivo.  Overall, these data suggest that treatment with mebendazole, also in combination with std. therapies, could provide a new protocol for the inhibition of adrenocortical carcinoma growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdwQ0oo1WtCLVg90H21EOLACvtfcHk0lhrJNxh6_JnBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitleru7c%253D&md5=723cfa4b786f346aa6a8789ee6a9b30e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00280-007-0538-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-007-0538-0%26sid%3Dliteratum%253Aachs%26aulast%3DMartarelli%26aufirst%3DD.%26aulast%3DPompei%26aufirst%3DP.%26aulast%3DBaldi%26aufirst%3DC.%26aulast%3DMazzoni%26aufirst%3DG.%26atitle%3DMebendazole%2520inhibits%2520growth%2520of%2520human%2520adrenocortical%2520carcinoma%2520cell%2520lines%2520implanted%2520in%2520nude%2520mice%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2008%26volume%3D61%26spage%3D809%26epage%3D817%26doi%3D10.1007%2Fs00280-007-0538-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomyo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, T.</span></span> <span> </span><span class="NLM_article-title">The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells</span>. <i>Mol. Cancer Ther</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1201</span>– <span class="NLM_lpage">1209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=12479701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=1201-1209&author=J.-i.+Sasakiauthor=R.+Rameshauthor=S.+Chadaauthor=Y.+Gomyoauthor=J.+A.+Rothauthor=T.+Mukhopadhyay&title=The+anthelmintic+drug+mebendazole+induces+mitotic+arrest+and+apoptosis+by+depolymerizing+tubulin+in+non-small+cell+lung+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells</span></div><div class="casAuthors">Sasaki, Ji-ichiro; Ramesh, Rajagopal; Chada, Sunil; Gomyo, Yoshihito; Roth, Jack A.; Mukhopadhyay, Tapas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1201-1209</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Microtubules have a crit. role in cell division, and consequently various microtubule inhibitors have been developed as anticancer drugs.  In this study, we assess mebendazole (MZ), a microtubule-disrupting anthelmintic that exhibits a potent antitumor property both in vitro and in vivo.  Treatment of lung cancer cell lines with MZ caused mitotic arrest, followed by apoptotic cell death with the feature of caspase activation and cytochrome c release.  MZ induces abnormal spindle formation in mitotic cancer cells and enhances the depolymn. of tubulin, but the efficacy of depolymn. by MZ is lower than that by nocodazole.  Oral administration of MZ in mice elicited a strong antitumor effect in a s.c. model and reduced lung colonies in exptl. induced lung metastasis without any toxicity when compared with paclitaxel-treated mice.  We speculate that tumor cells may be defective in one mitotic checkpoint function and sensitive to the spindle inhibitor MZ.  Abnormal spindle formation may be the key factor detg. whether a cell undergoes apoptosis, whereas strong microtubule inhibitors elicit toxicity even in normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUgBAyDMQdALVg90H21EOLACvtfcHk0lhwUiOCSrxlLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFOgsA%253D%253D&md5=d1968c17a75ec56f41f390b29a126149</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DJ.-i.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DChada%26aufirst%3DS.%26aulast%3DGomyo%26aufirst%3DY.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26aulast%3DMukhopadhyay%26aufirst%3DT.%26atitle%3DThe%2520anthelmintic%2520drug%2520mebendazole%2520induces%2520mitotic%2520arrest%2520and%2520apoptosis%2520by%2520depolymerizing%2520tubulin%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther%26date%3D2002%26volume%3D1%26spage%3D1201%26epage%3D1209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J. A.</span></span> <span> </span><span class="NLM_article-title">Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2963</span>– <span class="NLM_lpage">2969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=12231542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVWitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2963-2969&author=T.+Mukhopadhyayauthor=J.-i.+Sasakiauthor=R.+Rameshauthor=J.+A.+Roth&title=Mebendazole+elicits+a+potent+antitumor+effect+on+human+cancer+cell+lines+both+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo</span></div><div class="casAuthors">Mukhopadhyay, Tapas; Sasaki, Ji-ichiro; Ramesh, Rajagopal; Roth, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2963-2969</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The authors have found that mebendazole (MZ), a deriv. of benzimidazole, induces a dose- and time-dependent apoptotic response in human lung cancer cell lines.  In this study, MZ arrested, cells at the G2-M phase before the onset of apoptosis, as detected by using fluorescence-activated cell sorter anal.  MZ treatment also resulted in mitochondrial cytochrome c release, followed by apoptotic cell death.  Addnl., MZ appeared to be a potent inhibitor of tumor cell growth with little toxicity to normal WI38 and human umbilical vein endothelial cells.  When administered p.o. to nu/nu mice, MZ strongly inhibited the growth of human tumor xenografts and significantly reduced the no. and size of tumors in an exptl. model of lung metastasis.  In assessing angiogenesis, the authors found significantly reduced vessel densities in MZ-treated mice compared with those in control mice.  These results suggest that MZ is effective in the treatment of cancer and other angiogenesis-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrugueCb-tSCrVg90H21EOLACvtfcHk0lhwUiOCSrxlLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVWitrY%253D&md5=ead554fcf3e9eea65f30dd241b0420ac</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukhopadhyay%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DJ.-i.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26atitle%3DMebendazole%2520elicits%2520a%2520potent%2520antitumor%2520effect%2520on%2520human%2520cancer%2520cell%2520lines%2520both%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D2963%26epage%3D2969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, J. o. d. J.
V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assumpção, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbano, R. M. r. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montenegro, R. C.</span></span> <span> </span><span class="NLM_article-title">The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2038</span>– <span class="NLM_lpage">2044</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2015.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2Fj.tiv.2015.08.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=2038-2044&author=L.+C.+Pintoauthor=B.+M.+Soaresauthor=J.+o.+d.+J.%0AV.+Pinheiroauthor=G.+J.+Rigginsauthor=P.+P.+Assump%C3%A7%C3%A3oauthor=R.+M.+r.+R.+Burbanoauthor=R.+C.+Montenegro&title=The+anthelmintic+drug+mebendazole+inhibits+growth%2C+migration+and+invasion+in+gastric+cancer+cell+model&doi=10.1016%2Fj.tiv.2015.08.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2015.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2015.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DPinto%26aufirst%3DL.%2BC.%26aulast%3DSoares%26aufirst%3DB.%2BM.%26aulast%3DPinheiro%26aufirst%3DJ.%2Bo.%2Bd.%2BJ.%2BV.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DAssump%25C3%25A7%25C3%25A3o%26aufirst%3DP.%2BP.%26aulast%3DBurbano%26aufirst%3DR.%2BM.%2Br.%2BR.%26aulast%3DMontenegro%26aufirst%3DR.%2BC.%26atitle%3DThe%2520anthelmintic%2520drug%2520mebendazole%2520inhibits%2520growth%252C%2520migration%2520and%2520invasion%2520in%2520gastric%2520cancer%2520cell%2520model%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2015%26volume%3D29%26spage%3D2038%26epage%3D2044%26doi%3D10.1016%2Fj.tiv.2015.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nygren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryknäs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ågerup, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, R.</span></span> <span> </span><span class="NLM_article-title">Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer</span>. <i>J. Cancer Res. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">2133</span>– <span class="NLM_lpage">2140</span>, <span class="refDoi"> DOI: 10.1007/s00432-013-1539-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1007%2Fs00432-013-1539-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2013&pages=2133-2140&author=P.+Nygrenauthor=M.+Frykn%C3%A4sauthor=B.+%C3%85gerupauthor=R.+Larsson&title=Repositioning+of+the+anthelmintic+drug+mebendazole+for+the+treatment+for+colon+cancer&doi=10.1007%2Fs00432-013-1539-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00432-013-1539-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00432-013-1539-5%26sid%3Dliteratum%253Aachs%26aulast%3DNygren%26aufirst%3DP.%26aulast%3DFrykn%25C3%25A4s%26aufirst%3DM.%26aulast%3D%25C3%2585gerup%26aufirst%3DB.%26aulast%3DLarsson%26aufirst%3DR.%26atitle%3DRepositioning%2520of%2520the%2520anthelmintic%2520drug%2520mebendazole%2520for%2520the%2520treatment%2520for%2520colon%2520cancer%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D139%26spage%3D2133%26epage%3D2140%26doi%3D10.1007%2Fs00432-013-1539-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doudican, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlow, S. J.</span></span> <span> </span><span class="NLM_article-title">Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1315</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-07-2159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1158%2F1541-7786.MCR-07-2159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=18667591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvVaru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=1308-1315&author=N.+Doudicanauthor=A.+Rodriguezauthor=I.+Osmanauthor=S.+J.+Orlow&title=Mebendazole+induces+apoptosis+via+Bcl-2+inactivation+in+chemoresistant+melanoma+cells&doi=10.1158%2F1541-7786.MCR-07-2159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells</span></div><div class="casAuthors">Doudican, Nicole; Rodriguez, Adrianna; Osman, Iman; Orlow, Seth J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1308-1315</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most metastatic melanoma patients fail to respond to available therapy, underscoring the need for novel approaches to identify new effective treatments.  In this study, we screened 2000 compds. from the Spectrum Library at a concn. of 1 μmol/L using two chemoresistant melanoma cell lines (M-14 and SK-Mel-19) and a spontaneously immortalized, nontumorigenic melanocyte cell line (melan-a).  We identified 10 compds. that inhibited the growth of the melanoma cells yet were largely nontoxic to melanocytes.  Strikingly, 4 of the 10 compds. (mebendazole, albendazole, fenbendazole, and oxybendazole) are benzimidazoles, a class of structurally related, tubulin-disrupting drugs.  Mebendazole was prioritized to further characterize its mechanism of melanoma growth inhibition based on its favorable pharmacokinetic profile.  Our data reveal that mebendazole inhibits melanoma growth with an av. IC50 of 0.32 μmol/L and preferentially induces apoptosis in melanoma cells compared with melanocytes.  The intrinsic apoptotic response is mediated through phosphorylation of Bcl-2, which occurs rapidly after treatment with mebendazole in melanoma cells but not in melanocytes.  Phosphorylation of Bcl-2 in melanoma cells prevents its interaction with proapoptotic Bax, thereby promoting apoptosis.  We further show that mebendazole-resistant melanocytes can be sensitized through redn. of Bcl-2 protein levels, showing the essential role of Bcl-2 in the cellular response to mebendazole-mediated tubulin disruption.  Our results suggest that this screening approach is useful for identifying agents that show promise in the treatment of even chemoresistant melanoma and identifies mebendazole as a potent, melanoma-specific cytotoxic agent. (Mol Cancer Res 2008;6(8):1308-15).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGralwYWYl7TOLVg90H21EOLACvtfcHk0lhwUiOCSrxlLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvVaru7w%253D&md5=602db897f9fa2887989a01a427f37bad</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-07-2159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-07-2159%26sid%3Dliteratum%253Aachs%26aulast%3DDoudican%26aufirst%3DN.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DOsman%26aufirst%3DI.%26aulast%3DOrlow%26aufirst%3DS.%2BJ.%26atitle%3DMebendazole%2520induces%2520apoptosis%2520via%2520Bcl-2%2520inactivation%2520in%2520chemoresistant%2520melanoma%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2008%26volume%3D6%26spage%3D1308%26epage%3D1315%26doi%3D10.1158%2F1541-7786.MCR-07-2159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Witt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markowitz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Dimassi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atlas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boockvar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggieri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, M.</span></span> <span> </span><span class="NLM_article-title">Repurposing mebendazole as a replacement for vincristine for the treatment of brain tumors</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.2119/molmed.2017.00011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.2119%2Fmolmed.2017.00011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2jt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=50-56&author=M.+De%0AWittauthor=A.+Gambleauthor=D.+Hansonauthor=D.+Markowitzauthor=C.+Powellauthor=S.+Al+Dimassiauthor=M.+Atlasauthor=J.+Boockvarauthor=R.+Ruggieriauthor=M.+Symons&title=Repurposing+mebendazole+as+a+replacement+for+vincristine+for+the+treatment+of+brain+tumors&doi=10.2119%2Fmolmed.2017.00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing mebendazole as a replacement for vincristine for the treatment of brain tumors</span></div><div class="casAuthors">De Witt, Michelle; Gamble, Alexander; Hanson, Derek; Markowitz, Daniel; Powell, Caitlin; Al Dimassi, Saleh; Atlas, Mark; Boockvar, John; Ruggieri, Rosamaria; Symons, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-56</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">The microtubule inhibitor vincristine is currently used to treat a variety of brain tumors, including low-grade glioma and anaplastic oligodendroglioma.  Vincristine, however, does not penetrate well into brain tumor tissue, and moreover, it displays dose-limiting toxicities, including peripheral neuropathy.  Mebendazole, a Food and Drug Administration-approved anthelmintic drug with a favorable safety profile, has recently been shown to display strong therapeutic efficacy in animal models of both glioma and medulloblastoma.  Importantly, appropriate formulations of mebendazole yield therapeutically effective concns. in the brain.  Mebendazole has been shown to inhibit microtubule formation, but it is not known whether its potency against tumor cells is mediated by this inhibitory effect.  To investigate this, we examd. the effects of mebendazole on GL261 glioblastoma cell viability, microtubule polymn. and metaphase arrest, and found that the effective concns. to inhibit these functions are very similar.  In addn., using mebendazole as a seed for the National Cancer Institute (NCI) COMPARE program revealed that the top-scoring drugs were highly enriched in microtubule-targeting drugs.  Taken together, these results indicate that the cell toxicity of mebendazole is indeed caused by inhibiting microtubule formation.  We also compared the therapeutic efficacy of mebendazole and vincristine against GL261 orthotopic tumors.  We found that mebendazole showed a significant increase in animal survival time, whereas vincristine, even at a dose close to its max. tolerated dose, failed to show any efficacy.  In conclusion, our results strongly support the clin. use of mebendazole as a replacement for vincristine for the treatment of brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLaLlA48oseLVg90H21EOLACvtfcHk0lj8IBlTan06Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2jt7vM&md5=f40e1baab1509e5bd4eb2f4fb8649e9d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2017.00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2017.00011%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BWitt%26aufirst%3DM.%26aulast%3DGamble%26aufirst%3DA.%26aulast%3DHanson%26aufirst%3DD.%26aulast%3DMarkowitz%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DAl%2BDimassi%26aufirst%3DS.%26aulast%3DAtlas%26aufirst%3DM.%26aulast%3DBoockvar%26aufirst%3DJ.%26aulast%3DRuggieri%26aufirst%3DR.%26aulast%3DSymons%26aufirst%3DM.%26atitle%3DRepurposing%2520mebendazole%2520as%2520a%2520replacement%2520for%2520vincristine%2520for%2520the%2520treatment%2520of%2520brain%2520tumors%26jtitle%3DMol.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D50%26epage%3D56%26doi%3D10.2119%2Fmolmed.2017.00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staedtke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span> <span> </span><span class="NLM_article-title">Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis</span>. <i>J. Neuro-Oncol</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nou234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1093%2Fneuonc%2Fnou234" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=545-554&author=R.+Y.+Baiauthor=V.+Staedtkeauthor=C.+M.+Rudinauthor=F.+Bunzauthor=G.+J.+Riggins&title=Effective+treatment+of+diverse+medulloblastoma+models+with+mebendazole+and+its+impact+on+tumor+angiogenesis&doi=10.1093%2Fneuonc%2Fnou234"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnou234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnou234%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DR.%2BY.%26aulast%3DStaedtke%26aufirst%3DV.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DBunz%26aufirst%3DF.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26atitle%3DEffective%2520treatment%2520of%2520diverse%2520medulloblastoma%2520models%2520with%2520mebendazole%2520and%2520its%2520impact%2520on%2520tumor%2520angiogenesis%26jtitle%3DJ.%2520Neuro-Oncol%26date%3D2015%26volume%3D17%26spage%3D545%26epage%3D554%26doi%3D10.1093%2Fneuonc%2Fnou234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staedtke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aprhys, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallia, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span> <span> </span><span class="NLM_article-title">Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme</span>. <i>J. Neuro-Oncol</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">974</span>– <span class="NLM_lpage">982</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nor077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1093%2Fneuonc%2Fnor077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=974-982&author=R.-Y.+Baiauthor=V.+Staedtkeauthor=C.+M.+Aprhysauthor=G.+L.+Galliaauthor=G.+J.+Riggins&title=Antiparasitic+mebendazole+shows+survival+benefit+in+2+preclinical+models+of+glioblastoma+multiforme&doi=10.1093%2Fneuonc%2Fnor077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnor077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnor077%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DR.-Y.%26aulast%3DStaedtke%26aufirst%3DV.%26aulast%3DAprhys%26aufirst%3DC.%2BM.%26aulast%3DGallia%26aufirst%3DG.%2BL.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26atitle%3DAntiparasitic%2520mebendazole%2520shows%2520survival%2520benefit%2520in%25202%2520preclinical%2520models%2520of%2520glioblastoma%2520multiforme%26jtitle%3DJ.%2520Neuro-Oncol%26date%3D2011%26volume%3D13%26spage%3D974%26epage%3D982%26doi%3D10.1093%2Fneuonc%2Fnor077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borodovsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunz, F.</span></span> <span> </span><span class="NLM_article-title">Repurposing the antihelmintic mebendazole as a hedgehog inhibitor</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0755-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1158%2F1535-7163.MCT-14-0755-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=25376612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=3-13&author=A.+R.+Larsenauthor=R.+Y.+Baiauthor=J.+H.+Chungauthor=A.+Borodovskyauthor=C.+M.+Rudinauthor=G.+J.+Rigginsauthor=F.+Bunz&title=Repurposing+the+antihelmintic+mebendazole+as+a+hedgehog+inhibitor&doi=10.1158%2F1535-7163.MCT-14-0755-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor</span></div><div class="casAuthors">Larsen, Andrew R.; Bai, Ren-Yuan; Chung, Jon H.; Borodovsky, Alexandra; Rudin, Charles M.; Riggins, Gregory J.; Bunz, Fred</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-13</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The hedgehog (Hh) signaling pathway is activated in many types of cancer and therefore presents an attractive target for new anticancer agents.  Here, we show that mebendazole, a benzamidazole with a long history of safe use against nematode infestations and hydatid disease, potently inhibited Hh signaling and slowed the growth of Hh-driven human medulloblastoma cells at clin. attainable concns.  As an antiparasitic, mebendazole avidly binds nematode tubulin and causes inhibition of intestinal microtubule synthesis.  In human cells, mebendazole suppressed the formation of the primary cilium, a microtubule-based organelle that functions as a signaling hub for Hh pathway activation.  The inhibition of Hh signaling by mebendazole was unaffected by mutants in the gene that encodes human Smoothened (SMO), which are selectively propagated in cell clones that survive treatment with the Hh inhibitor vismodegib.  Combination of vismodegib and mebendazole resulted in additive Hh signaling inhibition.  Because mebendazole can be safely administered to adults and children at high doses over extended time periods, we propose that mebendazole could be rapidly repurposed and clin. tested as a prospective therapeutic agent for many tumors that are dependent on Hh signaling.  Mol Cancer Ther; 14(1); 3-13. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApjZTGzyUjbVg90H21EOLACvtfcHk0lj8IBlTan06Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWltg%253D%253D&md5=0367c7cd03ecf9d4c9a108940962fb55</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0755-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0755-T%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DA.%2BR.%26aulast%3DBai%26aufirst%3DR.%2BY.%26aulast%3DChung%26aufirst%3DJ.%2BH.%26aulast%3DBorodovsky%26aufirst%3DA.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DBunz%26aufirst%3DF.%26atitle%3DRepurposing%2520the%2520antihelmintic%2520mebendazole%2520as%2520a%2520hedgehog%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D3%26epage%3D13%26doi%3D10.1158%2F1535-7163.MCT-14-0755-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span>Mebendazole
in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide. <a href="https://ClinicalTrials.gov/show/NCT01729260" class="extLink">https://ClinicalTrials.gov/show/NCT01729260</a> (accessed March 14, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mebendazole%0Ain+Newly+Diagnosed+High-Grade+Glioma+Patients+Receiving+Temozolomide.+https%3A%2F%2FClinicalTrials.gov%2Fshow%2FNCT01729260+%28accessed+March+14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span>A Phase
I Study of Mebendazole for the Treatment of Pediatric Gliomas. <a href="https://ClinicalTrials.gov/show/NCT01837862" class="extLink">https://ClinicalTrials.gov/show/NCT01837862</a> (accessed March 14, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase%0AI+Study+of+Mebendazole+for+the+Treatment+of+Pediatric+Gliomas.+https%3A%2F%2FClinicalTrials.gov%2Fshow%2FNCT01837862+%28accessed+March+14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span>Phase
I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric
Brain Tumors. <a href="https://ClinicalTrials.gov/show/NCT02644291" class="extLink">https://ClinicalTrials.gov/show/NCT02644291</a> (accessed March
14, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phase%0AI+Study+of+Mebendazole+Therapy+for+Recurrent%2FProgressive+Pediatric%0ABrain+Tumors.+https%3A%2F%2FClinicalTrials.gov%2Fshow%2FNCT02644291+%28accessed+March%0A14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span>Study
of the Safety, Tolerability and Efficacy of Metabolic Combination
Treatments on Cancer. <a href="https://ClinicalTrials.gov/show/NCT02201381" class="extLink">https://ClinicalTrials.gov/show/NCT02201381</a> (accessed March 14, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study%0Aof+the+Safety%2C+Tolerability+and+Efficacy+of+Metabolic+Combination%0ATreatments+on+Cancer.+https%3A%2F%2FClinicalTrials.gov%2Fshow%2FNCT02201381+%28accessed+March+14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carlert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akesson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerndal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindfors, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennernas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsson, B.</span></span> <span> </span><span class="NLM_article-title">In vivo dog intestinal precipitation of mebendazole: a basic BCS class II drug</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2903</span>– <span class="NLM_lpage">2911</span>, <span class="refDoi"> DOI: 10.1021/mp300224h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300224h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=2903-2911&author=S.+Carlertauthor=P.+Akessonauthor=G.+Jerndalauthor=L.+Lindforsauthor=H.+Lennernasauthor=B.+Abrahamsson&title=In+vivo+dog+intestinal+precipitation+of+mebendazole%3A+a+basic+BCS+class+II+drug&doi=10.1021%2Fmp300224h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Dog Intestinal Precipitation of Mebendazole: A Basic BCS Class II Drug</span></div><div class="casAuthors">Carlert, Sara; Aakesson, Pernilla; Jerndal, Gunilla; Lindfors, Lennart; Lennernaes, Hans; Abrahamsson, Bertil</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2903-2911</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate in vivo intestinal pptn. of a model drug mebendazole, a basic BCS class II drug, using dogs with intestinal stomas for administration or sampling.  After oral administration of a soln. with an expected intestinal supersatn. of approx. 20 times the soly., the measured supersatn. in dog intestinal fluid (DIF) was up to 10 times and, on av., only 11% of the given dose was retrieved as solid drug in the collected fluid from the stoma.  The drug was rapidly absorbed with >90% of the total systemic exposure reached within three hours after duodenal administration of a soln.  In silico absorption modeling showed that in vivo data were reasonably well described by a nonpptg. soln.  An in vitro model of pptn. in DIF predicted that the intestinal concn. of dissolved mebendazole would be less than 1/5 of the initial concn. within 10 min at concns. comparable to in vivo.  It was concluded that intestinal pptn. did not have any major influence on mebendazole absorption.  The extent of pptn. was over-predicted in vitro given the in vivo absorption rate, and further work is needed to identify in vitro factors that could enable more accurate in vivo predictions of intestinal pptn. from solns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYBoyuqddhl7Vg90H21EOLACvtfcHk0lgzNVbK3oGkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrnF&md5=697d8c0c812ce8f71d0102bca6ec78a5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fmp300224h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300224h%26sid%3Dliteratum%253Aachs%26aulast%3DCarlert%26aufirst%3DS.%26aulast%3DAkesson%26aufirst%3DP.%26aulast%3DJerndal%26aufirst%3DG.%26aulast%3DLindfors%26aufirst%3DL.%26aulast%3DLennernas%26aufirst%3DH.%26aulast%3DAbrahamsson%26aufirst%3DB.%26atitle%3DIn%2520vivo%2520dog%2520intestinal%2520precipitation%2520of%2520mebendazole%253A%2520a%2520basic%2520BCS%2520class%2520II%2520drug%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D2903%26epage%3D2911%26doi%3D10.1021%2Fmp300224h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martins, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neves, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellena, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cami, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brusau, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narda, G. E.</span></span> <span> </span><span class="NLM_article-title">Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">2336</span>– <span class="NLM_lpage">2344</span>, <span class="refDoi"> DOI: 10.1002/jps.21593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1002%2Fjps.21593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=18855910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslCgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=2336-2344&author=F.+T.+Martinsauthor=P.+P.+Nevesauthor=J.+Ellenaauthor=G.+E.+Camiauthor=E.+V.+Brusauauthor=G.+E.+Narda&title=Intermolecular+contacts+influencing+the+conformational+and+geometric+features+of+the+pharmaceutically+preferred+mebendazole+polymorph+C&doi=10.1002%2Fjps.21593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C</span></div><div class="casAuthors">Martins, Felipe T.; Neves, Person P.; Ellena, Javier; Cami, Gerardo E.; Brusau, Elena V.; Narda, Griselda E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2336-2344</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Mebendazole (MBZ) is a common benzimidazole anthelmintic that exists in three different polymorphic forms, A, B, and C. Polymorph C is the pharmaceutically preferred form due to its adequated aq. soly.  No single crystal structure detns. depicting the nature of the crystal packing and mol. conformation and geometry have been performed on this compd.  The crystal structure of mebendazole form C is resolved for the first time.  Mebendazole form C crystallizes in the triclinic centrosym. space group and this drug is practically planar, since the least-squares Me benzimidazolylcarbamate plane is much fitted on the forming atoms.  However, the benzoyl group is twisted by 31(1)° from the benzimidazole ring, likewise the torsional angle between the benzene and carbonyl moieties is 27(1)°.  The formerly described bends and other interesting intramol. geometry features were viewed as consequence of the intermol. contacts occurring within mebendazole C structure.  Among these features, a conjugation decreasing through the imine nitrogen atom of the benzimidazole core and a further resonance path crossing the carbamate one were described.  At last, the X-ray powder diffractogram of a form C rich mebendazole mixt. was overlaid to the calcd. one with the mebendazole crystal structure. © 2008 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 98:2336-2344, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocDeRh92bDTbVg90H21EOLACvtfcHk0lgzNVbK3oGkvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslCgtr4%253D&md5=475bf5c6a50615335e0fc389f675e5a1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fjps.21593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21593%26sid%3Dliteratum%253Aachs%26aulast%3DMartins%26aufirst%3DF.%2BT.%26aulast%3DNeves%26aufirst%3DP.%2BP.%26aulast%3DEllena%26aufirst%3DJ.%26aulast%3DCami%26aufirst%3DG.%2BE.%26aulast%3DBrusau%26aufirst%3DE.%2BV.%26aulast%3DNarda%26aufirst%3DG.%2BE.%26atitle%3DIntermolecular%2520contacts%2520influencing%2520the%2520conformational%2520and%2520geometric%2520features%2520of%2520the%2520pharmaceutically%2520preferred%2520mebendazole%2520polymorph%2520C%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D2336%26epage%3D2344%26doi%3D10.1002%2Fjps.21593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, T. R.</span></span> <span> </span><span class="NLM_article-title">The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]-mebendazole</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">455</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.1982.tb02008.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1111%2Fj.1365-2125.1982.tb02008.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=7126419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaL38XmtVOlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1982&pages=453-455&author=M.+Dawsonauthor=R.+J.+Allanauthor=T.+R.+Watson&title=The+pharmacokinetics+and+bioavailability+of+mebendazole+in+man%3A+a+pilot+study+using+%5B3H%5D-mebendazole&doi=10.1111%2Fj.1365-2125.1982.tb02008.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]mebendazole</span></div><div class="casAuthors">Dawson, M.; Allan, R. J.; Watson, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">453-5</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">Following the i.v. administration of a tracer dose (1.7 μg) of mebendazole (I)  [31431-39-7] to a man, an elimination half-life of 1.16 h was obsd. and the vol. of distribution was calcd. to be 2.03 L/kg.  After oral administration of the same dose, an elimination half-life of 0.74 h was obsd.  The bioavailability of mebendazole from the soln. was found to be 17%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDYYE3xy_zqbVg90H21EOLACvtfcHk0lj9P7SmpjZnpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XmtVOlt7g%253D&md5=8519b2e6abb3007ff74654b1b918b770</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1982.tb02008.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1982.tb02008.x%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DAllan%26aufirst%3DR.%2BJ.%26aulast%3DWatson%26aufirst%3DT.%2BR.%26atitle%3DThe%2520pharmacokinetics%2520and%2520bioavailability%2520of%2520mebendazole%2520in%2520man%253A%2520a%2520pilot%2520study%2520using%2520%255B3H%255D-mebendazole%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1982%26volume%3D14%26spage%3D453%26epage%3D455%26doi%3D10.1111%2Fj.1365-2125.1982.tb02008.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braithwaite, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, T. R.</span></span> <span> </span><span class="NLM_article-title">The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.1985.tb02616.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1111%2Fj.1365-2125.1985.tb02616.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=3978023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaL2MXhvFOnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1985&pages=79-86&author=M.+Dawsonauthor=P.+A.+Braithwaiteauthor=M.+S.+Robertsauthor=T.+R.+Watson&title=The+pharmacokinetics+and+bioavailability+of+a+tracer+dose+of+%5B3H%5D-mebendazole+in+man&doi=10.1111%2Fj.1365-2125.1985.tb02616.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man</span></div><div class="casAuthors">Dawson, M.; Braithwaite, P. A.; Roberts, M. S.; Watson, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-86</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">Five volunteers (37-64 yr) took part in a cross-over study to det. the pharmacokinetics and bioavailability of mebendazole (I)  [31431-39-7] in man following i.v. and oral administration.  Following i.v. administration, the av. distribution half-life, elimination half-life, and rate of clearance were 0.20 h, 1.12 h, and 1.063 min, resp.  After oral administration of the soln. the av. elimination half-life was 0.93 h, the apparent rate of clearance was 0.846 L/min, the av. time to peak plasma concn. was 0.42 h, and the bioavailability was 22%.  Comparison of metabolite area under the plasma concn. vs. time data from each route of administration indicates that absorption from the gastrointestinal tract at this does level is almost complete.  The low bioavailability obsd. following oral administration at this dose level is postulated to be due to high first-pass elimination.  Approx. half of the administered dose of radioactivity following i.v. and oral administration of I-3H was detected in the urine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL0-wvrzs8xrVg90H21EOLACvtfcHk0lj9P7SmpjZnpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhvFOnsLs%253D&md5=aa85847a228047d11269133f5fc6df04</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1985.tb02616.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1985.tb02616.x%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DBraithwaite%26aufirst%3DP.%2BA.%26aulast%3DRoberts%26aufirst%3DM.%2BS.%26aulast%3DWatson%26aufirst%3DT.%2BR.%26atitle%3DThe%2520pharmacokinetics%2520and%2520bioavailability%2520of%2520a%2520tracer%2520dose%2520of%2520%255B3H%255D-mebendazole%2520in%2520man%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1985%26volume%3D19%26spage%3D79%26epage%3D86%26doi%3D10.1111%2Fj.1365-2125.1985.tb02616.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Himmelreich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, T. R.</span></span> <span> </span><span class="NLM_article-title">Polymorphic forms of mebendazole</span>. <i>Aust. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1971&pages=123-125&author=M.+Himmelreichauthor=B.+J.+Rawsonauthor=T.+R.+Watson&title=Polymorphic+forms+of+mebendazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHimmelreich%26aufirst%3DM.%26aulast%3DRawson%26aufirst%3DB.%2BJ.%26aulast%3DWatson%26aufirst%3DT.%2BR.%26atitle%3DPolymorphic%2520forms%2520of%2520mebendazole%26jtitle%3DAust.%2520J.%2520Pharm.%2520Sci.%26date%3D1971%26volume%3D6%26spage%3D123%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staedtke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanjiku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallia, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span> <span> </span><span class="NLM_article-title">Brain penetration and efficacy of different mebendazole polymorphs in a mouse brain tumor model</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3462</span>– <span class="NLM_lpage">3470</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-2681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1158%2F1078-0432.CCR-14-2681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=25862759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1yqtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=3462-3470&author=R.+Y.+Baiauthor=V.+Staedtkeauthor=T.+Wanjikuauthor=M.+A.+Rudekauthor=A.+Joshiauthor=G.+L.+Galliaauthor=G.+J.+Riggins&title=Brain+penetration+and+efficacy+of+different+mebendazole+polymorphs+in+a+mouse+brain+tumor+model&doi=10.1158%2F1078-0432.CCR-14-2681"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model</span></div><div class="casAuthors">Bai, Ren-Yuan; Staedtke, Verena; Wanjiku, Teresia; Rudek, Michelle A.; Joshi, Avadhut; Gallia, Gary L.; Riggins, Gregory J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3462-3470</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Mebendazole (MBZ), first used as an antiparasitic drug, shows preclin. efficacy in models of glioblastoma and medulloblastoma.  Three different mebendazole polymorphs (A, B, and C) exist, and a detailed assessment of the brain penetration, pharmacokinetics, and antitumor properties of each individual mebendazole polymorph is necessary to improve mebendazole-based brain cancer therapy.  Exptl. Design and Results: In this study, various marketed and custom-formulated mebendazole tablets were analyzed for their polymorph content by IR spectroscopy and subsequently tested in an orthotopic GL261 mouse glioma model for efficacy and tolerability.  The pharmacokinetics and brain concn. of mebendazole polymorphs and two main metabolites were analyzed by LC/MS.  We found that polymorph B and C both increased survival in a GL261 glioma model, as B exhibited greater toxicity.  Polymorph A showed no benefit.  Polymorph B and C both reached concns. in the brain that exceeded the IC50 in GL261 cells 29-fold.  In addn., polymorph C demonstrated an AUC0-24h brain-to-plasma (B/P) ratio of 0.82, whereas B showed higher plasma AUC and lower B/P ratio.  In contrast, polymorph A presented markedly lower levels in the plasma and brain.  Furthermore, the combination with elacridar was able to significantly improve the efficacy of polymorph C in GL261 glioma and D425 medulloblastoma models in mice.  Conclusions: Among mebendazole polymorphs, C reaches therapeutically effective concns. in the brain tissue and tumor with fewer side effects, and is the better choice for brain cancer therapy.  Its efficacy can be further enhanced by combination with elacridar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQBtBGtrQ5JbVg90H21EOLACvtfcHk0lgFAHZuBaeDsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1yqtrnL&md5=92d3feae588ea27cea5378307de1b3b8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-2681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-2681%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DR.%2BY.%26aulast%3DStaedtke%26aufirst%3DV.%26aulast%3DWanjiku%26aufirst%3DT.%26aulast%3DRudek%26aufirst%3DM.%2BA.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DGallia%26aufirst%3DG.%2BL.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26atitle%3DBrain%2520penetration%2520and%2520efficacy%2520of%2520different%2520mebendazole%2520polymorphs%2520in%2520a%2520mouse%2520brain%2520tumor%2520model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D3462%26epage%3D3470%26doi%3D10.1158%2F1078-0432.CCR-14-2681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Caabeiro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criado-Fornelio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igual, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujol, M.</span></span> <span> </span><span class="NLM_article-title">Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms</span>. <i>Chemotherapy</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">266</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1159/000238506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1159%2F000238506" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2004&pages=266-271&author=F.+Rodriguez-Caabeiroauthor=A.+Criado-Fornelioauthor=A.+Jimenez-Gonzalezauthor=L.+Guzmanauthor=A.+Igualauthor=A.+Perezauthor=M.+Pujol&title=Experimental+chemotherapy+and+toxicity+in+mice+of+three+mebendazole+polymorphic+forms&doi=10.1159%2F000238506"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1159%2F000238506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000238506%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Caabeiro%26aufirst%3DF.%26aulast%3DCriado-Fornelio%26aufirst%3DA.%26aulast%3DJimenez-Gonzalez%26aufirst%3DA.%26aulast%3DGuzman%26aufirst%3DL.%26aulast%3DIgual%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DA.%26aulast%3DPujol%26aufirst%3DM.%26atitle%3DExperimental%2520chemotherapy%2520and%2520toxicity%2520in%2520mice%2520of%2520three%2520mebendazole%2520polymorphic%2520forms%26jtitle%3DChemotherapy%26date%3D2004%26volume%3D33%26spage%3D266%26epage%3D271%26doi%3D10.1159%2F000238506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brits, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebenberg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Villiers, M. M.</span></span> <span> </span><span class="NLM_article-title">Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">1138</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1002/jps.21899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1002%2Fjps.21899" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=1138-1151&author=M.+Britsauthor=W.+Liebenbergauthor=M.+M.+de+Villiers&title=Characterization+of+polymorph+transformations+that+decrease+the+stability+of+tablets+containing+the+WHO+essential+drug+mebendazole&doi=10.1002%2Fjps.21899"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjps.21899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21899%26sid%3Dliteratum%253Aachs%26aulast%3DBrits%26aufirst%3DM.%26aulast%3DLiebenberg%26aufirst%3DW.%26aulast%3Dde%2BVilliers%26aufirst%3DM.%2BM.%26atitle%3DCharacterization%2520of%2520polymorph%2520transformations%2520that%2520decrease%2520the%2520stability%2520of%2520tablets%2520containing%2520the%2520WHO%2520essential%2520drug%2520mebendazole%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26spage%3D1138%26epage%3D1151%26doi%3D10.1002%2Fjps.21899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honorato, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farfan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filho, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarao, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fechine, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, M. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabbene, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuffini, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, A. P.</span></span> <span> </span><span class="NLM_article-title">Polymorphism evaluation in generic tablets containing mebendazole by dissolution tests</span>. <i>J. Braz. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1590/S0103-50532012000200005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1590%2FS0103-50532012000200005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFaku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=220-227&author=S.+B.+Honoratoauthor=S.+Farfanauthor=A.+Vianaauthor=J.+M.+Filhoauthor=G.+C.+Camaraoauthor=F.+V.+Fechineauthor=M.+E.+A.+Moraesauthor=M.+O.+Moraesauthor=M.+Ferroauthor=V.+Dabbeneauthor=S.+L.+Cuffiniauthor=A.+P.+Ayala&title=Polymorphism+evaluation+in+generic+tablets+containing+mebendazole+by+dissolution+tests&doi=10.1590%2FS0103-50532012000200005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Polymorphism evaluation in generic tablets containing mebendazole by dissolution tests</span></div><div class="casAuthors">Honorato, Sara B.; Farfan, Silvia; Viana, Arnaldo; Filho, Josue M.; Camarao, Gisela C.; Fechine, Francisco V.; Moraes, Maria E. A.; Moraes, Manoel O.; Ferro, Maribel; Dabbene, Viviana; Cuffini, Silvia L.; Ayala, Alejandro P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Brazilian Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-227</span>CODEN:
                <span class="NLM_cas:coden">JOCSET</span>;
        ISSN:<span class="NLM_cas:issn">0103-5053</span>.
    
            (<span class="NLM_cas:orgname">Sociedade Brasileira de Quimica</span>)
        </div><div class="casAbstract">This study evaluates the incidence of the polymorphic forms of mebendazole (MBZ) in tablets within the Brazilian market by dissoln. tests.  The indicated dissoln. medium by the USP 30 (United States Pharmacopoeia) and a proposed modified medium were duly compared in order to verify whether they are able to discriminate the polymorph A from polymorph C in com. tablets.  Dissoln. assay tests of phys. mixts. in raw materials of polymorph A and polymorph C, as well as of nine tablets of MBZ (available in the Brazilian market), were properly performed.  For the dissoln. tests, the USP 30 medium (I) and a modified medium (II) were used.  The modified medium allowed a reproducible and reliable quality control of MBZ polymorphism in com. tablets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmK5rJsSrB5rVg90H21EOLACvtfcHk0ljHEdWJZS13Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFaku78%253D&md5=00aff2d21cb42e9c24b431ff025040b0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1590%2FS0103-50532012000200005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0103-50532012000200005%26sid%3Dliteratum%253Aachs%26aulast%3DHonorato%26aufirst%3DS.%2BB.%26aulast%3DFarfan%26aufirst%3DS.%26aulast%3DViana%26aufirst%3DA.%26aulast%3DFilho%26aufirst%3DJ.%2BM.%26aulast%3DCamarao%26aufirst%3DG.%2BC.%26aulast%3DFechine%26aufirst%3DF.%2BV.%26aulast%3DMoraes%26aufirst%3DM.%2BE.%2BA.%26aulast%3DMoraes%26aufirst%3DM.%2BO.%26aulast%3DFerro%26aufirst%3DM.%26aulast%3DDabbene%26aufirst%3DV.%26aulast%3DCuffini%26aufirst%3DS.%2BL.%26aulast%3DAyala%26aufirst%3DA.%2BP.%26atitle%3DPolymorphism%2520evaluation%2520in%2520generic%2520tablets%2520containing%2520mebendazole%2520by%2520dissolution%2520tests%26jtitle%3DJ.%2520Braz.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D23%26spage%3D220%26epage%3D227%26doi%3D10.1590%2FS0103-50532012000200005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swanepoel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebenberg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Villiers, M. M.</span></span> <span> </span><span class="NLM_article-title">Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/S0939-6411(03)00004-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2FS0939-6411%2803%2900004-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=12754010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1GjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=345-349&author=E.+Swanepoelauthor=W.+Liebenbergauthor=M.+M.+de+Villiers&title=Quality+evaluation+of+generic+drugs+by+dissolution+test%3A+changing+the+USP+dissolution+medium+to+distinguish+between+active+and+non-active+mebendazole+polymorphs&doi=10.1016%2FS0939-6411%2803%2900004-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs</span></div><div class="casAuthors">Swanepoel, Erna; Liebenberg, Wilna; de Villiers, Melgardt M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-349</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Mebendazole is practically insol. in water and studies of its polymorphism has led to the identification and characterization of 3 polymorphic forms (A, B, C) displaying soly. and therapeutic differences that show that polymorph C is therapeutically favored.  The objective of this study was to adjust the USP dissoln. test for mebendazole so that it was able to distinguish between the dissoln. properties of 3 mebendazole polymorphs.  This would provide generic manufacturers with one more test to ensure that the therapeutically active polymorph C is used.  The results obtained in this study show that the USP dissoln. test conditions were not able to distinguish between the dissoln. properties of completely dispersed mebendazole polymorphs with comparable particle sizes.  When sodium lauryl sulfate was removed from the dissoln. medium, the percentage dissolved vs. time profiles changed so that polymorph C dissolved faster (70% within 120 min) compared to polymorph B (37% within 120 min) and polymorph A (20% within 120 min).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ9HaQgzS_rrVg90H21EOLACvtfcHk0ljHEdWJZS13Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1GjtL0%253D&md5=f2f9f3acd689faf2dd73c2078e55892c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0939-6411%2803%2900004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0939-6411%252803%252900004-3%26sid%3Dliteratum%253Aachs%26aulast%3DSwanepoel%26aufirst%3DE.%26aulast%3DLiebenberg%26aufirst%3DW.%26aulast%3Dde%2BVilliers%26aufirst%3DM.%2BM.%26atitle%3DQuality%2520evaluation%2520of%2520generic%2520drugs%2520by%2520dissolution%2520test%253A%2520changing%2520the%2520USP%2520dissolution%2520medium%2520to%2520distinguish%2520between%2520active%2520and%2520non-active%2520mebendazole%2520polymorphs%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2003%26volume%3D55%26spage%3D345%26epage%3D349%26doi%3D10.1016%2FS0939-6411%2803%2900004-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charoenlarp, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waikagul, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muennoo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinophakun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitayaporn, D.</span></span> <span> </span><span class="NLM_article-title">Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections</span>. <i>Southeast Asian J. Trop. Med. Public Health</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=7939946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fis1aiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1993&pages=712-716&author=P.+Charoenlarpauthor=J.+Waikagulauthor=C.+Muennooauthor=S.+Srinophakunauthor=D.+Kitayaporn&title=Efficacy+of+single-dose+mebendazole%2C+polymorphic+forms+A+and+C%2C+in+the+treatment+of+hookworm+and+Trichuris+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections</span></div><div class="casAuthors">Charoenlarp P; Waikagul J; Muennoo C; Srinophakun S; Kitayaporn D</div><div class="citationInfo"><span class="NLM_cas:title">The Southeast Asian journal of tropical medicine and public health</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">712-6</span>
        ISSN:<span class="NLM_cas:issn">0125-1562</span>.
    </div><div class="casAbstract">A therapeutic trial of single mebendazole, 300 mg polymorph A, 300 mg polymorph C and 500 mg polymorph C, in the treatment of hookworm and Trichuris infections was carried out at primary schools in Southern Thailand.  The total of 958 children were randomly allocated in seven treatment groups including the placebo control and the standard dose control (100 mg polymorph C bid for 3 days).  The egg reduction rates and the cure rates of 300 mg and 500 mg polymorph C were similar, but inferior to those of the standard dose in both hookworm and Trichuris infections.  The efficacy of single dose 300 mg polymorph A was not different from that of the placebo control (alpha = 0.05) in both infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlHN-cXSKOG5QHPYJuLg8TfW6udTcc2eagAhC2m2nqVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fis1aiug%253D%253D&md5=86594a91a3f4f8152c8464fbefa59bc7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharoenlarp%26aufirst%3DP.%26aulast%3DWaikagul%26aufirst%3DJ.%26aulast%3DMuennoo%26aufirst%3DC.%26aulast%3DSrinophakun%26aufirst%3DS.%26aulast%3DKitayaporn%26aufirst%3DD.%26atitle%3DEfficacy%2520of%2520single-dose%2520mebendazole%252C%2520polymorphic%2520forms%2520A%2520and%2520C%252C%2520in%2520the%2520treatment%2520of%2520hookworm%2520and%2520Trichuris%2520infections%26jtitle%3DSoutheast%2520Asian%2520J.%2520Trop.%2520Med.%2520Public%2520Health%26date%3D1993%26volume%3D24%26spage%3D712%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Paula, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cami, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brusau, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narda, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellena, J.</span></span> <span> </span><span class="NLM_article-title">Mebendazole mesylate monohydrate: a new route to improve the solubility of mebendazole polymorphs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">3528</span>– <span class="NLM_lpage">3538</span>, <span class="refDoi"> DOI: 10.1002/jps.23658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1002%2Fjps.23658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=23897162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFygsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=3528-3538&author=K.+de%0APaulaauthor=G.+E.+Camiauthor=E.+V.+Brusauauthor=G.+E.+Nardaauthor=J.+Ellena&title=Mebendazole+mesylate+monohydrate%3A+a+new+route+to+improve+the+solubility+of+mebendazole+polymorphs&doi=10.1002%2Fjps.23658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Mebendazole Mesylate Monohydrate: A New Route to Improve the Solubility of Mebendazole Polymorphs</span></div><div class="casAuthors">De Paula, Karina; Cami, Gerardo E.; Brusau, Elena V.; Narda, Griselda E.; Ellena, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3528-3538</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Mebendazole mesylate monohydrate, a new stable salt of mebendazole (MBZ), has been synthesized and fully characterized.  It was obtained from recrystn. of MBZ forms A, B, or C in diverse solvents with the addn. of Me sulfonic acid soln.  The crystal packing is first organized as a two-dimensional array consisting of rows of alternating MBZ mols. linked to columns of mesylate ions by hydrogen bonds.  The three-dimensional structure is further developed by classical intermol. interactions involving water mols.  In addn., nonclassical contacts are also found.  The vibrational behavior is consistent with the crystal structure, the most important functional groups showing shifts to lower or higher frequencies in relation to the MBZ polymorphs.  Thermal anal. indicates that the compd. is stable up to 50°C.  Decompn. occurs in five steps.  Soly. studies show that the title compd. presents a significant higher performance than polymorph C. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXSoOnRfS53rVg90H21EOLACvtfcHk0lhgDyKAqKO5Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFygsb3N&md5=0e9625daf3046c28d7a7e9e20a107995</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fjps.23658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23658%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BPaula%26aufirst%3DK.%26aulast%3DCami%26aufirst%3DG.%2BE.%26aulast%3DBrusau%26aufirst%3DE.%2BV.%26aulast%3DNarda%26aufirst%3DG.%2BE.%26aulast%3DEllena%26aufirst%3DJ.%26atitle%3DMebendazole%2520mesylate%2520monohydrate%253A%2520a%2520new%2520route%2520to%2520improve%2520the%2520solubility%2520of%2520mebendazole%2520polymorphs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D3528%26epage%3D3538%26doi%3D10.1002%2Fjps.23658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, A. D.</span></span> <span> </span><span class="NLM_article-title">Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1205</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.1007/s00436-012-2954-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1007%2Fs00436-012-2954-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=22661241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A280%3ADC%252BC38nosFamug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2012&pages=1205-1211&author=C.+S.+Liuauthor=H.+B.+Zhangauthor=B.+Jiangauthor=J.+M.+Yaoauthor=Y.+Taoauthor=J.+Xueauthor=A.+D.+Wen&title=Enhanced+bioavailability+and+cysticidal+effect+of+three+mebendazole-oil+preparations+in+mice+infected+with+secondary+cysts+of+Echinococcus+granulosus&doi=10.1007%2Fs00436-012-2954-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus</span></div><div class="casAuthors">Liu Cong-shan; Zhang Hao-bing; Jiang Bin; Yao Jun-min; Tao Yi; Xue Jian; Wen Ai-dan</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1205-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of the present study is to explore the possibility to increase the efficacy of mebendazole (MBZ) against secondary cysts of Echinococcus granulosus harbored in mice by augmenting the solubility and bioavailability of the drug.  Firstly, the saturated solubility of MBZ in nine kinds of oil was determined by high performance liquid chromatography (HPLC), and MBZ was found exhibiting the highest, secondary, and lowest solubility in oleic acid (OA), glycerol trioleate (GT), and soybean oil (SB), respectively.  Secondly, MBZ-OA suspension, MBZ-GT suspension, MBZ-SB suspension, and MBZ suspended in 1 % tragacanth (MBZ-1 % tragacanth) were selected for further studies on pharmacokinetics and experimental therapy in mice.  Four groups of mice were treated orally with one of aforementioned four MBZ preparations at a single dose of 25 mg/kg, and concentrations of MBZ in plasma obtained from each mouse at various intervals within 24 h postadministration were determined by HPLC.  The major pharmacokinetic parameters calculated by MBZ plasma concentration-time curve demonstrated that the peak concentration of the drug (C (max) ) values obtained from three MBZ-oil preparation groups was 1.6-2.8 times higher than that of MBZ-1 % tragacanth group.  The same was true that the area under the drug concentration-time curve (AUC(0-∞)) values of 19.8 (2.5)-28.2 (2.5) μg/ml × h revealed in the three MBZ-oil preparation groups was significantly higher than that of 11.6 (2.0) μg/ml × h in MBZ-1 % tragacanth group, and the bioavailability of the three MBZ-oil preparation groups was 71-143 % higher than that of MBZ-1 % tragacanth group.  In mice infected with secondary cysts of E. granulosus for 8 months treated orally with MBZ-1 % tragacanth at a daily dose of 25 mg/kg for 14 consecutive days, the mean cyst weight was lower than that of untreated control, but the difference was not statistically significant with cyst weight reduction of 48 %.  When the infected mice received three MBZ-oil preparations at the same oral dose schedule as aforementioned, the mean cyst weights were significantly lower than those in MBZ-1 % tragacanth group or control group with cyst weight reductions of 71.2-84.7 %.  The results indicate that the solubility of MBZ in oils may increase to various degrees according to the kinds of oil used.  Meanwhile, three MBZ-oil (OA, GT, and SB) preparations administered orally to mice not only improve the bioavailability of MBZ relative to that of MBZ suspended in 1 % tragacanth, but their effects against hydatid cysts also significantly enhance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRm42_WGF52m5cXNb62YGmbfW6udTcc2ea_y8K53pYaHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nosFamug%253D%253D&md5=ba48d8a86d1d0fb18642a6f0c37ba742</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00436-012-2954-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-012-2954-2%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BS.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DJ.%2BM.%26aulast%3DTao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DA.%2BD.%26atitle%3DEnhanced%2520bioavailability%2520and%2520cysticidal%2520effect%2520of%2520three%2520mebendazole-oil%2520preparations%2520in%2520mice%2520infected%2520with%2520secondary%2520cysts%2520of%2520Echinococcus%2520granulosus%26jtitle%3DParasitol.%2520Res.%26date%3D2012%26volume%3D111%26spage%3D1205%26epage%3D1211%26doi%3D10.1007%2Fs00436-012-2954-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X. M.</span></span> <span> </span><span class="NLM_article-title">An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">589</span>, <span class="refDoi"> DOI: 10.1186/s13071-014-0589-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1186%2Fs13071-014-0589-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=25491386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlChsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=589&author=C.+S.+Liuauthor=H.+B.+Zhangauthor=W.+Leiauthor=C.+W.+Zhangauthor=B.+Jiangauthor=Q.+Zhengauthor=J.+H.+Yinauthor=X.+M.+Han&title=An+alternative+mebendazole+formulation+for+cystic+echinococcosis%3A+the+treatment+efficacy%2C+pharmacokinetics+and+safety+in+mice&doi=10.1186%2Fs13071-014-0589-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice</span></div><div class="casAuthors">Liu, Cong-Shan; Zhang, Hao-Bing; Lei, Wen; Zhang, Chao-Wei; Jiang, Bin; Zheng, Qi; Yin, Jian-Hai; Han, Xiu-Min</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & Vectors</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">589/1-589/24</span>CODEN:
                <span class="NLM_cas:coden">PVAEAK</span>;
        ISSN:<span class="NLM_cas:issn">1756-3305</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Cystic echinococcosis is a serious zoonotic infection worldwide caused by metacestodes of Echinococcus gruanulosus.  Mebendazole and albendazole are the only two drugs used in the treatment of this disease with cure rates only about 30% due to the poor oral absorption.  Thus an alternative treatment for this disease is needed.  Methods: A mebendazole oily suspension (MBZ-OS) was prepd. and orally administrated to mice infected with echinococcus cysts for 8 mo at 12.5 mg/kg and 25 mg/kg for 14 consecutive days.  Mebendazole suspended in 1% tragacanth (MBZ-1% tragacanth) served as treated control.  In addn., liver and serum samples were collected from these treated mice (25 mg/kg) for histopathol. examn. and liver function test.  For pharmacokinetic anal., plasma, parasite (cyst wall and cyst fluid) and tissue samples were collected at 0.25, 0.5, 1, 2, 4, 8, 16 and 24 h after orally administrating MBZ-OS and MBZ-1% tragacanth to E. granulosus-infected mice at 25 mg/kg.  These samples were then processed and quant. analyzed by HPLC.  Results: The administration of MBZ-OS resulted in a treatment efficacy with the cyst wt. redns. higher than 80%, significantly better than the corresponding MBZ-1% tragacanth groups.  The better treatment efficacy of MBZ-OS was related to the higher drug concn. in plasma, parasites and tissues.  It was also shown that the injury of the liver was not significantly altered by taking MBZ-OS compared to the untreated control.  Conclusion: These findings demonstrate that MBZ-OS is a promising new formulation of MBZ for treatment of hydatid diseases without showing significantly liver toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8E_-Zx3M7o7Vg90H21EOLACvtfcHk0ljRMoyVFZyFtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlChsbw%253D&md5=dc7f4ad797f66d43fabf681b5ae6f4d3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs13071-014-0589-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13071-014-0589-0%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BS.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%2BW.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DQ.%26aulast%3DYin%26aufirst%3DJ.%2BH.%26aulast%3DHan%26aufirst%3DX.%2BM.%26atitle%3DAn%2520alternative%2520mebendazole%2520formulation%2520for%2520cystic%2520echinococcosis%253A%2520the%2520treatment%2520efficacy%252C%2520pharmacokinetics%2520and%2520safety%2520in%2520mice%26jtitle%3DParasites%2520Vectors%26date%3D2014%26volume%3D7%26spage%3D589%26doi%3D10.1186%2Fs13071-014-0589-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniel-Mwuambete, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponce-Gordo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrado, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuesta-Bandera, C.</span></span> <span> </span><span class="NLM_article-title">Effect of two formulations of benzimidazole carbamates on the viability of cysts of Echinococcus granulosus in vivo</span>. <i>Parasite</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1051/parasite/2003104371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1051%2Fparasite%2F2003104371" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=371-373&author=K.+Daniel-Mwuambeteauthor=F.+Ponce-Gordoauthor=J.+Torradoauthor=S.+Torradoauthor=C.+Cuesta-Bandera&title=Effect+of+two+formulations+of+benzimidazole+carbamates+on+the+viability+of+cysts+of+Echinococcus+granulosus+in+vivo&doi=10.1051%2Fparasite%2F2003104371"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1051%2Fparasite%2F2003104371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fparasite%252F2003104371%26sid%3Dliteratum%253Aachs%26aulast%3DDaniel-Mwuambete%26aufirst%3DK.%26aulast%3DPonce-Gordo%26aufirst%3DF.%26aulast%3DTorrado%26aufirst%3DJ.%26aulast%3DTorrado%26aufirst%3DS.%26aulast%3DCuesta-Bandera%26aufirst%3DC.%26atitle%3DEffect%2520of%2520two%2520formulations%2520of%2520benzimidazole%2520carbamates%2520on%2520the%2520viability%2520of%2520cysts%2520of%2520Echinococcus%2520granulosus%2520in%2520vivo%26jtitle%3DParasite%26date%3D2003%26volume%3D10%26spage%3D371%26epage%3D373%26doi%3D10.1051%2Fparasite%2F2003104371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, T. R.</span></span> <span> </span><span class="NLM_article-title">The effect of dose form on the bioavailability of mebendazole in man</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.1985.tb02617.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1111%2Fj.1365-2125.1985.tb02617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=3978024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaL2MXitV2hsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1985&pages=87-90&author=M.+Dawsonauthor=T.+R.+Watson&title=The+effect+of+dose+form+on+the+bioavailability+of+mebendazole+in+man&doi=10.1111%2Fj.1365-2125.1985.tb02617.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of dose form on the bioavailability of mebendazole in man</span></div><div class="casAuthors">Dawson, M.; Watson, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-90</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">Four dosage forms of mebendazole (I)  [31431-39-7] were administered to human volunteers, and urine was collected and assayed for I and unconjugated metabolites.  Oral administration as an oily suspension enhanced the bioavailability of I slightly as compared with capsules and tablets; however, I was not absorbed following rectal administration.  The major (86%) urinary metabolite of I in humans was 2-amino-5(6)-[α-hydroxybenzyl]benzimidazole  [75501-05-2], not 2-amino-5(6)-benzoylbenzimidazole  [52329-60-9], as previously reported; the latter was present in lesser amts. (∼12%).  The pattern of metabolite excretion was not affected by route of administration.  Metabolites were detd. by extn. with EtOAc and liq. chromatog. on a LiChrosorb RP8 column with a gradient of MeOH-0.01M ammonium phosphate in MeOH-H2O (53:47) and detection at 254 and 280 nm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXxnye76QhcbVg90H21EOLACvtfcHk0likc0kHVloY8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXitV2hsbc%253D&md5=3296c90f4dfe46829341928ec1c64783</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1985.tb02617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1985.tb02617.x%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DWatson%26aufirst%3DT.%2BR.%26atitle%3DThe%2520effect%2520of%2520dose%2520form%2520on%2520the%2520bioavailability%2520of%2520mebendazole%2520in%2520man%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1985%26volume%3D19%26spage%3D87%26epage%3D90%26doi%3D10.1111%2Fj.1365-2125.1985.tb02617.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iseki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span> <span> </span><span class="NLM_article-title">Improvement of dissolution and bioavailability for mebendazole, an agent for human Echinococcosis, by preparing solid dispersion with polyethylene glycol</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2158</span>– <span class="NLM_lpage">2160</span>, <span class="refDoi"> DOI: 10.1248/cpb.39.2158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1248%2Fcpb.39.2158" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=2158-2160&author=Y.+Chibaauthor=N.+Kohriauthor=K.+Isekiauthor=K.+Miyazaki&title=Improvement+of+dissolution+and+bioavailability+for+mebendazole%2C+an+agent+for+human+Echinococcosis%2C+by+preparing+solid+dispersion+with+polyethylene+glycol&doi=10.1248%2Fcpb.39.2158"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1248%2Fcpb.39.2158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.39.2158%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DY.%26aulast%3DKohri%26aufirst%3DN.%26aulast%3DIseki%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DK.%26atitle%3DImprovement%2520of%2520dissolution%2520and%2520bioavailability%2520for%2520mebendazole%252C%2520an%2520agent%2520for%2520human%2520Echinococcosis%252C%2520by%2520preparing%2520solid%2520dispersion%2520with%2520polyethylene%2520glycol%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1991%26volume%3D39%26spage%3D2158%26epage%3D2160%26doi%3D10.1248%2Fcpb.39.2158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, T. R.</span></span> <span> </span><span class="NLM_article-title">4-Amino-3-(3′-methoxycarbonyl-2′-thioureido)benzophenone, a prodrug of mebendazole</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1007/BF03188765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1007%2FBF03188765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=6673970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaL2cXitVejt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1983&pages=329-334&author=M.+Dawsonauthor=T.+R.+Watson&title=4-Amino-3-%283%E2%80%B2-methoxycarbonyl-2%E2%80%B2-thioureido%29benzophenone%2C+a+prodrug+of+mebendazole&doi=10.1007%2FBF03188765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">4-Amino-3-(3'-methoxycarbonyl-2'-thioureido)benzophenone, a prodrug of mebendazole</span></div><div class="casAuthors">Dawson, Michael; Watson, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-34</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0398-7639</span>.
    </div><div class="casAbstract">4-Amino-3-(3'-methoxycarbonyl-2'-thioureido)benzophenone (I)  [39070-62-7], a prodrug of mebendazole  [31431-39-7], was stable in acid and neutral media and was rapidly hydrolyzed in basic media.  A high-performance liq.-chromatog. assay for mebendazole, the prodrug, and their known or expected metabolites and degrdn. products in aq. media and rat blood was developed.  The prodrug administered orally to rats was rapidly converted to mebendazole.  The area under the blood level vs. time curve of mebendazole, in rats dosed with the prodrug, was more than twice that obtained after giving rats an equimolar amt. of mebendazole.  Only the prodrug, mebendazole, and known metabolites of mebendazole were detected in rats given the prodrug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojBLlTpw0QibVg90H21EOLACvtfcHk0likc0kHVloY8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXitVejt7Y%253D&md5=a9308a598c0aa283446b3e32a984f9d8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2FBF03188765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03188765%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DWatson%26aufirst%3DT.%2BR.%26atitle%3D4-Amino-3-%25283%25E2%2580%25B2-methoxycarbonyl-2%25E2%2580%25B2-thioureido%2529benzophenone%252C%2520a%2520prodrug%2520of%2520mebendazole%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1983%26volume%3D8%26spage%3D329%26epage%3D334%26doi%3D10.1007%2FBF03188765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, L.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, H.</span></span> <span> </span><span class="NLM_article-title">N-alkoxycarbonyl prodrugs of mebendazole with increased water solubility</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/0378-5173(94)90060-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2F0378-5173%2894%2990060-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaK2cXhslehtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1994&pages=231-239&author=L.%0AS.+Nielsenauthor=F.+Sloekauthor=H.+Bundgaard&title=N-alkoxycarbonyl+prodrugs+of+mebendazole+with+increased+water+solubility&doi=10.1016%2F0378-5173%2894%2990060-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">N-alkoxycarbonyl prodrugs of mebendazole with increased water solubility</span></div><div class="casAuthors">Nielsen, Lise Sylvest; Sloek, Frank; Bundgaard, Hans</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">231-9</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    </div><div class="casAbstract">Bioreversible derivatization of mebendazole to improve its poor water soly., which is attributed to its low peroral bioavailability, was performed by N-acylation of the benzimidazole moiety with various chloroformates.  The N-alkoxycarbonyl derivs. (I, R = Me, Et or Pr) were readily hydrolyzed to mebendazole in the rabbit liver homogenate and in human and rabbit plasma.  The pH-rate profiles for the hydrolysis of the derivs. were derived at 37°C, and the lipophilicity of the compds. was assessed by partition expts. in octanol-aq. buffer systems.  The water soly. of the N-alkoxycarbonyl derivs. was up to 16-times higher than that of the parent drug.  The results obtained suggest that N-alkoxycarbonyl derivs. of benzimidazole anthelmintics may be useful to improve the peroral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIyKcTfUU55bVg90H21EOLACvtfcHk0likE9CqOg_lEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhslehtLk%253D&md5=d4df2d6e9122dd904e1b38315d91566c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0378-5173%2894%2990060-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-5173%252894%252990060-4%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DL.%2BS.%26aulast%3DSloek%26aufirst%3DF.%26aulast%3DBundgaard%26aufirst%3DH.%26atitle%3DN-alkoxycarbonyl%2520prodrugs%2520of%2520mebendazole%2520with%2520increased%2520water%2520solubility%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D1994%26volume%3D102%26spage%3D231%26epage%3D239%26doi%3D10.1016%2F0378-5173%2894%2990060-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, L. S.</span></span> <span> </span><span class="NLM_article-title">Improved peroral bioavailability of mebendazole in rabbits by administration of various N-alkoxycarbonyl derivatives of mebendazole</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1016/0378-5173(94)90193-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2F0378-5173%2894%2990193-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaK2cXit1Kktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1994&pages=175-179&author=L.+S.+Nielsen&title=Improved+peroral+bioavailability+of+mebendazole+in+rabbits+by+administration+of+various+N-alkoxycarbonyl+derivatives+of+mebendazole&doi=10.1016%2F0378-5173%2894%2990193-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Improved peroroal bioavailability of mebendazole in rabbits by administration of various N-alkoxycarbonyl derivatives of mebendazole</span></div><div class="casAuthors">Nielsen, Lise Sylvest</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-9</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    </div><div class="casAbstract">The absorption of mebendazole, a very poorly sol. benzimidazole carbamate, used in the treatment of hydatid disease, and various N-alkoxycarbonyl prodrugs, was investigated after peroral administration to rabbits.  The compds. were administered in the form of aq. suspensions at pH 5.0.  All prodrugs were rapidly hydrolyzed to mebendazole after absorption.  The bioavailability was improved for all prodrugs.  The highest bioavailability was obtained with the N-methoxycarbonyl deriv. which showed a 13-fold improvement in bioavailability compared to mebendazole.  The improved bioavailability of the prodrugs was ascribed to the increased water solubilities and appropriate lipophilicities.  The N-alkoxycarbonylation of the benzimidazole moiety in mebendazole and in other widely used benzimidazole carbamates may be a promising prodrug approach to enhance poor absorption which follows peroral administration of this type of poorly sol. drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryGbqJlsgPr7Vg90H21EOLACvtfcHk0likE9CqOg_lEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXit1Kktrs%253D&md5=2059b42090dc7e6dfa9ee0834d420e3e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0378-5173%2894%2990193-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-5173%252894%252990193-7%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DL.%2BS.%26atitle%3DImproved%2520peroral%2520bioavailability%2520of%2520mebendazole%2520in%2520rabbits%2520by%2520administration%2520of%2520various%2520N-alkoxycarbonyl%2520derivatives%2520of%2520mebendazole%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D1994%26volume%3D104%26spage%3D175%26epage%3D179%26doi%3D10.1016%2F0378-5173%2894%2990193-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garbuio, A. Q. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanashiro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markman, B. E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, F. L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perazzo, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, P. C. P.</span></span> <span> </span><span class="NLM_article-title">Evaluation and study of mebendazole polymorphs present in raw materials and tablets available in the Brazilian pharmaceutical market</span>. <i>J. Appl. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">001</span>– <span class="NLM_lpage">007</span>, <span class="refDoi"> DOI: 10.7324/JAPS.2014.4111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.7324%2FJAPS.2014.4111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=001-007&author=A.+Q.+P.+Garbuioauthor=T.+Hanashiroauthor=B.+E.+O.+Markmanauthor=F.+L.+A.+Fonsecaauthor=F.+F.+Perazzoauthor=P.+C.+P.+Rosa&title=Evaluation+and+study+of+mebendazole+polymorphs+present+in+raw+materials+and+tablets+available+in+the+Brazilian+pharmaceutical+market&doi=10.7324%2FJAPS.2014.4111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.7324%2FJAPS.2014.4111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7324%252FJAPS.2014.4111%26sid%3Dliteratum%253Aachs%26aulast%3DGarbuio%26aufirst%3DA.%2BQ.%2BP.%26aulast%3DHanashiro%26aufirst%3DT.%26aulast%3DMarkman%26aufirst%3DB.%2BE.%2BO.%26aulast%3DFonseca%26aufirst%3DF.%2BL.%2BA.%26aulast%3DPerazzo%26aufirst%3DF.%2BF.%26aulast%3DRosa%26aufirst%3DP.%2BC.%2BP.%26atitle%3DEvaluation%2520and%2520study%2520of%2520mebendazole%2520polymorphs%2520present%2520in%2520raw%2520materials%2520and%2520tablets%2520available%2520in%2520the%2520Brazilian%2520pharmaceutical%2520market%26jtitle%3DJ.%2520Appl.%2520Pharm.%2520Sci.%26date%3D2014%26volume%3D4%26spage%3D001%26epage%3D007%26doi%3D10.7324%2FJAPS.2014.4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jancarik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krecmerova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tichy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenora, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wozniak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally available prodrugs of the glutamate carboxypeptidase II (GCPII) inhibitor 2-Phosphonomethylpentanedioic acid (2-PMPA)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2810</span>– <span class="NLM_lpage">2819</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFaqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2810-2819&author=P.+Majerauthor=A.+Jancarikauthor=M.+Krecmerovaauthor=T.+Tichyauthor=L.+Tenoraauthor=K.+Wozniakauthor=Y.+Wuauthor=E.+Pommierauthor=D.+Ferrarisauthor=R.+Raisauthor=B.+S.+Slusher&title=Discovery+of+orally+available+prodrugs+of+the+glutamate+carboxypeptidase+II+%28GCPII%29+inhibitor+2-Phosphonomethylpentanedioic+acid+%282-PMPA%29&doi=10.1021%2Facs.jmedchem.6b00062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Orally Available Prodrugs of the Glutamate Carboxypeptidase II (GCPII) Inhibitor 2-Phosphonomethylpentanedioic Acid (2-PMPA)</span></div><div class="casAuthors">Majer, Pavel; Jancarik, Andrej; Krecmerova, Marcela; Tichy, Tomas; Tenora, Lukas; Wozniak, Krystyna; Wu, Ying; Pommier, Elie; Ferraris, Dana; Rais, Rana; Slusher, Barbara S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2810-2819</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-Phosphonomethylpentanedioic acid (I) (2-PMPA), is a potent inhibitor of glutamate carboxypeptidase II which has demonstrated robust neuroprotective efficacy in many neurol. disease models.  However, I is highly polar contg. a phosphonate and two carboxylates, severely limiting its oral bioavailability.  Our initial strategy was to cover the phosphonate with hydrophobic moieties such as pivaloyloxymethyl (POM) and isopropyloxycarbonyloxymethyl (POC) while keeping the α- and γ-carboxylates unsubstituted.  This attempt was unsuccessful due to the chem. instability of the bis-POC/POM derivs.  Addn. of α,γ-diesters and α-monoesters enhanced chem. stability and provided excellent oral exposure in mice, but these mixed esters were too stable in vivo, resulting in minimal release of I.  By introducing POC groups on both the phosphonate and α-carboxylate, we synthesized Tris-POC-2-PMPA, which afforded excellent release of I following oral administration in both mice and dog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTAKK5dMYGiLVg90H21EOLACvtfcHk0lhiX0fDBZ6VnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFaqt7c%253D&md5=3108f3d3bbb360dd7366ed2abea116dc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00062%26sid%3Dliteratum%253Aachs%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DJancarik%26aufirst%3DA.%26aulast%3DKrecmerova%26aufirst%3DM.%26aulast%3DTichy%26aufirst%3DT.%26aulast%3DTenora%26aufirst%3DL.%26aulast%3DWozniak%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DPommier%26aufirst%3DE.%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DDiscovery%2520of%2520orally%2520available%2520prodrugs%2520of%2520the%2520glutamate%2520carboxypeptidase%2520II%2520%2528GCPII%2529%2520inhibitor%25202-Phosphonomethylpentanedioic%2520acid%2520%25282-PMPA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2810%26epage%3D2819%26doi%3D10.1021%2Facs.jmedchem.6b00062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dando, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plosker, G.</span></span> <span> </span><span class="NLM_article-title">Adefovir dipivoxil: a review of its use in chronic hepatitis B</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2215</span>– <span class="NLM_lpage">2234</span>, <span class="refDoi"> DOI: 10.2165/00003495-200363200-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.2165%2F00003495-200363200-00007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2215-2234&author=T.+Dandoauthor=G.+Plosker&title=Adefovir+dipivoxil%3A+a+review+of+its+use+in+chronic+hepatitis+B&doi=10.2165%2F00003495-200363200-00007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2165%2F00003495-200363200-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-200363200-00007%26sid%3Dliteratum%253Aachs%26aulast%3DDando%26aufirst%3DT.%26aulast%3DPlosker%26aufirst%3DG.%26atitle%3DAdefovir%2520dipivoxil%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520chronic%2520hepatitis%2520B%26jtitle%3DDrugs%26date%3D2003%26volume%3D63%26spage%3D2215%26epage%3D2234%26doi%3D10.2165%2F00003495-200363200-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kearney, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, J.</span></span> <span> </span><span class="NLM_article-title">Tenofovir disoproxil fumarate</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.2165/00003088-200443090-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.2165%2F00003088-200443090-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=15217303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=595-612&author=B.+P.+Kearneyauthor=J.+F.+Flahertyauthor=J.+Shah&title=Tenofovir+disoproxil+fumarate&doi=10.2165%2F00003088-200443090-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics</span></div><div class="casAuthors">Kearney, Brian P.; Flaherty, John F.; Shah, Jaymin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">595-612</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Tenofovir disoproxil fumarate (tenofovir DF) is an oral prodrug of tenofovir, a nucleotide (nucleoside monophosphate) analog with activity against retroviruses, including HIV-1, HIV-2 and hepadnaviruses.  Following absorption, tenofovir DF is rapidly converted to tenofovir, which is metabolized intracellularly to its active anabolite tenofovir diphosphate, which is a competitive inhibitor of HIV-1 reverse transcriptase and terminates the growing DNA chain.  Tenofovir exerts antiviral effects in a variety of cell types, including resting cells.  Tenofovir exhibits longer serum (17 h) and intracellular (≥60 h) half-lives than those of nucleoside analogs, which supports a flexible once-daily administration schedule.  The pharmacokinetics of tenofovir are dose-proportional and similar in healthy volunteers and HIV-infected individuals.  The oral bioavailability of tenofovir is enhanced by administration with a high-fat meal, but is similar at steady state when administered with or without a typical meal.  Tenofovir is not a substrate, inducer or inhibitor of human cytochrome P 450 enzymes in vitro or in vivo.  Tenofovir DF has been studied with 15 other antiretroviral and other concomitant medications frequently used in the HIV-1-infected population.  With the exception of didanosine and atazanavir, which require dosage modifications, no clin. significant drug interactions have been obsd. with tenofovir DF.  The recommended oral dosage of tenofovir DF in adults is 300 mg/day.  Tenofovir is eliminated by renal elimination, including tubular secretion; dose-interval adjustments are necessary for tenofovir DF in patients with significant renal impairment.  No dosage adjustment of tenofovir DF is necessary in patients with liver disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh33s_geBBMLVg90H21EOLACvtfcHk0lhiX0fDBZ6VnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVCksLo%253D&md5=90abda8650560aa57a3173cccc289efb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2165%2F00003088-200443090-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200443090-00003%26sid%3Dliteratum%253Aachs%26aulast%3DKearney%26aufirst%3DB.%2BP.%26aulast%3DFlaherty%26aufirst%3DJ.%2BF.%26aulast%3DShah%26aufirst%3DJ.%26atitle%3DTenofovir%2520disoproxil%2520fumarate%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2004%26volume%3D43%26spage%3D595%26epage%3D612%26doi%3D10.2165%2F00003088-200443090-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chanteux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Bambeke, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingeot-Leclercq, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulkens, P. M.</span></span> <span> </span><span class="NLM_article-title">Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1279</span>– <span class="NLM_lpage">1288</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.4.1279-1288.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1128%2FAAC.49.4.1279-1288.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=15793098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1Cqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=1279-1288&author=H.+Chanteuxauthor=F.+Van+Bambekeauthor=M.-P.+Mingeot-Leclercqauthor=P.+M.+Tulkens&title=Accumulation+and+oriented+transport+of+ampicillin+in+Caco-2+cells+from+its+pivaloyloxymethylester+prodrug%2C+pivampicillin&doi=10.1128%2FAAC.49.4.1279-1288.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin</span></div><div class="casAuthors">Chanteux, Hugues; Van Bambeke, Francoise; Mingeot-Leclercq, Marie-Paule; Tulkens, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1279-1288</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pivampicillin (PIVA), an acyloxymethylester of ampicillin, is thought to enhance the oral bioavailability of ampicillin because of its greater lipophilicity compared to that of ampicillin.  The fate of PIVA in intestinal cells and the exact location of its conversion into ampicillin have, however, never been unambiguously established.  Polarized Caco-2 cells have been used to examine the handling of PIVA and the release of ampicillin from PIVA by the intestinal epithelium.  Expts. were limited to 3 h.  Cells incubated with PIVA (apical pole) showed a fast accumulation of ampicillin and transport toward the basolateral medium, whereas PIVA itself was only poorly accumulated and transported.  Cells incubated with free ampicillin accumulated and transported only minimal amts. of this drug.  Release of ampicillin from cells incubated with PIVA was unaffected by PEPT1 and OCTN2 inhibitors but was sharply decreased after ATP depletion or addn. of bis(4-nitrophenyl)-phosphate (BNPP; an esterase inhibitor).  PIVA incubated with Caco-2 lysates released free ampicillin, and this release was inhibited by BNPP.  Efflux studies showed that the ampicillin that accumulated in cells after incubation with PIVA was preferentially transported out of the cells through the basolateral pole.  This efflux was decreased by multidrug resistance-assocd. protein (MRP) inhibitors (probenecid, MK-571) and by ATP depletion.  A phthalimidomethylester of ampicillin that resists cellular esterases failed to cause any significant release (cell lysate) or transport (polarized Caco-2 cells) of ampicillin.  These results show that when PIVA is given to Caco-2 cells from their apical pole, ampicillin is released intracellularly and that ampicillin is thereafter preferentially effluxed into the basolateral medium through an MRP-like transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6OLAyYvqg7LVg90H21EOLACvtfcHk0lgszyyjBcoItA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Cqu7g%253D&md5=ef1d80e8202cf377ce2bb126a355c902</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.4.1279-1288.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.4.1279-1288.2005%26sid%3Dliteratum%253Aachs%26aulast%3DChanteux%26aufirst%3DH.%26aulast%3DVan%2BBambeke%26aufirst%3DF.%26aulast%3DMingeot-Leclercq%26aufirst%3DM.-P.%26aulast%3DTulkens%26aufirst%3DP.%2BM.%26atitle%3DAccumulation%2520and%2520oriented%2520transport%2520of%2520ampicillin%2520in%2520Caco-2%2520cells%2520from%2520its%2520pivaloyloxymethylester%2520prodrug%252C%2520pivampicillin%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D1279%26epage%3D1288%26doi%3D10.1128%2FAAC.49.4.1279-1288.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hai, L.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3651</span>– <span class="NLM_lpage">3661</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.05.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2Fj.ejmech.2011.05.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3651-3661&author=W.+Fanauthor=Y.+Wuauthor=X.+K.+Liauthor=N.+Yaoauthor=X.+Liauthor=Y.+G.+Yuauthor=L.+Hai&title=Design%2C+synthesis+and+biological+evaluation+of+brain-specific+glucosyl+thiamine+disulfide+prodrugs+of+naproxen&doi=10.1016%2Fj.ejmech.2011.05.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.05.029%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%2BK.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DY.%2BG.%26aulast%3DHai%26aufirst%3DL.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520brain-specific%2520glucosyl%2520thiamine%2520disulfide%2520prodrugs%2520of%2520naproxen%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3651%26epage%3D3661%26doi%3D10.1016%2Fj.ejmech.2011.05.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matiskella, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudyma, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejwani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J. J.</span></span> <span> </span><span class="NLM_article-title">Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">3669</span>– <span class="NLM_lpage">3672</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2Fj.bmcl.2003.08.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3669-3672&author=Y.+Uedaauthor=J.+D.+Matiskellaauthor=J.+Golikauthor=T.+P.+Connollyauthor=T.+W.+Hudymaauthor=S.+Venkateshauthor=M.+Daliauthor=S.+H.+Kangauthor=N.+Barbourauthor=R.+Tejwaniauthor=S.+Variaauthor=J.+Knipeauthor=M.+Zhengauthor=M.+Mathewauthor=K.+Mosureauthor=J.+Clarkauthor=L.+Lambauthor=I.+Medinauthor=Q.+Gaoauthor=S.+Huangauthor=C.+P.+Chenauthor=J.+J.+Bronson&title=Phosphonooxymethyl+prodrugs+of+the+broad+spectrum+antifungal+azole%2C+ravuconazole%3A+synthesis+and+biological+properties&doi=10.1016%2Fj.bmcl.2003.08.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMatiskella%26aufirst%3DJ.%2BD.%26aulast%3DGolik%26aufirst%3DJ.%26aulast%3DConnolly%26aufirst%3DT.%2BP.%26aulast%3DHudyma%26aufirst%3DT.%2BW.%26aulast%3DVenkatesh%26aufirst%3DS.%26aulast%3DDali%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DS.%2BH.%26aulast%3DBarbour%26aufirst%3DN.%26aulast%3DTejwani%26aufirst%3DR.%26aulast%3DVaria%26aufirst%3DS.%26aulast%3DKnipe%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DMathew%26aufirst%3DM.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DLamb%26aufirst%3DL.%26aulast%3DMedin%26aufirst%3DI.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%2BP.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26atitle%3DPhosphonooxymethyl%2520prodrugs%2520of%2520the%2520broad%2520spectrum%2520antifungal%2520azole%252C%2520ravuconazole%253A%2520synthesis%2520and%2520biological%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3669%26epage%3D3672%26doi%3D10.1016%2Fj.bmcl.2003.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chassaing, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckeroth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uphoff, M.</span></span> <span> </span><span class="NLM_article-title">Highly water-soluble prodrugs of anthelmintic benzimidazole carbamates: synthesis, pharmacodynamics, and pharmacokinetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1111</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1021/jm701456r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701456r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVamtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1111-1114&author=C.+Chassaingauthor=M.+Bergerauthor=A.+Heckerothauthor=T.+Ilgauthor=M.+Jaegerauthor=C.+Kernauthor=K.+Schmidauthor=M.+Uphoff&title=Highly+water-soluble+prodrugs+of+anthelmintic+benzimidazole+carbamates%3A+synthesis%2C+pharmacodynamics%2C+and+pharmacokinetics&doi=10.1021%2Fjm701456r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Water-Soluble Prodrugs of Anthelmintic Benzimidazole Carbamates: Synthesis, Pharmacodynamics, and Pharmacokinetics</span></div><div class="casAuthors">Chassaing, C.; Berger, M.; Heckeroth, A.; Ilg, T.; Jaeger, M.; Kern, C.; Schmid, K.; Uphoff, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1111-1114</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Highly water-sol. prodrugs, e.g. I, of anthelmintic benzimidazole carbamates, e.g. II, were synthesized.  These prodrugs combine high aq. soly. and stability with high lability in the presence of alk. phosphatases.  The veterinary utility of I and its regioisomer was shown by a pharmacodynamic and pharmacokinetic study performed in swine.  Comparable anthelmintic efficacy was obsd. with prodrug I and its regioisomer or the parent fenbendazole II.  The pharmacokinetic results showed that II is better absorbed when derived from I and its regioisomer than when applied as such.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_J3-sHxpdQrVg90H21EOLACvtfcHk0ljJcx2_e4m2Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVamtb8%253D&md5=3815f9d75c781a5e58bec26439255120</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm701456r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701456r%26sid%3Dliteratum%253Aachs%26aulast%3DChassaing%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DHeckeroth%26aufirst%3DA.%26aulast%3DIlg%26aufirst%3DT.%26aulast%3DJaeger%26aufirst%3DM.%26aulast%3DKern%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DK.%26aulast%3DUphoff%26aufirst%3DM.%26atitle%3DHighly%2520water-soluble%2520prodrugs%2520of%2520anthelmintic%2520benzimidazole%2520carbamates%253A%2520synthesis%252C%2520pharmacodynamics%252C%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1111%26epage%3D1114%26doi%3D10.1021%2Fjm701456r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grampovnik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flosi, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span> <span> </span><span class="NLM_article-title">Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavir</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2964</span>– <span class="NLM_lpage">2970</span>, <span class="refDoi"> DOI: 10.1021/jm900080g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900080g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFeltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2964-2970&author=D.+A.+DeGoeyauthor=D.+J.+Grampovnikauthor=W.+J.+Flosiauthor=K.+C.+Marshauthor=X.+C.+Wangauthor=L.+L.+Kleinauthor=K.+F.+McDanielauthor=Y.+Liuauthor=M.+A.+Longauthor=W.+M.+Katiauthor=A.+Mollaauthor=D.+J.+Kempf&title=Water-soluble+prodrugs+of+the+human+immunodeficiency+virus+protease+inhibitors+lopinavir+and+ritonavir&doi=10.1021%2Fjm900080g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Water-Soluble Prodrugs of the Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir</span></div><div class="casAuthors">DeGoey, David A.; Grampovnik, David J.; Flosi, William J.; Marsh, Kennan C.; Wang, Xiu C.; Klein, Larry L.; McDaniel, Keith F.; Liu, Yaya; Long, Michelle A.; Kati, Warren M.; Molla, Akhteruzzaman; Kempf, Dale J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2964-2970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We studied the synthesis, cleavage rates, and oral administration of prodrugs of the HIV protease inhibitors (PIs) lopinavir and ritonavir.  Phosphate esters attached directly to the central hydroxyl groups of these PIs did not demonstrate enzyme-mediated cleavage in vitro and did not provide measurable plasma levels of the parent drugs in vivo.  However, oxymethylphosphate (OMP) and oxyethylphosphate (OEP) prodrugs provided improved rates of cleavage, high levels of aq. soly., and high plasma levels of the parent drugs when dosed orally in rats and dogs.  Dosing unformulated capsules contg. the solid prodrugs led to plasma levels equiv. to those obsd. for dosing formulated solns. of the parent drugs.  A direct synthetic process for the prepn. of OMP and OEP prodrugs was developed, and the improved synthetic method may be applicable to the prepn. of analogous sol. prodrugs of other drug classes with limited soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeiB07ekQMJ7Vg90H21EOLACvtfcHk0ljejzLQsjjtoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFeltLs%253D&md5=6e64ddfeabd5725929cac142bdfe782d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm900080g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900080g%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DGrampovnik%26aufirst%3DD.%2BJ.%26aulast%3DFlosi%26aufirst%3DW.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DWang%26aufirst%3DX.%2BC.%26aulast%3DKlein%26aufirst%3DL.%2BL.%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DM.%2BA.%26aulast%3DKati%26aufirst%3DW.%2BM.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26atitle%3DWater-soluble%2520prodrugs%2520of%2520the%2520human%2520immunodeficiency%2520virus%2520protease%2520inhibitors%2520lopinavir%2520and%2520ritonavir%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2964%26epage%3D2970%26doi%3D10.1021%2Fjm900080g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dack, K.</span></span> <span> </span><span class="NLM_article-title">Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">485</span>, <span class="refDoi"> DOI: 10.2174/1389200033489253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.2174%2F1389200033489253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=14683475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslShtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=461-485&author=K.+Beaumontauthor=R.+Websterauthor=I.+Gardnerauthor=K.+Dack&title=Design+of+ester+prodrugs+to+enhance+oral+absorption+of+poorly+permeable+compounds%3A+challenges+to+the+discovery+scientist&doi=10.2174%2F1389200033489253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist</span></div><div class="casAuthors">Beaumont, Kevin; Webster, Robert; Gardner, Iain; Dack, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">461-485</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review and discussion.  Many drugs are administered at sites that are remote from their site of action.  The most common route of drug delivery is the oral route.  The optimal physicochem. properties to allow high transcellular absorption following oral administration are well established and include a limit on mol. size, hydrogen bonding potential and adequate lipophilicity.  For many drug targets, synthetic strategies can be devised to balance the physicochem. properties required for high transcellular absorption and the SAR for the drug target.  However, there are drug targets where the SAR requires properties at odds with good membrane permeability.  These include a requirement for significant polarity and groups that exhibit high hydrogen bonding potential such as carboxylic acids and alcs.  In such cases, prodrug strategies have been employed.  The rationale behind the prodrug strategy is to introduce lipophilicity and mask hydrogen bonding groups of an active compd. by the addn. of another moiety, most commonly an ester.  An ideal ester prodrug should exhibit the following properties:.  (1) Weak (or no) activity against any pharmacol. target,.  (2) Chem. stability across a pH range,.  (3) High aq. soly.,.  (4) Good transcellular absorption,.  (5) Resistance to hydrolysis during the absorption phase,.  (6) Rapid and quant. breakdown to yield high circulating concns. of the active component post absorption.  This paper will review the literature around marketed prodrugs and det. the most appropriate prodrug characteristics.  In addn., it will examine potential discovery approaches to optimizing prodrug delivery and recommend a strategy for prosecuting an oral prodrug approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJklGnlqCIqbVg90H21EOLACvtfcHk0lgugBGa69rayg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslShtLo%253D&md5=442e3b78efc2e601c688c03eeeaa6e54</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F1389200033489253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200033489253%26sid%3Dliteratum%253Aachs%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DDack%26aufirst%3DK.%26atitle%3DDesign%2520of%2520ester%2520prodrugs%2520to%2520enhance%2520oral%2520absorption%2520of%2520poorly%2520permeable%2520compounds%253A%2520challenges%2520to%2520the%2520discovery%2520scientist%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2003%26volume%3D4%26spage%3D461%26epage%3D485%26doi%3D10.2174%2F1389200033489253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klepser, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marangos, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintiliani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nightingale, C. H.</span></span> <span> </span><span class="NLM_article-title">Clinical pharmacokinetics of newer cephalosporins</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">361</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.2165/00003088-199528050-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.2165%2F00003088-199528050-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=7614776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaK2MXmsV2itb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1995&pages=361-384&author=M.+E.+Klepserauthor=M.+N.+Marangosauthor=K.+B.+Patelauthor=D.+P.+Nicolauauthor=R.+Quintilianiauthor=C.+H.+Nightingale&title=Clinical+pharmacokinetics+of+newer+cephalosporins&doi=10.2165%2F00003088-199528050-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics of newer cephalosporins</span></div><div class="casAuthors">Klepser, Michael E.; Marangos, Markos N.; Patel, Kalpana B.; Nicolau, David P.; Quintiliani, Richard; Nightingale, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">361-84</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    </div><div class="casAbstract">A review with 122 refs.  Several new cephalosporins have been developed in recent years.  These agents include several oral and parenteral agents with extended activity against Gramneg. pathogens.  The pharmacokinetic literature for these agents is quite extensive; therefore, we have summarized this information and presented it in tabular form for crit. comparison.  With a few exceptions, the newer cephalosporins share similar pharmacokinetic properties.  Cefixime, cefetamet pivoxil and ceftibuten differ from the others in that they exhibit nonlinear pharmacokinetic properties.  The nonlinear nature of these agents is reflected by decreasing maximal concns. with escalating doses of cefixime and cefetamet pivoxil, decreasing area under the serum concn.-time curve with increasing doses for cefixime, and a reduced bioavailability with large doses of ceftibuten.  Attention to such characteristics aid the clinician in selecting appropriate dosage regimens that will optimize drug absorption.  The majority of agents are primarily renally eliminated; however, renal elimination accounts for only 20% of cefixime elimination.  The pharmacokinetic parameters noted for the newer cephalosporins are not influenced by multiple dose administration, suggesting lack of drug accumulation over time.  The pharmacodynamics of antimicrobials should be considered when extrapolating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLIpb_YKe08rVg90H21EOLACvtfcHk0lgugBGa69rayg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsV2itb0%253D&md5=53e11c37a3f14bb05015326c538c7962</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2165%2F00003088-199528050-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199528050-00003%26sid%3Dliteratum%253Aachs%26aulast%3DKlepser%26aufirst%3DM.%2BE.%26aulast%3DMarangos%26aufirst%3DM.%2BN.%26aulast%3DPatel%26aufirst%3DK.%2BB.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26aulast%3DQuintiliani%26aufirst%3DR.%26aulast%3DNightingale%26aufirst%3DC.%2BH.%26atitle%3DClinical%2520pharmacokinetics%2520of%2520newer%2520cephalosporins%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1995%26volume%3D28%26spage%3D361%26epage%3D384%26doi%3D10.2165%2F00003088-199528050-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">3052</span>– <span class="NLM_lpage">3071</span>, <span class="refDoi"> DOI: 10.1002/jps.20913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1002%2Fjps.20913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=17722003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jtrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=3052-3071&author=L.+Zhouauthor=L.+Yangauthor=S.+Tiltonauthor=J.+Wang&title=Development+of+a+high+throughput+equilibrium+solubility+assay+using+miniaturized+shake-flask+method+in+early+drug+discovery&doi=10.1002%2Fjps.20913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery</span></div><div class="casAuthors">Zhou, Liping; Yang, Linhong; Tilton, Suzanne; Wang, Jianling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3052-3071</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Increasingly, pharmaceutical and biotech companies have begun to realize the importance of obtaining soly. information in early drug discovery as it is one of the crit. parameters for lead selection and optimization.  This report introduces a high-throughput equil. soly. (HT-Eq sol) assay using a novel miniaturized shake-flask approach and streamlined HPLC anal.  The new HT-Eq sol assay, validated and optimized via a test set of 85 marketed drugs and Novartis internal compds., shows an excellent correlation to the conventional shake-flask thermodn. soly. data generated inhouse and the equil. soly. results reported in literature.  It therefore offers a fast, reliable and cost-effective screening tool for soly. assessment in early drug discovery, allowing for prioritization of drug candidates using aq. soly. in conjunction with other profiling information and efficacy data.  Our work demonstrates that presence of a small amt. of DMSO (0.5-5%) will result in significant overestimation of equil. soly. (up to 6 folds).  In addn., monitoring of drug dissoln. process using the current approach as well as the interplay between equil. soly. data and those from kinetic soly. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLEKUmI4vDMLVg90H21EOLACvtfcHk0ljV3xK7xBIp8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jtrrO&md5=e04d5b859372d08551b4a6af19e23fb5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjps.20913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20913%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DTilton%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520high%2520throughput%2520equilibrium%2520solubility%2520assay%2520using%2520miniaturized%2520shake-flask%2520method%2520in%2520early%2520drug%2520discovery%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D3052%26epage%3D3071%26doi%3D10.1002%2Fjps.20913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, A. K.</span></span> <span> </span><span class="NLM_article-title">Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis</span>. <i>Artif. Cells, Nanomed., Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">937</span>– <span class="NLM_lpage">942</span>, <span class="refDoi"> DOI: 10.3109/21691401.2014.1000493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.3109%2F21691401.2014.1000493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=25783855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvVGnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=937-942&author=S.+Chaudharyauthor=T.+Gargauthor=G.+Rathauthor=R.+R.+Murthyauthor=A.+K.+Goyal&title=Enhancing+the+bioavailability+of+mebendazole+by+integrating+the+principles+solid+dispersion+and+nanocrystal+techniques%2C+for+safe+and+effective+management+of+human+echinococcosis&doi=10.3109%2F21691401.2014.1000493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis</span></div><div class="casAuthors">Chaudhary, Sushant; Garg, Tarun; Rath, Goutam; Murthy, Rs Rayasa; Goyal, Amit K.</div><div class="citationInfo"><span class="NLM_cas:title">Artificial Cells, Nanomedicine, and Biotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">937-942</span>CODEN:
                <span class="NLM_cas:coden">ACNBCI</span>;
        ISSN:<span class="NLM_cas:issn">2169-141X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The method based on integrating the principles of solid dispersion and nanocrystal techniques was developed to prep. polymer crystals (PCs) of mebendazole (MBZ) and polyethylene glycol (PEG).  Powder X-Ray diffraction (PXRD) of the PC crystals shows the required integrated cryst. and amorphous regions.  The in vitro soly. studies showed a 32-fold increase in the soly. of the drug.  Tests of dissoln. of the PCs showed that the crystals have an enhanced dissoln. rate in comparison to those in the MF.  The results of the pharmacokinetic study showed a 2.12-fold increase in the bioavailability of the drug.  Thus, the present study has proved the potential in enhancing soly., dissoln., and bioavailability of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqINAkL-gD7ZbVg90H21EOLACvtfcHk0lgHrlCsg3Sz-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvVGnsbY%253D&md5=bd5a401ae0ecd4f2a806189c860c224d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3109%2F21691401.2014.1000493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F21691401.2014.1000493%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DS.%26aulast%3DGarg%26aufirst%3DT.%26aulast%3DRath%26aufirst%3DG.%26aulast%3DMurthy%26aufirst%3DR.%2BR.%26aulast%3DGoyal%26aufirst%3DA.%2BK.%26atitle%3DEnhancing%2520the%2520bioavailability%2520of%2520mebendazole%2520by%2520integrating%2520the%2520principles%2520solid%2520dispersion%2520and%2520nanocrystal%2520techniques%252C%2520for%2520safe%2520and%2520effective%2520management%2520of%2520human%2520echinococcosis%26jtitle%3DArtif.%2520Cells%252C%2520Nanomed.%252C%2520Biotechnol.%26date%3D2016%26volume%3D44%26spage%3D937%26epage%3D942%26doi%3D10.3109%2F21691401.2014.1000493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graves, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledet, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nation, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pramar, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostanian, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, T. K.</span></span> <span> </span><span class="NLM_article-title">Effect of squalane on mebendazole-loaded Compritol(R) nanoparticles</span>. <i>J. Biomater. Sci., Polym. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1080/09205063.2015.1061351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1080%2F09205063.2015.1061351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=26062393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCktb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=868-880&author=R.+A.+Gravesauthor=G.+A.+Ledetauthor=C.+A.+Nationauthor=Y.+V.+Pramarauthor=L.+A.+Bostanianauthor=T.+K.+Mandal&title=Effect+of+squalane+on+mebendazole-loaded+Compritol%28R%29+nanoparticles&doi=10.1080%2F09205063.2015.1061351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of squalane on mebendazole-loaded Compritol nanoparticles</span></div><div class="casAuthors">Graves, Richard A.; Ledet, Grace A.; Nation, Cedric A.; Pramar, Yashoda V.; Bostanian, Levon A.; Mandal, Tarun K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomaterials Science, Polymer Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">868-880</span>CODEN:
                <span class="NLM_cas:coden">JBSEEA</span>;
        ISSN:<span class="NLM_cas:issn">0920-5063</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The objective of this study was to develop nanostructured lipid formulations of Compritol for the delivery of mebendazole.  The formulations were prepd. with Compritol 888 ATO, squalane, and Pluronic F68.  Nine batches with different amts. of modifier, squalane, and drug were prepd.  The formulations were characterized by evaluating particle size, morphol., and zeta potential.  The thermal properties of the formulations were analyzed by DSC.  The encapsulation efficiency of each formulation and the drug release rates from each formulation were quantified by UPLC.  The particles were spherical and had median particle sizes between 300 and 600 nm.  A linear relationship was obsd. between Compritol/squalane compn. and the m.p. of the mixt.  The DSC scans of the formulations revealed some recrystn. of the drug from the formulations, and the amt. of recrystn. correlated with the amt. of squalane in the formulation.  Approx., 70% efficiency of encapsulation was obsd. in the formulations with 30% (wt./wt.) squalane, and these formulations also had faster dissoln. rates compared to the other formulations.  Overall, the formulations with 30% squalane are the preferred formulation for future testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-rX1hkyq4YbVg90H21EOLACvtfcHk0lgHrlCsg3Sz-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCktb3N&md5=29c732125eef87b3514fa684a59e7bdf</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F09205063.2015.1061351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09205063.2015.1061351%26sid%3Dliteratum%253Aachs%26aulast%3DGraves%26aufirst%3DR.%2BA.%26aulast%3DLedet%26aufirst%3DG.%2BA.%26aulast%3DNation%26aufirst%3DC.%2BA.%26aulast%3DPramar%26aufirst%3DY.%2BV.%26aulast%3DBostanian%26aufirst%3DL.%2BA.%26aulast%3DMandal%26aufirst%3DT.%2BK.%26atitle%3DEffect%2520of%2520squalane%2520on%2520mebendazole-loaded%2520Compritol%2528R%2529%2520nanoparticles%26jtitle%3DJ.%2520Biomater.%2520Sci.%252C%2520Polym.%2520Ed.%26date%3D2015%26volume%3D26%26spage%3D868%26epage%3D880%26doi%3D10.1080%2F09205063.2015.1061351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span> <span> </span><span class="NLM_article-title">Evaluation of in vitro models for screening alkaline phosphatase-mediated bioconversion of phosphate ester prodrugs</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1443</span>– <span class="NLM_lpage">1447</span>, <span class="refDoi"> DOI: 10.1124/dmd.108.026245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1124%2Fdmd.108.026245" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1443-1447&author=H.+Yuanauthor=N.+Liauthor=Y.+Lai&title=Evaluation+of+in+vitro+models+for+screening+alkaline+phosphatase-mediated+bioconversion+of+phosphate+ester+prodrugs&doi=10.1124%2Fdmd.108.026245"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.026245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.026245%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLai%26aufirst%3DY.%26atitle%3DEvaluation%2520of%2520in%2520vitro%2520models%2520for%2520screening%2520alkaline%2520phosphatase-mediated%2520bioconversion%2520of%2520phosphate%2520ester%2520prodrugs%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1443%26epage%3D1447%26doi%3D10.1124%2Fdmd.108.026245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreskin, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locke, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartizal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokocimer, P.</span></span> <span> </span><span class="NLM_article-title">Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1284</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.056697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1124%2Fdmd.113.056697" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1275-1284&author=V.+Ongauthor=S.+Flanaganauthor=E.+Fangauthor=H.+J.+Dreskinauthor=J.+B.+Lockeauthor=K.+Bartizalauthor=P.+Prokocimer&title=Absorption%2C+distribution%2C+metabolism%2C+and+excretion+of+the+novel+antibacterial+prodrug+tedizolid+phosphate&doi=10.1124%2Fdmd.113.056697"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.056697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.056697%26sid%3Dliteratum%253Aachs%26aulast%3DOng%26aufirst%3DV.%26aulast%3DFlanagan%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DE.%26aulast%3DDreskin%26aufirst%3DH.%2BJ.%26aulast%3DLocke%26aufirst%3DJ.%2BB.%26aulast%3DBartizal%26aufirst%3DK.%26aulast%3DProkocimer%26aufirst%3DP.%26atitle%3DAbsorption%252C%2520distribution%252C%2520metabolism%252C%2520and%2520excretion%2520of%2520the%2520novel%2520antibacterial%2520prodrug%2520tedizolid%2520phosphate%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D1275%26epage%3D1284%26doi%3D10.1124%2Fdmd.113.056697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flores-Ramos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibarra-Velarde, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Campos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera-Montenegro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung-Cook, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canto-Alarcon, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Rivero, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, R.</span></span> <span> </span><span class="NLM_article-title">A highly water soluble benzimidazole derivative useful for the treatment of fasciolosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5814</span>– <span class="NLM_lpage">5817</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2Fj.bmcl.2014.10.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5814-5817&author=M.+Flores-Ramosauthor=F.+Ibarra-Velardeauthor=A.+Hernandez-Camposauthor=Y.+Vera-Montenegroauthor=H.+Jung-Cookauthor=G.+J.+Canto-Alarconauthor=L.+M.+del+Riveroauthor=R.+Castillo&title=A+highly+water+soluble+benzimidazole+derivative+useful+for+the+treatment+of+fasciolosis&doi=10.1016%2Fj.bmcl.2014.10.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DFlores-Ramos%26aufirst%3DM.%26aulast%3DIbarra-Velarde%26aufirst%3DF.%26aulast%3DHernandez-Campos%26aufirst%3DA.%26aulast%3DVera-Montenegro%26aufirst%3DY.%26aulast%3DJung-Cook%26aufirst%3DH.%26aulast%3DCanto-Alarcon%26aufirst%3DG.%2BJ.%26aulast%3Ddel%2BRivero%26aufirst%3DL.%2BM.%26aulast%3DCastillo%26aufirst%3DR.%26atitle%3DA%2520highly%2520water%2520soluble%2520benzimidazole%2520derivative%2520useful%2520for%2520the%2520treatment%2520of%2520fasciolosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5814%26epage%3D5817%26doi%3D10.1016%2Fj.bmcl.2014.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span>; <span class="NLM_string-name">Kanda, Y.</span>; <span class="NLM_string-name">Yamaguchi, H.</span>; <span class="NLM_string-name">Ashizawa, T.</span>; <span class="NLM_string-name">Murakata, C.</span>; <span class="NLM_string-name">Ikeda, S.-i.</span>; <span class="NLM_string-name">Tamaoki, T.</span></span> <span> </span><span class="NLM_article-title">DC107 Derivatives</span>. U.S. Patent <span class="NLM_patent">5,981,558</span>, Nov 9, <span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=H.+Arai&author=Y.+Kanda&author=H.+Yamaguchi&author=T.+Ashizawa&author=C.+Murakata&author=S.-i.+Ikeda&author=T.+Tamaoki&title=DC107+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DH.%26atitle%3DDC107%2520Derivatives%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ranjeet
P. Dash, Tomáš Tichý, Vijayabhaskar Veeravalli, Jenny Lam, Jesse Alt, Ying Wu, Lukáš Tenora, Pavel Majer, Barbara S. Slusher, <span class="NLM_string-name hlFld-ContribAuthor">Rana Rais</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced Oral Bioavailability of 2-(Phosphonomethyl)-pentanedioic Acid (2-PMPA) from its (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (ODOL)-Based Prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2019,</strong> <em>16 </em>
                                    (10)
                                     , 4292-4301. <a href="https://doi.org/10.1021/acs.molpharmaceut.9b00637" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.9b00637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.9b00637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.9b00637%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DEnhanced%252BOral%252BBioavailability%252Bof%252B2-%252528Phosphonomethyl%252529-pentanedioic%252BAcid%252B%2525282-PMPA%252529%252Bfrom%252Bits%252B%2525285-Methyl-2-oxo-1%25252C3-dioxol-4-yl%252529methyl%252B%252528ODOL%252529-Based%252BProdrugs%26aulast%3DDash%26aufirst%3DRanjeet%2BP.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07062019%26date%3D10092019%26date%3D12082019%26date%3D24092019%26date%3D10092019%26volume%3D16%26issue%3D10%26spage%3D4292%26epage%3D4301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kader Poturcu, <span class="NLM_string-name hlFld-ContribAuthor">Ebru Çubuk Demiralay</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of Some Physicochemical Properties of Mebendazole with RPLC Method. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical & Engineering Data</span><span> <strong>2019,</strong> <em>64 </em>
                                    (6)
                                     , 2736-2741. <a href="https://doi.org/10.1021/acs.jced.9b00131" title="DOI URL">https://doi.org/10.1021/acs.jced.9b00131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jced.9b00131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jced.9b00131%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520%2526%2520Engineering%2520Data%26atitle%3DDetermination%252Bof%252BSome%252BPhysicochemical%252BProperties%252Bof%252BMebendazole%252Bwith%252BRPLC%252BMethod%26aulast%3DPoturcu%26aufirst%3DKader%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04022019%26date%3D29032019%26date%3D10042019%26volume%3D64%26issue%3D6%26spage%3D2736%26epage%3D2741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lukáš Tenora, Jesse Alt, Ranjeet P. Dash, Alexandra J. Gadiano, Kateřina Novotná, Vijayabhaskar Veeravalli, Jenny Lam, Quinn R. Kirkpatrick, Kathryn M. Lemberg, Pavel Majer, Rana Rais, <span class="NLM_string-name hlFld-ContribAuthor">Barbara S. Slusher</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3524-3538. <a href="https://doi.org/10.1021/acs.jmedchem.8b02009" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b02009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b02009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b02009%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTumor-Targeted%252BDelivery%252Bof%252B6-Diazo-5-oxo-l-norleucine%252B%252528DON%252529%252BUsing%252BSubstituted%252BAcetylated%252BLysine%252BProdrugs%26aulast%3DTenora%26aufirst%3DLuk%25C3%25A1%25C5%25A1%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21122018%26date%3D29032019%26date%3D20032019%26volume%3D62%26issue%3D7%26spage%3D3524%26epage%3D3538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Mansoori</span>, <span class="hlFld-ContribAuthor ">M.  Fryknäs</span>, <span class="hlFld-ContribAuthor ">C.  Alvfors</span>, <span class="hlFld-ContribAuthor ">A.  Loskog</span>, <span class="hlFld-ContribAuthor ">R.  Larsson</span>, <span class="hlFld-ContribAuthor ">P.  Nygren</span>. </span><span class="cited-content_cbyCitation_article-title">A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-88433-y" title="DOI URL">https://doi.org/10.1038/s41598-021-88433-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-88433-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-88433-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252Bphase%252B2a%252Bclinical%252Bstudy%252Bon%252Bthe%252Bsafety%252Band%252Befficacy%252Bof%252Bindividualized%252Bdosed%252Bmebendazole%252Bin%252Bpatients%252Bwith%252Badvanced%252Bgastrointestinal%252Bcancer%26aulast%3DMansoori%26aufirst%3DS.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Studenovský</span>, <span class="hlFld-ContribAuthor ">Anna  Rumlerová</span>, <span class="hlFld-ContribAuthor ">Libor  Kostka</span>, <span class="hlFld-ContribAuthor ">Tomáš  Etrych</span>. </span><span class="cited-content_cbyCitation_article-title">HPMA-Based Polymer Conjugates for Repurposed Drug Mebendazole and Other Imidazole-Based Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Polymers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (15)
                                     , 2530. <a href="https://doi.org/10.3390/polym13152530" title="DOI URL">https://doi.org/10.3390/polym13152530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/polym13152530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpolym13152530%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymers%26atitle%3DHPMA-Based%252BPolymer%252BConjugates%252Bfor%252BRepurposed%252BDrug%252BMebendazole%252Band%252BOther%252BImidazole-Based%252BTherapeutics%26aulast%3DStudenovsk%25C3%25BD%26aufirst%3DMartin%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D15%26spage%3D2530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seyed Ebrahim  Alavi</span>, <span class="hlFld-ContribAuthor ">Hasan  Ebrahimi Shahmabadi</span>. </span><span class="cited-content_cbyCitation_article-title">Anthelmintics for drug repurposing: Opportunities and challenges. </span><span class="cited-content_cbyCitation_journal-name">Saudi Pharmaceutical Journal</span><span> <strong>2021,</strong> <em>29 </em>
                                    (5)
                                     , 434-445. <a href="https://doi.org/10.1016/j.jsps.2021.04.004" title="DOI URL">https://doi.org/10.1016/j.jsps.2021.04.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsps.2021.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsps.2021.04.004%26sid%3Dliteratum%253Aachs%26jtitle%3DSaudi%2520Pharmaceutical%2520Journal%26atitle%3DAnthelmintics%252Bfor%252Bdrug%252Brepurposing%25253A%252BOpportunities%252Band%252Bchallenges%26aulast%3DAlavi%26aufirst%3DSeyed%2BEbrahim%26date%3D2021%26volume%3D29%26issue%3D5%26spage%3D434%26epage%3D445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosalba  Florio</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Serena  Veschi</span>, <span class="hlFld-ContribAuthor ">Davide  Brocco</span>, <span class="hlFld-ContribAuthor ">Teresa  Di Genni</span>, <span class="hlFld-ContribAuthor ">Roberto  Cirilli</span>, <span class="hlFld-ContribAuthor ">Adriano  Casulli</span>, <span class="hlFld-ContribAuthor ">Alessandro  Cama</span>, <span class="hlFld-ContribAuthor ">Laura  De Lellis</span>. </span><span class="cited-content_cbyCitation_article-title">Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (4)
                                     , 372. <a href="https://doi.org/10.3390/ph14040372" title="DOI URL">https://doi.org/10.3390/ph14040372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14040372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14040372%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DScreening%252Bof%252BBenzimidazole-Based%252BAnthelmintics%252Band%252BTheir%252BEnantiomers%252Bas%252BRepurposed%252BDrug%252BCandidates%252Bin%252BCancer%252BTherapy%26aulast%3DFlorio%26aufirst%3DRosalba%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D4%26spage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary L  Gallia</span>, <span class="hlFld-ContribAuthor ">Matthias  Holdhoff</span>, <span class="hlFld-ContribAuthor ">Henry  Brem</span>, <span class="hlFld-ContribAuthor ">Avadhut D  Joshi</span>, <span class="hlFld-ContribAuthor ">Christine L  Hann</span>, <span class="hlFld-ContribAuthor ">Ren-Yuan  Bai</span>, <span class="hlFld-ContribAuthor ">Verena  Staedtke</span>, <span class="hlFld-ContribAuthor ">Jaishri O  Blakeley</span>, <span class="hlFld-ContribAuthor ">Soma  Sengupta</span>, <span class="hlFld-ContribAuthor ">T Che  Jarrell</span>, <span class="hlFld-ContribAuthor ">Jessica  Wollett</span>, <span class="hlFld-ContribAuthor ">Kelly  Szajna</span>, <span class="hlFld-ContribAuthor ">Nicole  Helie</span>, <span class="hlFld-ContribAuthor ">Austin K  Mattox</span>, <span class="hlFld-ContribAuthor ">Xiaobu  Ye</span>, <span class="hlFld-ContribAuthor ">Michelle A  Rudek</span>, <span class="hlFld-ContribAuthor ">Gregory J  Riggins</span>. </span><span class="cited-content_cbyCitation_article-title">Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial. </span><span class="cited-content_cbyCitation_journal-name">Neuro-Oncology Advances</span><span> <strong>2021,</strong> <em>3 </em>
                                    (1)
                                     <a href="https://doi.org/10.1093/noajnl/vdaa154" title="DOI URL">https://doi.org/10.1093/noajnl/vdaa154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/noajnl/vdaa154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnoajnl%2Fvdaa154%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuro-Oncology%2520Advances%26atitle%3DMebendazole%252Band%252Btemozolomide%252Bin%252Bpatients%252Bwith%252Bnewly%252Bdiagnosed%252Bhigh-grade%252Bgliomas%25253A%252Bresults%252Bof%252Ba%252Bphase%252B1%252Bclinical%252Btrial%26aulast%3DGallia%26aufirst%3DGary%2BL%26date%3D2021%26date%3D2020%26volume%3D3%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prashant  Kumar</span>, <span class="hlFld-ContribAuthor ">Sriparna  Dutta</span>, <span class="hlFld-ContribAuthor ">Sandeep  Kumar</span>, <span class="hlFld-ContribAuthor ">Vijay  Bahadur</span>, <span class="hlFld-ContribAuthor ">Erik V.  Van der Eycken</span>, <span class="hlFld-ContribAuthor ">Karani Santhanarishnan  Vimaleswaran</span>, <span class="hlFld-ContribAuthor ">Virinder S.  Parmar</span>, <span class="hlFld-ContribAuthor ">Brajendra K.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Aldehydes: magnificent acyl equivalents for direct acylation. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (40)
                                     , 7987-8033. <a href="https://doi.org/10.1039/D0OB01458C" title="DOI URL">https://doi.org/10.1039/D0OB01458C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01458C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01458C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAldehydes%25253A%252Bmagnificent%252Bacyl%252Bequivalents%252Bfor%252Bdirect%252Bacylation%26aulast%3DKumar%26aufirst%3DPrashant%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D40%26spage%3D7987%26epage%3D8033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolei  Wang</span>, <span class="hlFld-ContribAuthor ">Kaiyan  Lou</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Song</span>, <span class="hlFld-ContribAuthor ">Huijuan  Ma</span>, <span class="hlFld-ContribAuthor ">Xinyi  Zhou</span>, <span class="hlFld-ContribAuthor ">Huan  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells. </span><span class="cited-content_cbyCitation_journal-name">Toxicology and Applied Pharmacology</span><span> <strong>2020,</strong> <em>396 </em>, 115001. <a href="https://doi.org/10.1016/j.taap.2020.115001" title="DOI URL">https://doi.org/10.1016/j.taap.2020.115001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.taap.2020.115001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.taap.2020.115001%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520and%2520Applied%2520Pharmacology%26atitle%3DMebendazole%252Bis%252Ba%252Bpotent%252Binhibitor%252Bto%252Bchemoresistant%252BT%252Bcell%252Bacute%252Blymphoblastic%252Bleukemia%252Bcells%26aulast%3DWang%26aufirst%3DXiaolei%26date%3D2020%26volume%3D396%26spage%3D115001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mixia  Hu</span>, <span class="hlFld-ContribAuthor ">YaLi  Yan</span>, <span class="hlFld-ContribAuthor ">Baohua  Zhu</span>, <span class="hlFld-ContribAuthor ">Fei  Chang</span>, <span class="hlFld-ContribAuthor ">Shiyong  Yu</span>, <span class="hlFld-ContribAuthor ">Gaole  Alatan</span>. </span><span class="cited-content_cbyCitation_article-title">A series of Mn(
              i
              ) photo-activated carbon monoxide-releasing molecules with benzimidazole coligands: synthesis, structural characterization, CO releasing properties and biological activity evaluation. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (36)
                                     , 20505-20512. <a href="https://doi.org/10.1039/C9RA01370A" title="DOI URL">https://doi.org/10.1039/C9RA01370A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA01370A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA01370A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bseries%252Bof%252BMn%252528%252Bi%252B%252529%252Bphoto-activated%252Bcarbon%252Bmonoxide-releasing%252Bmolecules%252Bwith%252Bbenzimidazole%252Bcoligands%25253A%252Bsynthesis%25252C%252Bstructural%252Bcharacterization%25252C%252BCO%252Breleasing%252Bproperties%252Band%252Bbiological%252Bactivity%252Bevaluation%26aulast%3DHu%26aufirst%3DMixia%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D36%26spage%3D20505%26epage%3D20512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhao  Wang</span>, <span class="hlFld-ContribAuthor ">Zhao  Yu</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Dirk  Daelemans</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (3)
                                     , 447-456. <a href="https://doi.org/10.1016/j.bmc.2018.12.039" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.12.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.12.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.12.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bacetamide-substituted%252Bdoravirine%252Band%252Bits%252Bprodrugs%252Bas%252Bpotent%252BHIV-1%252BNNRTIs%26aulast%3DWang%26aufirst%3DZhao%26date%3D2019%26volume%3D27%26issue%3D3%26spage%3D447%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nian-Qiu  Shi</span>, <span class="hlFld-ContribAuthor ">Ying  Jin</span>, <span class="hlFld-ContribAuthor ">Yong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Xia  Che</span>, <span class="hlFld-ContribAuthor ">Xiao  Xiao</span>, <span class="hlFld-ContribAuthor ">Gui-Hua  Cui</span>, <span class="hlFld-ContribAuthor ">Yu-Zhou  Chen</span>, <span class="hlFld-ContribAuthor ">Bo  Feng</span>, <span class="hlFld-ContribAuthor ">Zheng-Qiang  Li</span>, <span class="hlFld-ContribAuthor ">Xian-Rong  Qi</span>. </span><span class="cited-content_cbyCitation_article-title">The Influence of Cellulosic Polymer’s Variables on Dissolution/Solubility of Amorphous Felodipine and Crystallization Inhibition from a Supersaturated State. </span><span class="cited-content_cbyCitation_journal-name">AAPS PharmSciTech</span><span> <strong>2019,</strong> <em>20 </em>
                                    (1)
                                     <a href="https://doi.org/10.1208/s12249-018-1266-y" title="DOI URL">https://doi.org/10.1208/s12249-018-1266-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12249-018-1266-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12249-018-1266-y%26sid%3Dliteratum%253Aachs%26jtitle%3DAAPS%2520PharmSciTech%26atitle%3DThe%252BInfluence%252Bof%252BCellulosic%252BPolymer%2525E2%252580%252599s%252BVariables%252Bon%252BDissolution%25252FSolubility%252Bof%252BAmorphous%252BFelodipine%252Band%252BCrystallization%252BInhibition%252Bfrom%252Ba%252BSupersaturated%252BState%26aulast%3DShi%26aufirst%3DNian-Qiu%26date%3D2019%26date%3D2018%26volume%3D20%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">秋玥  范</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Evaluation of Diaryl Ketones against SHP2. </span><span class="cited-content_cbyCitation_journal-name">Hans Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>07 </em>
                                    (02)
                                     , 19-24. <a href="https://doi.org/10.12677/HJMCe.2019.72004" title="DOI URL">https://doi.org/10.12677/HJMCe.2019.72004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12677/HJMCe.2019.72004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12677%2FHJMCe.2019.72004%26sid%3Dliteratum%253Aachs%26jtitle%3DHans%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiological%252BEvaluation%252Bof%252BDiaryl%252BKetones%252Bagainst%252BSHP2%26aulast%3D%25E8%258C%2583%26aufirst%3D%25E7%25A7%258B%25E7%258E%25A5%26date%3D2019%26volume%3D07%26issue%3D02%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Prodrugs <b>1</b>, <b>2</b>, and <b>7</b>–<b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) <i>t</i>-BuOK, DMSO, rt, 15 min; (ii) Cl-R, rt, 1 h; (b) (i) <b>3</b>, HCl, dioxane, 0 °C, 1 h; (ii) Boc-<span class="smallcaps smallerCapital">l</span>-Leu-OH, HOBt, EDC, DIPEA, DMF, rt, overnight; (c) (i) <b>6</b>, HCl, dioxane, 0 °C; (ii) AcOH, HOBt, EDC, DIPEA, DMF, 0 °C to rt, overnight; (d) <b>4</b> or <b>5</b>, TFA, DCM, 0 °C to rt, 3.5 or 2 h.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Prodrug <b>11</b>, <b>12</b>, and <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NaH, DMF, 0 °C, 1 h; (ii) Cl-R, DMF, 0 °C to rt, 16 h; (b) <b>10</b> or <b>13,</b> TFA, DCM, rt, 16 h; (c) <b>11</b>, <i>N</i>,<i>N</i>′-dicyclohexyl-4-morpholinecarboxamidine, DMF, chloromethyl isopropyl carbonate, rt, 24 h.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Aqueous solubility of MBZ and MBZ prodrugs <b>1</b>, <b>2</b>, <b>7</b>–<b>9</b>, <b>11</b>, and <b>12</b> in 0.01 M PBS determined using equilibrium solubility methods. Data are expressed as the mean ± SEM (<i>n</i> = 3). The dotted line represents the solubility of MBZ-C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. MBZ plasma concentration at 1 h after oral administration of MBZ-C or prodrug administration. MBZ-C or <b>1</b>, <b>2</b>, <b>7</b>, <b>8</b>, <b>9</b>, <b>11</b>, <b>12</b> were administered to male CD-1 mice as a single dose by oral gavage at 30 mg/kg MBZ equivalent dose. Data are expressed as the mean ± SEM (<i>n</i> = 3), with statistics quantified using one-way ANOVA with Dunnett’s multiple comparison test: (∗) <i>p</i> < 0.05, (∗∗) <i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. MBZ pharmacokinetics in mice and dogs following iv administration. (A) MBZ-C was administered to male CD-1 mice as a single iv dose at 1.5 mg/kg, and plasma concentrations were determined over time. (B) MBZ-C was administered to male beagle dogs as a single iv dose of 0.3 mg/kg, and plasma concentrations were determined over time. (C) Pharmacokinetic parameters were calculated using noncompartmental analysis in WinNonlin. Data are expressed as the mean ± SEM for mouse (<i>n</i> = 3/time-point) and as the mean for dog (<i>n</i> = 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) MBZ plasma and (B) brain pharmacokinetics in mice after oral administration of MBZ-C or <b>12</b>. MBZ-C and <b>12</b> were administered to mice as a single po dose of 30 mg/kg equivalent for <b>12</b>. (C) Pharmacokinetic parameters were calculated using noncompartmental analysis in WinNonlin, with data expressed as the mean ± SEM (<i>n</i> = 3 mice/time-point).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/medium/jm-2017-017922_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) MBZ plasma exposure in male beagle dogs after oral administration of MBZ-C or <b>12</b>. MBZ-C and prodrug <b>12</b> were administered to male beagle dogs (<i>n</i> = 2 per group) as a single po dose of 2.5 mg/kg or equivalent for <b>12</b>. (B) Pharmacokinetic parameters were calculated using noncompartmental analysis in WinNonlin, with data expressed as the mean.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-9/acs.jmedchem.7b01792/20180504/images/large/jm-2017-017922_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01792&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 53 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dayan, A. D.</span></span> <span> </span><span class="NLM_article-title">Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics</span>. <i>Acta Trop.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">159</span>, <span class="refDoi"> DOI: 10.1016/S0001-706X(03)00031-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2FS0001-706X%2803%2900031-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=12745134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1CksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2003&pages=141-159&author=A.+D.+Dayan&title=Albendazole%2C+mebendazole+and+praziquantel.+Review+of+non-clinical+toxicity+and+pharmacokinetics&doi=10.1016%2FS0001-706X%2803%2900031-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics</span></div><div class="casAuthors">Dayan, A. D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Tropica</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">141-159</span>CODEN:
                <span class="NLM_cas:coden">ACTRAQ</span>;
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The pharmacokinetics and toxicity of albendazole, mebendazole and praziquantel are extensively reviewed, drawing on original published work and reviews in the open scientific literature and on assessments by international agencies and official regulatory bodies in Europe and the USA.  Information about human and veterinary medical uses and adverse reactions is evaluated.  The totality of the non-clin. information available about these long-established drugs may not comply with current official guidelines for new medicines but reasons are given why the "deficiencies" are only apparent and the data gaps can be replaced by other results, largely obtained from the target species and the many years of clin. experience of safe use of these drugs in humans and animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1UR0n6yDH-7Vg90H21EOLACvtfcHk0lggI-V8K8WGEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1CksLc%253D&md5=2a4a89437c43489535f81a0af4451bc3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0001-706X%2803%2900031-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0001-706X%252803%252900031-7%26sid%3Dliteratum%253Aachs%26aulast%3DDayan%26aufirst%3DA.%2BD.%26atitle%3DAlbendazole%252C%2520mebendazole%2520and%2520praziquantel.%2520Review%2520of%2520non-clinical%2520toxicity%2520and%2520pharmacokinetics%26jtitle%3DActa%2520Trop.%26date%3D2003%26volume%3D86%26spage%3D141%26epage%3D159%26doi%3D10.1016%2FS0001-706X%2803%2900031-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martarelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzoni, G.</span></span> <span> </span><span class="NLM_article-title">Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">817</span>, <span class="refDoi"> DOI: 10.1007/s00280-007-0538-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1007%2Fs00280-007-0538-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=17581752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitleru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=809-817&author=D.+Martarelliauthor=P.+Pompeiauthor=C.+Baldiauthor=G.+Mazzoni&title=Mebendazole+inhibits+growth+of+human+adrenocortical+carcinoma+cell+lines+implanted+in+nude+mice&doi=10.1007%2Fs00280-007-0538-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice</span></div><div class="casAuthors">Martarelli, Daniele; Pompei, Pierluigi; Baldi, Caterina; Mazzoni, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">809-817</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Adrenocortical carcinoma is a rare tumor of the adrenal gland which requires new therapeutic approaches as its early diagnosis is difficult and prognosis poor despite therapies used.  Recently, mebendazole has been proved to be effective against different cancers.  The aim of our study was to evaluate whether mebendazole may result therapeutically useful in the treatment of human adrenocortical carcinoma.  We analyzed the effect of mebendazole on human adrenocortical carcinoma cells in vitro and after implantation in nude mice.  In order to clarify mechanisms of mebendazole action, metastases formation, apoptosis and angiogenesis were also investigated.  Mebendazole significantly inhibited cancer cells growth, both in vitro and in vivo, the effects being due to the induction of apoptosis.  Moreover, mebendazole inhibited invasion and migration of cancer cells in vitro, and metastases formation in vivo.  Overall, these data suggest that treatment with mebendazole, also in combination with std. therapies, could provide a new protocol for the inhibition of adrenocortical carcinoma growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdwQ0oo1WtCLVg90H21EOLACvtfcHk0lggI-V8K8WGEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitleru7c%253D&md5=723cfa4b786f346aa6a8789ee6a9b30e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00280-007-0538-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-007-0538-0%26sid%3Dliteratum%253Aachs%26aulast%3DMartarelli%26aufirst%3DD.%26aulast%3DPompei%26aufirst%3DP.%26aulast%3DBaldi%26aufirst%3DC.%26aulast%3DMazzoni%26aufirst%3DG.%26atitle%3DMebendazole%2520inhibits%2520growth%2520of%2520human%2520adrenocortical%2520carcinoma%2520cell%2520lines%2520implanted%2520in%2520nude%2520mice%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2008%26volume%3D61%26spage%3D809%26epage%3D817%26doi%3D10.1007%2Fs00280-007-0538-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomyo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, T.</span></span> <span> </span><span class="NLM_article-title">The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells</span>. <i>Mol. Cancer Ther</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1201</span>– <span class="NLM_lpage">1209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=12479701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFOgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=1201-1209&author=J.-i.+Sasakiauthor=R.+Rameshauthor=S.+Chadaauthor=Y.+Gomyoauthor=J.+A.+Rothauthor=T.+Mukhopadhyay&title=The+anthelmintic+drug+mebendazole+induces+mitotic+arrest+and+apoptosis+by+depolymerizing+tubulin+in+non-small+cell+lung+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells</span></div><div class="casAuthors">Sasaki, Ji-ichiro; Ramesh, Rajagopal; Chada, Sunil; Gomyo, Yoshihito; Roth, Jack A.; Mukhopadhyay, Tapas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1201-1209</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Microtubules have a crit. role in cell division, and consequently various microtubule inhibitors have been developed as anticancer drugs.  In this study, we assess mebendazole (MZ), a microtubule-disrupting anthelmintic that exhibits a potent antitumor property both in vitro and in vivo.  Treatment of lung cancer cell lines with MZ caused mitotic arrest, followed by apoptotic cell death with the feature of caspase activation and cytochrome c release.  MZ induces abnormal spindle formation in mitotic cancer cells and enhances the depolymn. of tubulin, but the efficacy of depolymn. by MZ is lower than that by nocodazole.  Oral administration of MZ in mice elicited a strong antitumor effect in a s.c. model and reduced lung colonies in exptl. induced lung metastasis without any toxicity when compared with paclitaxel-treated mice.  We speculate that tumor cells may be defective in one mitotic checkpoint function and sensitive to the spindle inhibitor MZ.  Abnormal spindle formation may be the key factor detg. whether a cell undergoes apoptosis, whereas strong microtubule inhibitors elicit toxicity even in normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUgBAyDMQdALVg90H21EOLACvtfcHk0lggI-V8K8WGEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFOgsA%253D%253D&md5=d1968c17a75ec56f41f390b29a126149</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSasaki%26aufirst%3DJ.-i.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DChada%26aufirst%3DS.%26aulast%3DGomyo%26aufirst%3DY.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26aulast%3DMukhopadhyay%26aufirst%3DT.%26atitle%3DThe%2520anthelmintic%2520drug%2520mebendazole%2520induces%2520mitotic%2520arrest%2520and%2520apoptosis%2520by%2520depolymerizing%2520tubulin%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DMol.%2520Cancer%2520Ther%26date%3D2002%26volume%3D1%26spage%3D1201%26epage%3D1209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, J.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J. A.</span></span> <span> </span><span class="NLM_article-title">Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2963</span>– <span class="NLM_lpage">2969</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=12231542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvVWitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=2963-2969&author=T.+Mukhopadhyayauthor=J.-i.+Sasakiauthor=R.+Rameshauthor=J.+A.+Roth&title=Mebendazole+elicits+a+potent+antitumor+effect+on+human+cancer+cell+lines+both+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo</span></div><div class="casAuthors">Mukhopadhyay, Tapas; Sasaki, Ji-ichiro; Ramesh, Rajagopal; Roth, Jack A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2963-2969</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The authors have found that mebendazole (MZ), a deriv. of benzimidazole, induces a dose- and time-dependent apoptotic response in human lung cancer cell lines.  In this study, MZ arrested, cells at the G2-M phase before the onset of apoptosis, as detected by using fluorescence-activated cell sorter anal.  MZ treatment also resulted in mitochondrial cytochrome c release, followed by apoptotic cell death.  Addnl., MZ appeared to be a potent inhibitor of tumor cell growth with little toxicity to normal WI38 and human umbilical vein endothelial cells.  When administered p.o. to nu/nu mice, MZ strongly inhibited the growth of human tumor xenografts and significantly reduced the no. and size of tumors in an exptl. model of lung metastasis.  In assessing angiogenesis, the authors found significantly reduced vessel densities in MZ-treated mice compared with those in control mice.  These results suggest that MZ is effective in the treatment of cancer and other angiogenesis-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrugueCb-tSCrVg90H21EOLACvtfcHk0lijifO3VBadeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvVWitrY%253D&md5=ead554fcf3e9eea65f30dd241b0420ac</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukhopadhyay%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DJ.-i.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DJ.%2BA.%26atitle%3DMebendazole%2520elicits%2520a%2520potent%2520antitumor%2520effect%2520on%2520human%2520cancer%2520cell%2520lines%2520both%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D2963%26epage%3D2969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinheiro, J. o. d. J.
V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assumpção, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbano, R. M. r. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montenegro, R. C.</span></span> <span> </span><span class="NLM_article-title">The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2038</span>– <span class="NLM_lpage">2044</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2015.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2Fj.tiv.2015.08.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=2038-2044&author=L.+C.+Pintoauthor=B.+M.+Soaresauthor=J.+o.+d.+J.%0AV.+Pinheiroauthor=G.+J.+Rigginsauthor=P.+P.+Assump%C3%A7%C3%A3oauthor=R.+M.+r.+R.+Burbanoauthor=R.+C.+Montenegro&title=The+anthelmintic+drug+mebendazole+inhibits+growth%2C+migration+and+invasion+in+gastric+cancer+cell+model&doi=10.1016%2Fj.tiv.2015.08.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2015.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2015.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DPinto%26aufirst%3DL.%2BC.%26aulast%3DSoares%26aufirst%3DB.%2BM.%26aulast%3DPinheiro%26aufirst%3DJ.%2Bo.%2Bd.%2BJ.%2BV.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DAssump%25C3%25A7%25C3%25A3o%26aufirst%3DP.%2BP.%26aulast%3DBurbano%26aufirst%3DR.%2BM.%2Br.%2BR.%26aulast%3DMontenegro%26aufirst%3DR.%2BC.%26atitle%3DThe%2520anthelmintic%2520drug%2520mebendazole%2520inhibits%2520growth%252C%2520migration%2520and%2520invasion%2520in%2520gastric%2520cancer%2520cell%2520model%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2015%26volume%3D29%26spage%3D2038%26epage%3D2044%26doi%3D10.1016%2Fj.tiv.2015.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nygren, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryknäs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ågerup, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, R.</span></span> <span> </span><span class="NLM_article-title">Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer</span>. <i>J. Cancer Res. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">2133</span>– <span class="NLM_lpage">2140</span>, <span class="refDoi"> DOI: 10.1007/s00432-013-1539-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1007%2Fs00432-013-1539-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2013&pages=2133-2140&author=P.+Nygrenauthor=M.+Frykn%C3%A4sauthor=B.+%C3%85gerupauthor=R.+Larsson&title=Repositioning+of+the+anthelmintic+drug+mebendazole+for+the+treatment+for+colon+cancer&doi=10.1007%2Fs00432-013-1539-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00432-013-1539-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00432-013-1539-5%26sid%3Dliteratum%253Aachs%26aulast%3DNygren%26aufirst%3DP.%26aulast%3DFrykn%25C3%25A4s%26aufirst%3DM.%26aulast%3D%25C3%2585gerup%26aufirst%3DB.%26aulast%3DLarsson%26aufirst%3DR.%26atitle%3DRepositioning%2520of%2520the%2520anthelmintic%2520drug%2520mebendazole%2520for%2520the%2520treatment%2520for%2520colon%2520cancer%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D139%26spage%3D2133%26epage%3D2140%26doi%3D10.1007%2Fs00432-013-1539-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doudican, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlow, S. J.</span></span> <span> </span><span class="NLM_article-title">Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1315</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-07-2159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1158%2F1541-7786.MCR-07-2159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=18667591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvVaru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=1308-1315&author=N.+Doudicanauthor=A.+Rodriguezauthor=I.+Osmanauthor=S.+J.+Orlow&title=Mebendazole+induces+apoptosis+via+Bcl-2+inactivation+in+chemoresistant+melanoma+cells&doi=10.1158%2F1541-7786.MCR-07-2159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells</span></div><div class="casAuthors">Doudican, Nicole; Rodriguez, Adrianna; Osman, Iman; Orlow, Seth J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1308-1315</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most metastatic melanoma patients fail to respond to available therapy, underscoring the need for novel approaches to identify new effective treatments.  In this study, we screened 2000 compds. from the Spectrum Library at a concn. of 1 μmol/L using two chemoresistant melanoma cell lines (M-14 and SK-Mel-19) and a spontaneously immortalized, nontumorigenic melanocyte cell line (melan-a).  We identified 10 compds. that inhibited the growth of the melanoma cells yet were largely nontoxic to melanocytes.  Strikingly, 4 of the 10 compds. (mebendazole, albendazole, fenbendazole, and oxybendazole) are benzimidazoles, a class of structurally related, tubulin-disrupting drugs.  Mebendazole was prioritized to further characterize its mechanism of melanoma growth inhibition based on its favorable pharmacokinetic profile.  Our data reveal that mebendazole inhibits melanoma growth with an av. IC50 of 0.32 μmol/L and preferentially induces apoptosis in melanoma cells compared with melanocytes.  The intrinsic apoptotic response is mediated through phosphorylation of Bcl-2, which occurs rapidly after treatment with mebendazole in melanoma cells but not in melanocytes.  Phosphorylation of Bcl-2 in melanoma cells prevents its interaction with proapoptotic Bax, thereby promoting apoptosis.  We further show that mebendazole-resistant melanocytes can be sensitized through redn. of Bcl-2 protein levels, showing the essential role of Bcl-2 in the cellular response to mebendazole-mediated tubulin disruption.  Our results suggest that this screening approach is useful for identifying agents that show promise in the treatment of even chemoresistant melanoma and identifies mebendazole as a potent, melanoma-specific cytotoxic agent. (Mol Cancer Res 2008;6(8):1308-15).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGralwYWYl7TOLVg90H21EOLACvtfcHk0lijifO3VBadeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvVaru7w%253D&md5=602db897f9fa2887989a01a427f37bad</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-07-2159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-07-2159%26sid%3Dliteratum%253Aachs%26aulast%3DDoudican%26aufirst%3DN.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DOsman%26aufirst%3DI.%26aulast%3DOrlow%26aufirst%3DS.%2BJ.%26atitle%3DMebendazole%2520induces%2520apoptosis%2520via%2520Bcl-2%2520inactivation%2520in%2520chemoresistant%2520melanoma%2520cells%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2008%26volume%3D6%26spage%3D1308%26epage%3D1315%26doi%3D10.1158%2F1541-7786.MCR-07-2159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Witt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markowitz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Dimassi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atlas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boockvar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggieri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, M.</span></span> <span> </span><span class="NLM_article-title">Repurposing mebendazole as a replacement for vincristine for the treatment of brain tumors</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.2119/molmed.2017.00011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.2119%2Fmolmed.2017.00011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2jt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=50-56&author=M.+De%0AWittauthor=A.+Gambleauthor=D.+Hansonauthor=D.+Markowitzauthor=C.+Powellauthor=S.+Al+Dimassiauthor=M.+Atlasauthor=J.+Boockvarauthor=R.+Ruggieriauthor=M.+Symons&title=Repurposing+mebendazole+as+a+replacement+for+vincristine+for+the+treatment+of+brain+tumors&doi=10.2119%2Fmolmed.2017.00011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing mebendazole as a replacement for vincristine for the treatment of brain tumors</span></div><div class="casAuthors">De Witt, Michelle; Gamble, Alexander; Hanson, Derek; Markowitz, Daniel; Powell, Caitlin; Al Dimassi, Saleh; Atlas, Mark; Boockvar, John; Ruggieri, Rosamaria; Symons, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-56</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">The microtubule inhibitor vincristine is currently used to treat a variety of brain tumors, including low-grade glioma and anaplastic oligodendroglioma.  Vincristine, however, does not penetrate well into brain tumor tissue, and moreover, it displays dose-limiting toxicities, including peripheral neuropathy.  Mebendazole, a Food and Drug Administration-approved anthelmintic drug with a favorable safety profile, has recently been shown to display strong therapeutic efficacy in animal models of both glioma and medulloblastoma.  Importantly, appropriate formulations of mebendazole yield therapeutically effective concns. in the brain.  Mebendazole has been shown to inhibit microtubule formation, but it is not known whether its potency against tumor cells is mediated by this inhibitory effect.  To investigate this, we examd. the effects of mebendazole on GL261 glioblastoma cell viability, microtubule polymn. and metaphase arrest, and found that the effective concns. to inhibit these functions are very similar.  In addn., using mebendazole as a seed for the National Cancer Institute (NCI) COMPARE program revealed that the top-scoring drugs were highly enriched in microtubule-targeting drugs.  Taken together, these results indicate that the cell toxicity of mebendazole is indeed caused by inhibiting microtubule formation.  We also compared the therapeutic efficacy of mebendazole and vincristine against GL261 orthotopic tumors.  We found that mebendazole showed a significant increase in animal survival time, whereas vincristine, even at a dose close to its max. tolerated dose, failed to show any efficacy.  In conclusion, our results strongly support the clin. use of mebendazole as a replacement for vincristine for the treatment of brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLaLlA48oseLVg90H21EOLACvtfcHk0lgEZe6mqOICJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2jt7vM&md5=f40e1baab1509e5bd4eb2f4fb8649e9d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2017.00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2017.00011%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BWitt%26aufirst%3DM.%26aulast%3DGamble%26aufirst%3DA.%26aulast%3DHanson%26aufirst%3DD.%26aulast%3DMarkowitz%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DAl%2BDimassi%26aufirst%3DS.%26aulast%3DAtlas%26aufirst%3DM.%26aulast%3DBoockvar%26aufirst%3DJ.%26aulast%3DRuggieri%26aufirst%3DR.%26aulast%3DSymons%26aufirst%3DM.%26atitle%3DRepurposing%2520mebendazole%2520as%2520a%2520replacement%2520for%2520vincristine%2520for%2520the%2520treatment%2520of%2520brain%2520tumors%26jtitle%3DMol.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D50%26epage%3D56%26doi%3D10.2119%2Fmolmed.2017.00011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staedtke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span> <span> </span><span class="NLM_article-title">Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis</span>. <i>J. Neuro-Oncol</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nou234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1093%2Fneuonc%2Fnou234" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=545-554&author=R.+Y.+Baiauthor=V.+Staedtkeauthor=C.+M.+Rudinauthor=F.+Bunzauthor=G.+J.+Riggins&title=Effective+treatment+of+diverse+medulloblastoma+models+with+mebendazole+and+its+impact+on+tumor+angiogenesis&doi=10.1093%2Fneuonc%2Fnou234"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnou234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnou234%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DR.%2BY.%26aulast%3DStaedtke%26aufirst%3DV.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DBunz%26aufirst%3DF.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26atitle%3DEffective%2520treatment%2520of%2520diverse%2520medulloblastoma%2520models%2520with%2520mebendazole%2520and%2520its%2520impact%2520on%2520tumor%2520angiogenesis%26jtitle%3DJ.%2520Neuro-Oncol%26date%3D2015%26volume%3D17%26spage%3D545%26epage%3D554%26doi%3D10.1093%2Fneuonc%2Fnou234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staedtke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aprhys, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallia, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span> <span> </span><span class="NLM_article-title">Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme</span>. <i>J. Neuro-Oncol</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">974</span>– <span class="NLM_lpage">982</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nor077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1093%2Fneuonc%2Fnor077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=974-982&author=R.-Y.+Baiauthor=V.+Staedtkeauthor=C.+M.+Aprhysauthor=G.+L.+Galliaauthor=G.+J.+Riggins&title=Antiparasitic+mebendazole+shows+survival+benefit+in+2+preclinical+models+of+glioblastoma+multiforme&doi=10.1093%2Fneuonc%2Fnor077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnor077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnor077%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DR.-Y.%26aulast%3DStaedtke%26aufirst%3DV.%26aulast%3DAprhys%26aufirst%3DC.%2BM.%26aulast%3DGallia%26aufirst%3DG.%2BL.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26atitle%3DAntiparasitic%2520mebendazole%2520shows%2520survival%2520benefit%2520in%25202%2520preclinical%2520models%2520of%2520glioblastoma%2520multiforme%26jtitle%3DJ.%2520Neuro-Oncol%26date%3D2011%26volume%3D13%26spage%3D974%26epage%3D982%26doi%3D10.1093%2Fneuonc%2Fnor077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borodovsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunz, F.</span></span> <span> </span><span class="NLM_article-title">Repurposing the antihelmintic mebendazole as a hedgehog inhibitor</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0755-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1158%2F1535-7163.MCT-14-0755-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=25376612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=3-13&author=A.+R.+Larsenauthor=R.+Y.+Baiauthor=J.+H.+Chungauthor=A.+Borodovskyauthor=C.+M.+Rudinauthor=G.+J.+Rigginsauthor=F.+Bunz&title=Repurposing+the+antihelmintic+mebendazole+as+a+hedgehog+inhibitor&doi=10.1158%2F1535-7163.MCT-14-0755-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor</span></div><div class="casAuthors">Larsen, Andrew R.; Bai, Ren-Yuan; Chung, Jon H.; Borodovsky, Alexandra; Rudin, Charles M.; Riggins, Gregory J.; Bunz, Fred</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-13</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The hedgehog (Hh) signaling pathway is activated in many types of cancer and therefore presents an attractive target for new anticancer agents.  Here, we show that mebendazole, a benzamidazole with a long history of safe use against nematode infestations and hydatid disease, potently inhibited Hh signaling and slowed the growth of Hh-driven human medulloblastoma cells at clin. attainable concns.  As an antiparasitic, mebendazole avidly binds nematode tubulin and causes inhibition of intestinal microtubule synthesis.  In human cells, mebendazole suppressed the formation of the primary cilium, a microtubule-based organelle that functions as a signaling hub for Hh pathway activation.  The inhibition of Hh signaling by mebendazole was unaffected by mutants in the gene that encodes human Smoothened (SMO), which are selectively propagated in cell clones that survive treatment with the Hh inhibitor vismodegib.  Combination of vismodegib and mebendazole resulted in additive Hh signaling inhibition.  Because mebendazole can be safely administered to adults and children at high doses over extended time periods, we propose that mebendazole could be rapidly repurposed and clin. tested as a prospective therapeutic agent for many tumors that are dependent on Hh signaling.  Mol Cancer Ther; 14(1); 3-13. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrApjZTGzyUjbVg90H21EOLACvtfcHk0lgEZe6mqOICJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWltg%253D%253D&md5=0367c7cd03ecf9d4c9a108940962fb55</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0755-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0755-T%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DA.%2BR.%26aulast%3DBai%26aufirst%3DR.%2BY.%26aulast%3DChung%26aufirst%3DJ.%2BH.%26aulast%3DBorodovsky%26aufirst%3DA.%26aulast%3DRudin%26aufirst%3DC.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DBunz%26aufirst%3DF.%26atitle%3DRepurposing%2520the%2520antihelmintic%2520mebendazole%2520as%2520a%2520hedgehog%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D3%26epage%3D13%26doi%3D10.1158%2F1535-7163.MCT-14-0755-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span>Mebendazole
in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide. <a href="https://ClinicalTrials.gov/show/NCT01729260" class="extLink">https://ClinicalTrials.gov/show/NCT01729260</a> (accessed March 14, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mebendazole%0Ain+Newly+Diagnosed+High-Grade+Glioma+Patients+Receiving+Temozolomide.+https%3A%2F%2FClinicalTrials.gov%2Fshow%2FNCT01729260+%28accessed+March+14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span>A Phase
I Study of Mebendazole for the Treatment of Pediatric Gliomas. <a href="https://ClinicalTrials.gov/show/NCT01837862" class="extLink">https://ClinicalTrials.gov/show/NCT01837862</a> (accessed March 14, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase%0AI+Study+of+Mebendazole+for+the+Treatment+of+Pediatric+Gliomas.+https%3A%2F%2FClinicalTrials.gov%2Fshow%2FNCT01837862+%28accessed+March+14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span>Phase
I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric
Brain Tumors. <a href="https://ClinicalTrials.gov/show/NCT02644291" class="extLink">https://ClinicalTrials.gov/show/NCT02644291</a> (accessed March
14, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Phase%0AI+Study+of+Mebendazole+Therapy+for+Recurrent%2FProgressive+Pediatric%0ABrain+Tumors.+https%3A%2F%2FClinicalTrials.gov%2Fshow%2FNCT02644291+%28accessed+March%0A14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span>Study
of the Safety, Tolerability and Efficacy of Metabolic Combination
Treatments on Cancer. <a href="https://ClinicalTrials.gov/show/NCT02201381" class="extLink">https://ClinicalTrials.gov/show/NCT02201381</a> (accessed March 14, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Study%0Aof+the+Safety%2C+Tolerability+and+Efficacy+of+Metabolic+Combination%0ATreatments+on+Cancer.+https%3A%2F%2FClinicalTrials.gov%2Fshow%2FNCT02201381+%28accessed+March+14%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carlert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akesson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerndal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindfors, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lennernas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsson, B.</span></span> <span> </span><span class="NLM_article-title">In vivo dog intestinal precipitation of mebendazole: a basic BCS class II drug</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2903</span>– <span class="NLM_lpage">2911</span>, <span class="refDoi"> DOI: 10.1021/mp300224h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300224h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=2903-2911&author=S.+Carlertauthor=P.+Akessonauthor=G.+Jerndalauthor=L.+Lindforsauthor=H.+Lennernasauthor=B.+Abrahamsson&title=In+vivo+dog+intestinal+precipitation+of+mebendazole%3A+a+basic+BCS+class+II+drug&doi=10.1021%2Fmp300224h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In Vivo Dog Intestinal Precipitation of Mebendazole: A Basic BCS Class II Drug</span></div><div class="casAuthors">Carlert, Sara; Aakesson, Pernilla; Jerndal, Gunilla; Lindfors, Lennart; Lennernaes, Hans; Abrahamsson, Bertil</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2903-2911</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The purpose of this study was to investigate in vivo intestinal pptn. of a model drug mebendazole, a basic BCS class II drug, using dogs with intestinal stomas for administration or sampling.  After oral administration of a soln. with an expected intestinal supersatn. of approx. 20 times the soly., the measured supersatn. in dog intestinal fluid (DIF) was up to 10 times and, on av., only 11% of the given dose was retrieved as solid drug in the collected fluid from the stoma.  The drug was rapidly absorbed with >90% of the total systemic exposure reached within three hours after duodenal administration of a soln.  In silico absorption modeling showed that in vivo data were reasonably well described by a nonpptg. soln.  An in vitro model of pptn. in DIF predicted that the intestinal concn. of dissolved mebendazole would be less than 1/5 of the initial concn. within 10 min at concns. comparable to in vivo.  It was concluded that intestinal pptn. did not have any major influence on mebendazole absorption.  The extent of pptn. was over-predicted in vitro given the in vivo absorption rate, and further work is needed to identify in vitro factors that could enable more accurate in vivo predictions of intestinal pptn. from solns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYBoyuqddhl7Vg90H21EOLACvtfcHk0lhS8_AH1pLRgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrnF&md5=697d8c0c812ce8f71d0102bca6ec78a5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fmp300224h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300224h%26sid%3Dliteratum%253Aachs%26aulast%3DCarlert%26aufirst%3DS.%26aulast%3DAkesson%26aufirst%3DP.%26aulast%3DJerndal%26aufirst%3DG.%26aulast%3DLindfors%26aufirst%3DL.%26aulast%3DLennernas%26aufirst%3DH.%26aulast%3DAbrahamsson%26aufirst%3DB.%26atitle%3DIn%2520vivo%2520dog%2520intestinal%2520precipitation%2520of%2520mebendazole%253A%2520a%2520basic%2520BCS%2520class%2520II%2520drug%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D2903%26epage%3D2911%26doi%3D10.1021%2Fmp300224h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martins, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neves, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellena, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cami, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brusau, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narda, G. E.</span></span> <span> </span><span class="NLM_article-title">Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">2336</span>– <span class="NLM_lpage">2344</span>, <span class="refDoi"> DOI: 10.1002/jps.21593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1002%2Fjps.21593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=18855910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslCgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=2336-2344&author=F.+T.+Martinsauthor=P.+P.+Nevesauthor=J.+Ellenaauthor=G.+E.+Camiauthor=E.+V.+Brusauauthor=G.+E.+Narda&title=Intermolecular+contacts+influencing+the+conformational+and+geometric+features+of+the+pharmaceutically+preferred+mebendazole+polymorph+C&doi=10.1002%2Fjps.21593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C</span></div><div class="casAuthors">Martins, Felipe T.; Neves, Person P.; Ellena, Javier; Cami, Gerardo E.; Brusau, Elena V.; Narda, Griselda E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2336-2344</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Mebendazole (MBZ) is a common benzimidazole anthelmintic that exists in three different polymorphic forms, A, B, and C. Polymorph C is the pharmaceutically preferred form due to its adequated aq. soly.  No single crystal structure detns. depicting the nature of the crystal packing and mol. conformation and geometry have been performed on this compd.  The crystal structure of mebendazole form C is resolved for the first time.  Mebendazole form C crystallizes in the triclinic centrosym. space group and this drug is practically planar, since the least-squares Me benzimidazolylcarbamate plane is much fitted on the forming atoms.  However, the benzoyl group is twisted by 31(1)° from the benzimidazole ring, likewise the torsional angle between the benzene and carbonyl moieties is 27(1)°.  The formerly described bends and other interesting intramol. geometry features were viewed as consequence of the intermol. contacts occurring within mebendazole C structure.  Among these features, a conjugation decreasing through the imine nitrogen atom of the benzimidazole core and a further resonance path crossing the carbamate one were described.  At last, the X-ray powder diffractogram of a form C rich mebendazole mixt. was overlaid to the calcd. one with the mebendazole crystal structure. © 2008 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 98:2336-2344, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocDeRh92bDTbVg90H21EOLACvtfcHk0lhS8_AH1pLRgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslCgtr4%253D&md5=475bf5c6a50615335e0fc389f675e5a1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fjps.21593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21593%26sid%3Dliteratum%253Aachs%26aulast%3DMartins%26aufirst%3DF.%2BT.%26aulast%3DNeves%26aufirst%3DP.%2BP.%26aulast%3DEllena%26aufirst%3DJ.%26aulast%3DCami%26aufirst%3DG.%2BE.%26aulast%3DBrusau%26aufirst%3DE.%2BV.%26aulast%3DNarda%26aufirst%3DG.%2BE.%26atitle%3DIntermolecular%2520contacts%2520influencing%2520the%2520conformational%2520and%2520geometric%2520features%2520of%2520the%2520pharmaceutically%2520preferred%2520mebendazole%2520polymorph%2520C%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D2336%26epage%3D2344%26doi%3D10.1002%2Fjps.21593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, T. R.</span></span> <span> </span><span class="NLM_article-title">The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]-mebendazole</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">455</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.1982.tb02008.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1111%2Fj.1365-2125.1982.tb02008.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=7126419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaL38XmtVOlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1982&pages=453-455&author=M.+Dawsonauthor=R.+J.+Allanauthor=T.+R.+Watson&title=The+pharmacokinetics+and+bioavailability+of+mebendazole+in+man%3A+a+pilot+study+using+%5B3H%5D-mebendazole&doi=10.1111%2Fj.1365-2125.1982.tb02008.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]mebendazole</span></div><div class="casAuthors">Dawson, M.; Allan, R. J.; Watson, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">453-5</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">Following the i.v. administration of a tracer dose (1.7 μg) of mebendazole (I)  [31431-39-7] to a man, an elimination half-life of 1.16 h was obsd. and the vol. of distribution was calcd. to be 2.03 L/kg.  After oral administration of the same dose, an elimination half-life of 0.74 h was obsd.  The bioavailability of mebendazole from the soln. was found to be 17%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDYYE3xy_zqbVg90H21EOLACvtfcHk0lhS8_AH1pLRgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XmtVOlt7g%253D&md5=8519b2e6abb3007ff74654b1b918b770</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1982.tb02008.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1982.tb02008.x%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DAllan%26aufirst%3DR.%2BJ.%26aulast%3DWatson%26aufirst%3DT.%2BR.%26atitle%3DThe%2520pharmacokinetics%2520and%2520bioavailability%2520of%2520mebendazole%2520in%2520man%253A%2520a%2520pilot%2520study%2520using%2520%255B3H%255D-mebendazole%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1982%26volume%3D14%26spage%3D453%26epage%3D455%26doi%3D10.1111%2Fj.1365-2125.1982.tb02008.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braithwaite, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, T. R.</span></span> <span> </span><span class="NLM_article-title">The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.1985.tb02616.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1111%2Fj.1365-2125.1985.tb02616.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=3978023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaL2MXhvFOnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1985&pages=79-86&author=M.+Dawsonauthor=P.+A.+Braithwaiteauthor=M.+S.+Robertsauthor=T.+R.+Watson&title=The+pharmacokinetics+and+bioavailability+of+a+tracer+dose+of+%5B3H%5D-mebendazole+in+man&doi=10.1111%2Fj.1365-2125.1985.tb02616.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man</span></div><div class="casAuthors">Dawson, M.; Braithwaite, P. A.; Roberts, M. S.; Watson, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-86</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">Five volunteers (37-64 yr) took part in a cross-over study to det. the pharmacokinetics and bioavailability of mebendazole (I)  [31431-39-7] in man following i.v. and oral administration.  Following i.v. administration, the av. distribution half-life, elimination half-life, and rate of clearance were 0.20 h, 1.12 h, and 1.063 min, resp.  After oral administration of the soln. the av. elimination half-life was 0.93 h, the apparent rate of clearance was 0.846 L/min, the av. time to peak plasma concn. was 0.42 h, and the bioavailability was 22%.  Comparison of metabolite area under the plasma concn. vs. time data from each route of administration indicates that absorption from the gastrointestinal tract at this does level is almost complete.  The low bioavailability obsd. following oral administration at this dose level is postulated to be due to high first-pass elimination.  Approx. half of the administered dose of radioactivity following i.v. and oral administration of I-3H was detected in the urine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL0-wvrzs8xrVg90H21EOLACvtfcHk0lj96tzAtPbGAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXhvFOnsLs%253D&md5=aa85847a228047d11269133f5fc6df04</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1985.tb02616.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1985.tb02616.x%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DBraithwaite%26aufirst%3DP.%2BA.%26aulast%3DRoberts%26aufirst%3DM.%2BS.%26aulast%3DWatson%26aufirst%3DT.%2BR.%26atitle%3DThe%2520pharmacokinetics%2520and%2520bioavailability%2520of%2520a%2520tracer%2520dose%2520of%2520%255B3H%255D-mebendazole%2520in%2520man%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1985%26volume%3D19%26spage%3D79%26epage%3D86%26doi%3D10.1111%2Fj.1365-2125.1985.tb02616.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Himmelreich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, T. R.</span></span> <span> </span><span class="NLM_article-title">Polymorphic forms of mebendazole</span>. <i>Aust. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">123</span>– <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1971&pages=123-125&author=M.+Himmelreichauthor=B.+J.+Rawsonauthor=T.+R.+Watson&title=Polymorphic+forms+of+mebendazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHimmelreich%26aufirst%3DM.%26aulast%3DRawson%26aufirst%3DB.%2BJ.%26aulast%3DWatson%26aufirst%3DT.%2BR.%26atitle%3DPolymorphic%2520forms%2520of%2520mebendazole%26jtitle%3DAust.%2520J.%2520Pharm.%2520Sci.%26date%3D1971%26volume%3D6%26spage%3D123%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staedtke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanjiku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudek, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallia, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riggins, G. J.</span></span> <span> </span><span class="NLM_article-title">Brain penetration and efficacy of different mebendazole polymorphs in a mouse brain tumor model</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3462</span>– <span class="NLM_lpage">3470</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-14-2681</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1158%2F1078-0432.CCR-14-2681" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=25862759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1yqtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=3462-3470&author=R.+Y.+Baiauthor=V.+Staedtkeauthor=T.+Wanjikuauthor=M.+A.+Rudekauthor=A.+Joshiauthor=G.+L.+Galliaauthor=G.+J.+Riggins&title=Brain+penetration+and+efficacy+of+different+mebendazole+polymorphs+in+a+mouse+brain+tumor+model&doi=10.1158%2F1078-0432.CCR-14-2681"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model</span></div><div class="casAuthors">Bai, Ren-Yuan; Staedtke, Verena; Wanjiku, Teresia; Rudek, Michelle A.; Joshi, Avadhut; Gallia, Gary L.; Riggins, Gregory J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3462-3470</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Mebendazole (MBZ), first used as an antiparasitic drug, shows preclin. efficacy in models of glioblastoma and medulloblastoma.  Three different mebendazole polymorphs (A, B, and C) exist, and a detailed assessment of the brain penetration, pharmacokinetics, and antitumor properties of each individual mebendazole polymorph is necessary to improve mebendazole-based brain cancer therapy.  Exptl. Design and Results: In this study, various marketed and custom-formulated mebendazole tablets were analyzed for their polymorph content by IR spectroscopy and subsequently tested in an orthotopic GL261 mouse glioma model for efficacy and tolerability.  The pharmacokinetics and brain concn. of mebendazole polymorphs and two main metabolites were analyzed by LC/MS.  We found that polymorph B and C both increased survival in a GL261 glioma model, as B exhibited greater toxicity.  Polymorph A showed no benefit.  Polymorph B and C both reached concns. in the brain that exceeded the IC50 in GL261 cells 29-fold.  In addn., polymorph C demonstrated an AUC0-24h brain-to-plasma (B/P) ratio of 0.82, whereas B showed higher plasma AUC and lower B/P ratio.  In contrast, polymorph A presented markedly lower levels in the plasma and brain.  Furthermore, the combination with elacridar was able to significantly improve the efficacy of polymorph C in GL261 glioma and D425 medulloblastoma models in mice.  Conclusions: Among mebendazole polymorphs, C reaches therapeutically effective concns. in the brain tissue and tumor with fewer side effects, and is the better choice for brain cancer therapy.  Its efficacy can be further enhanced by combination with elacridar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQBtBGtrQ5JbVg90H21EOLACvtfcHk0lj96tzAtPbGAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1yqtrnL&md5=92d3feae588ea27cea5378307de1b3b8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-2681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-2681%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DR.%2BY.%26aulast%3DStaedtke%26aufirst%3DV.%26aulast%3DWanjiku%26aufirst%3DT.%26aulast%3DRudek%26aufirst%3DM.%2BA.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DGallia%26aufirst%3DG.%2BL.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26atitle%3DBrain%2520penetration%2520and%2520efficacy%2520of%2520different%2520mebendazole%2520polymorphs%2520in%2520a%2520mouse%2520brain%2520tumor%2520model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D3462%26epage%3D3470%26doi%3D10.1158%2F1078-0432.CCR-14-2681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Caabeiro, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criado-Fornelio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igual, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujol, M.</span></span> <span> </span><span class="NLM_article-title">Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms</span>. <i>Chemotherapy</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">266</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1159/000238506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1159%2F000238506" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2004&pages=266-271&author=F.+Rodriguez-Caabeiroauthor=A.+Criado-Fornelioauthor=A.+Jimenez-Gonzalezauthor=L.+Guzmanauthor=A.+Igualauthor=A.+Perezauthor=M.+Pujol&title=Experimental+chemotherapy+and+toxicity+in+mice+of+three+mebendazole+polymorphic+forms&doi=10.1159%2F000238506"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1159%2F000238506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000238506%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Caabeiro%26aufirst%3DF.%26aulast%3DCriado-Fornelio%26aufirst%3DA.%26aulast%3DJimenez-Gonzalez%26aufirst%3DA.%26aulast%3DGuzman%26aufirst%3DL.%26aulast%3DIgual%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DA.%26aulast%3DPujol%26aufirst%3DM.%26atitle%3DExperimental%2520chemotherapy%2520and%2520toxicity%2520in%2520mice%2520of%2520three%2520mebendazole%2520polymorphic%2520forms%26jtitle%3DChemotherapy%26date%3D2004%26volume%3D33%26spage%3D266%26epage%3D271%26doi%3D10.1159%2F000238506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brits, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebenberg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Villiers, M. M.</span></span> <span> </span><span class="NLM_article-title">Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">1138</span>– <span class="NLM_lpage">1151</span>, <span class="refDoi"> DOI: 10.1002/jps.21899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1002%2Fjps.21899" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=1138-1151&author=M.+Britsauthor=W.+Liebenbergauthor=M.+M.+de+Villiers&title=Characterization+of+polymorph+transformations+that+decrease+the+stability+of+tablets+containing+the+WHO+essential+drug+mebendazole&doi=10.1002%2Fjps.21899"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjps.21899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21899%26sid%3Dliteratum%253Aachs%26aulast%3DBrits%26aufirst%3DM.%26aulast%3DLiebenberg%26aufirst%3DW.%26aulast%3Dde%2BVilliers%26aufirst%3DM.%2BM.%26atitle%3DCharacterization%2520of%2520polymorph%2520transformations%2520that%2520decrease%2520the%2520stability%2520of%2520tablets%2520containing%2520the%2520WHO%2520essential%2520drug%2520mebendazole%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26spage%3D1138%26epage%3D1151%26doi%3D10.1002%2Fjps.21899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Honorato, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farfan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filho, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarao, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fechine, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, M. E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabbene, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuffini, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, A. P.</span></span> <span> </span><span class="NLM_article-title">Polymorphism evaluation in generic tablets containing mebendazole by dissolution tests</span>. <i>J. Braz. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1590/S0103-50532012000200005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1590%2FS0103-50532012000200005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFaku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=220-227&author=S.+B.+Honoratoauthor=S.+Farfanauthor=A.+Vianaauthor=J.+M.+Filhoauthor=G.+C.+Camaraoauthor=F.+V.+Fechineauthor=M.+E.+A.+Moraesauthor=M.+O.+Moraesauthor=M.+Ferroauthor=V.+Dabbeneauthor=S.+L.+Cuffiniauthor=A.+P.+Ayala&title=Polymorphism+evaluation+in+generic+tablets+containing+mebendazole+by+dissolution+tests&doi=10.1590%2FS0103-50532012000200005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Polymorphism evaluation in generic tablets containing mebendazole by dissolution tests</span></div><div class="casAuthors">Honorato, Sara B.; Farfan, Silvia; Viana, Arnaldo; Filho, Josue M.; Camarao, Gisela C.; Fechine, Francisco V.; Moraes, Maria E. A.; Moraes, Manoel O.; Ferro, Maribel; Dabbene, Viviana; Cuffini, Silvia L.; Ayala, Alejandro P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Brazilian Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-227</span>CODEN:
                <span class="NLM_cas:coden">JOCSET</span>;
        ISSN:<span class="NLM_cas:issn">0103-5053</span>.
    
            (<span class="NLM_cas:orgname">Sociedade Brasileira de Quimica</span>)
        </div><div class="casAbstract">This study evaluates the incidence of the polymorphic forms of mebendazole (MBZ) in tablets within the Brazilian market by dissoln. tests.  The indicated dissoln. medium by the USP 30 (United States Pharmacopoeia) and a proposed modified medium were duly compared in order to verify whether they are able to discriminate the polymorph A from polymorph C in com. tablets.  Dissoln. assay tests of phys. mixts. in raw materials of polymorph A and polymorph C, as well as of nine tablets of MBZ (available in the Brazilian market), were properly performed.  For the dissoln. tests, the USP 30 medium (I) and a modified medium (II) were used.  The modified medium allowed a reproducible and reliable quality control of MBZ polymorphism in com. tablets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmK5rJsSrB5rVg90H21EOLACvtfcHk0lhNUYtaieUqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFaku78%253D&md5=00aff2d21cb42e9c24b431ff025040b0</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1590%2FS0103-50532012000200005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0103-50532012000200005%26sid%3Dliteratum%253Aachs%26aulast%3DHonorato%26aufirst%3DS.%2BB.%26aulast%3DFarfan%26aufirst%3DS.%26aulast%3DViana%26aufirst%3DA.%26aulast%3DFilho%26aufirst%3DJ.%2BM.%26aulast%3DCamarao%26aufirst%3DG.%2BC.%26aulast%3DFechine%26aufirst%3DF.%2BV.%26aulast%3DMoraes%26aufirst%3DM.%2BE.%2BA.%26aulast%3DMoraes%26aufirst%3DM.%2BO.%26aulast%3DFerro%26aufirst%3DM.%26aulast%3DDabbene%26aufirst%3DV.%26aulast%3DCuffini%26aufirst%3DS.%2BL.%26aulast%3DAyala%26aufirst%3DA.%2BP.%26atitle%3DPolymorphism%2520evaluation%2520in%2520generic%2520tablets%2520containing%2520mebendazole%2520by%2520dissolution%2520tests%26jtitle%3DJ.%2520Braz.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D23%26spage%3D220%26epage%3D227%26doi%3D10.1590%2FS0103-50532012000200005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swanepoel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebenberg, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Villiers, M. M.</span></span> <span> </span><span class="NLM_article-title">Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/S0939-6411(03)00004-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2FS0939-6411%2803%2900004-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=12754010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1GjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=345-349&author=E.+Swanepoelauthor=W.+Liebenbergauthor=M.+M.+de+Villiers&title=Quality+evaluation+of+generic+drugs+by+dissolution+test%3A+changing+the+USP+dissolution+medium+to+distinguish+between+active+and+non-active+mebendazole+polymorphs&doi=10.1016%2FS0939-6411%2803%2900004-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs</span></div><div class="casAuthors">Swanepoel, Erna; Liebenberg, Wilna; de Villiers, Melgardt M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-349</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Mebendazole is practically insol. in water and studies of its polymorphism has led to the identification and characterization of 3 polymorphic forms (A, B, C) displaying soly. and therapeutic differences that show that polymorph C is therapeutically favored.  The objective of this study was to adjust the USP dissoln. test for mebendazole so that it was able to distinguish between the dissoln. properties of 3 mebendazole polymorphs.  This would provide generic manufacturers with one more test to ensure that the therapeutically active polymorph C is used.  The results obtained in this study show that the USP dissoln. test conditions were not able to distinguish between the dissoln. properties of completely dispersed mebendazole polymorphs with comparable particle sizes.  When sodium lauryl sulfate was removed from the dissoln. medium, the percentage dissolved vs. time profiles changed so that polymorph C dissolved faster (70% within 120 min) compared to polymorph B (37% within 120 min) and polymorph A (20% within 120 min).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ9HaQgzS_rrVg90H21EOLACvtfcHk0lhNUYtaieUqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1GjtL0%253D&md5=f2f9f3acd689faf2dd73c2078e55892c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0939-6411%2803%2900004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0939-6411%252803%252900004-3%26sid%3Dliteratum%253Aachs%26aulast%3DSwanepoel%26aufirst%3DE.%26aulast%3DLiebenberg%26aufirst%3DW.%26aulast%3Dde%2BVilliers%26aufirst%3DM.%2BM.%26atitle%3DQuality%2520evaluation%2520of%2520generic%2520drugs%2520by%2520dissolution%2520test%253A%2520changing%2520the%2520USP%2520dissolution%2520medium%2520to%2520distinguish%2520between%2520active%2520and%2520non-active%2520mebendazole%2520polymorphs%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2003%26volume%3D55%26spage%3D345%26epage%3D349%26doi%3D10.1016%2FS0939-6411%2803%2900004-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charoenlarp, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waikagul, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muennoo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinophakun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitayaporn, D.</span></span> <span> </span><span class="NLM_article-title">Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections</span>. <i>Southeast Asian J. Trop. Med. Public Health</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">716</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=7939946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A280%3ADyaK2M%252Fis1aiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1993&pages=712-716&author=P.+Charoenlarpauthor=J.+Waikagulauthor=C.+Muennooauthor=S.+Srinophakunauthor=D.+Kitayaporn&title=Efficacy+of+single-dose+mebendazole%2C+polymorphic+forms+A+and+C%2C+in+the+treatment+of+hookworm+and+Trichuris+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections</span></div><div class="casAuthors">Charoenlarp P; Waikagul J; Muennoo C; Srinophakun S; Kitayaporn D</div><div class="citationInfo"><span class="NLM_cas:title">The Southeast Asian journal of tropical medicine and public health</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">712-6</span>
        ISSN:<span class="NLM_cas:issn">0125-1562</span>.
    </div><div class="casAbstract">A therapeutic trial of single mebendazole, 300 mg polymorph A, 300 mg polymorph C and 500 mg polymorph C, in the treatment of hookworm and Trichuris infections was carried out at primary schools in Southern Thailand.  The total of 958 children were randomly allocated in seven treatment groups including the placebo control and the standard dose control (100 mg polymorph C bid for 3 days).  The egg reduction rates and the cure rates of 300 mg and 500 mg polymorph C were similar, but inferior to those of the standard dose in both hookworm and Trichuris infections.  The efficacy of single dose 300 mg polymorph A was not different from that of the placebo control (alpha = 0.05) in both infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlHN-cXSKOG5QHPYJuLg8TfW6udTcc2eb5s-G_ph9qebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M%252Fis1aiug%253D%253D&md5=86594a91a3f4f8152c8464fbefa59bc7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharoenlarp%26aufirst%3DP.%26aulast%3DWaikagul%26aufirst%3DJ.%26aulast%3DMuennoo%26aufirst%3DC.%26aulast%3DSrinophakun%26aufirst%3DS.%26aulast%3DKitayaporn%26aufirst%3DD.%26atitle%3DEfficacy%2520of%2520single-dose%2520mebendazole%252C%2520polymorphic%2520forms%2520A%2520and%2520C%252C%2520in%2520the%2520treatment%2520of%2520hookworm%2520and%2520Trichuris%2520infections%26jtitle%3DSoutheast%2520Asian%2520J.%2520Trop.%2520Med.%2520Public%2520Health%26date%3D1993%26volume%3D24%26spage%3D712%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Paula, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cami, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brusau, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narda, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellena, J.</span></span> <span> </span><span class="NLM_article-title">Mebendazole mesylate monohydrate: a new route to improve the solubility of mebendazole polymorphs</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">3528</span>– <span class="NLM_lpage">3538</span>, <span class="refDoi"> DOI: 10.1002/jps.23658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1002%2Fjps.23658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=23897162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFygsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=3528-3538&author=K.+de%0APaulaauthor=G.+E.+Camiauthor=E.+V.+Brusauauthor=G.+E.+Nardaauthor=J.+Ellena&title=Mebendazole+mesylate+monohydrate%3A+a+new+route+to+improve+the+solubility+of+mebendazole+polymorphs&doi=10.1002%2Fjps.23658"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Mebendazole Mesylate Monohydrate: A New Route to Improve the Solubility of Mebendazole Polymorphs</span></div><div class="casAuthors">De Paula, Karina; Cami, Gerardo E.; Brusau, Elena V.; Narda, Griselda E.; Ellena, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3528-3538</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Mebendazole mesylate monohydrate, a new stable salt of mebendazole (MBZ), has been synthesized and fully characterized.  It was obtained from recrystn. of MBZ forms A, B, or C in diverse solvents with the addn. of Me sulfonic acid soln.  The crystal packing is first organized as a two-dimensional array consisting of rows of alternating MBZ mols. linked to columns of mesylate ions by hydrogen bonds.  The three-dimensional structure is further developed by classical intermol. interactions involving water mols.  In addn., nonclassical contacts are also found.  The vibrational behavior is consistent with the crystal structure, the most important functional groups showing shifts to lower or higher frequencies in relation to the MBZ polymorphs.  Thermal anal. indicates that the compd. is stable up to 50°C.  Decompn. occurs in five steps.  Soly. studies show that the title compd. presents a significant higher performance than polymorph C. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXSoOnRfS53rVg90H21EOLACvtfcHk0lhNUYtaieUqNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFygsb3N&md5=0e9625daf3046c28d7a7e9e20a107995</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fjps.23658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23658%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BPaula%26aufirst%3DK.%26aulast%3DCami%26aufirst%3DG.%2BE.%26aulast%3DBrusau%26aufirst%3DE.%2BV.%26aulast%3DNarda%26aufirst%3DG.%2BE.%26aulast%3DEllena%26aufirst%3DJ.%26atitle%3DMebendazole%2520mesylate%2520monohydrate%253A%2520a%2520new%2520route%2520to%2520improve%2520the%2520solubility%2520of%2520mebendazole%2520polymorphs%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D3528%26epage%3D3538%26doi%3D10.1002%2Fjps.23658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, A. D.</span></span> <span> </span><span class="NLM_article-title">Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1205</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.1007/s00436-012-2954-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1007%2Fs00436-012-2954-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=22661241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A280%3ADC%252BC38nosFamug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2012&pages=1205-1211&author=C.+S.+Liuauthor=H.+B.+Zhangauthor=B.+Jiangauthor=J.+M.+Yaoauthor=Y.+Taoauthor=J.+Xueauthor=A.+D.+Wen&title=Enhanced+bioavailability+and+cysticidal+effect+of+three+mebendazole-oil+preparations+in+mice+infected+with+secondary+cysts+of+Echinococcus+granulosus&doi=10.1007%2Fs00436-012-2954-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus</span></div><div class="casAuthors">Liu Cong-shan; Zhang Hao-bing; Jiang Bin; Yao Jun-min; Tao Yi; Xue Jian; Wen Ai-dan</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1205-11</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of the present study is to explore the possibility to increase the efficacy of mebendazole (MBZ) against secondary cysts of Echinococcus granulosus harbored in mice by augmenting the solubility and bioavailability of the drug.  Firstly, the saturated solubility of MBZ in nine kinds of oil was determined by high performance liquid chromatography (HPLC), and MBZ was found exhibiting the highest, secondary, and lowest solubility in oleic acid (OA), glycerol trioleate (GT), and soybean oil (SB), respectively.  Secondly, MBZ-OA suspension, MBZ-GT suspension, MBZ-SB suspension, and MBZ suspended in 1 % tragacanth (MBZ-1 % tragacanth) were selected for further studies on pharmacokinetics and experimental therapy in mice.  Four groups of mice were treated orally with one of aforementioned four MBZ preparations at a single dose of 25 mg/kg, and concentrations of MBZ in plasma obtained from each mouse at various intervals within 24 h postadministration were determined by HPLC.  The major pharmacokinetic parameters calculated by MBZ plasma concentration-time curve demonstrated that the peak concentration of the drug (C (max) ) values obtained from three MBZ-oil preparation groups was 1.6-2.8 times higher than that of MBZ-1 % tragacanth group.  The same was true that the area under the drug concentration-time curve (AUC(0-∞)) values of 19.8 (2.5)-28.2 (2.5) μg/ml × h revealed in the three MBZ-oil preparation groups was significantly higher than that of 11.6 (2.0) μg/ml × h in MBZ-1 % tragacanth group, and the bioavailability of the three MBZ-oil preparation groups was 71-143 % higher than that of MBZ-1 % tragacanth group.  In mice infected with secondary cysts of E. granulosus for 8 months treated orally with MBZ-1 % tragacanth at a daily dose of 25 mg/kg for 14 consecutive days, the mean cyst weight was lower than that of untreated control, but the difference was not statistically significant with cyst weight reduction of 48 %.  When the infected mice received three MBZ-oil preparations at the same oral dose schedule as aforementioned, the mean cyst weights were significantly lower than those in MBZ-1 % tragacanth group or control group with cyst weight reductions of 71.2-84.7 %.  The results indicate that the solubility of MBZ in oils may increase to various degrees according to the kinds of oil used.  Meanwhile, three MBZ-oil (OA, GT, and SB) preparations administered orally to mice not only improve the bioavailability of MBZ relative to that of MBZ suspended in 1 % tragacanth, but their effects against hydatid cysts also significantly enhance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRm42_WGF52m5cXNb62YGmbfW6udTcc2eYgmmO3w-Ufnbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nosFamug%253D%253D&md5=ba48d8a86d1d0fb18642a6f0c37ba742</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00436-012-2954-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-012-2954-2%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BS.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DJ.%2BM.%26aulast%3DTao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DA.%2BD.%26atitle%3DEnhanced%2520bioavailability%2520and%2520cysticidal%2520effect%2520of%2520three%2520mebendazole-oil%2520preparations%2520in%2520mice%2520infected%2520with%2520secondary%2520cysts%2520of%2520Echinococcus%2520granulosus%26jtitle%3DParasitol.%2520Res.%26date%3D2012%26volume%3D111%26spage%3D1205%26epage%3D1211%26doi%3D10.1007%2Fs00436-012-2954-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X. M.</span></span> <span> </span><span class="NLM_article-title">An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">589</span>, <span class="refDoi"> DOI: 10.1186/s13071-014-0589-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1186%2Fs13071-014-0589-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=25491386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitlChsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=589&author=C.+S.+Liuauthor=H.+B.+Zhangauthor=W.+Leiauthor=C.+W.+Zhangauthor=B.+Jiangauthor=Q.+Zhengauthor=J.+H.+Yinauthor=X.+M.+Han&title=An+alternative+mebendazole+formulation+for+cystic+echinococcosis%3A+the+treatment+efficacy%2C+pharmacokinetics+and+safety+in+mice&doi=10.1186%2Fs13071-014-0589-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice</span></div><div class="casAuthors">Liu, Cong-Shan; Zhang, Hao-Bing; Lei, Wen; Zhang, Chao-Wei; Jiang, Bin; Zheng, Qi; Yin, Jian-Hai; Han, Xiu-Min</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & Vectors</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">589/1-589/24</span>CODEN:
                <span class="NLM_cas:coden">PVAEAK</span>;
        ISSN:<span class="NLM_cas:issn">1756-3305</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Cystic echinococcosis is a serious zoonotic infection worldwide caused by metacestodes of Echinococcus gruanulosus.  Mebendazole and albendazole are the only two drugs used in the treatment of this disease with cure rates only about 30% due to the poor oral absorption.  Thus an alternative treatment for this disease is needed.  Methods: A mebendazole oily suspension (MBZ-OS) was prepd. and orally administrated to mice infected with echinococcus cysts for 8 mo at 12.5 mg/kg and 25 mg/kg for 14 consecutive days.  Mebendazole suspended in 1% tragacanth (MBZ-1% tragacanth) served as treated control.  In addn., liver and serum samples were collected from these treated mice (25 mg/kg) for histopathol. examn. and liver function test.  For pharmacokinetic anal., plasma, parasite (cyst wall and cyst fluid) and tissue samples were collected at 0.25, 0.5, 1, 2, 4, 8, 16 and 24 h after orally administrating MBZ-OS and MBZ-1% tragacanth to E. granulosus-infected mice at 25 mg/kg.  These samples were then processed and quant. analyzed by HPLC.  Results: The administration of MBZ-OS resulted in a treatment efficacy with the cyst wt. redns. higher than 80%, significantly better than the corresponding MBZ-1% tragacanth groups.  The better treatment efficacy of MBZ-OS was related to the higher drug concn. in plasma, parasites and tissues.  It was also shown that the injury of the liver was not significantly altered by taking MBZ-OS compared to the untreated control.  Conclusion: These findings demonstrate that MBZ-OS is a promising new formulation of MBZ for treatment of hydatid diseases without showing significantly liver toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8E_-Zx3M7o7Vg90H21EOLACvtfcHk0lix8IiUQER8ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitlChsbw%253D&md5=dc7f4ad797f66d43fabf681b5ae6f4d3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs13071-014-0589-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13071-014-0589-0%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%2BS.%26aulast%3DZhang%26aufirst%3DH.%2BB.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DC.%2BW.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DQ.%26aulast%3DYin%26aufirst%3DJ.%2BH.%26aulast%3DHan%26aufirst%3DX.%2BM.%26atitle%3DAn%2520alternative%2520mebendazole%2520formulation%2520for%2520cystic%2520echinococcosis%253A%2520the%2520treatment%2520efficacy%252C%2520pharmacokinetics%2520and%2520safety%2520in%2520mice%26jtitle%3DParasites%2520Vectors%26date%3D2014%26volume%3D7%26spage%3D589%26doi%3D10.1186%2Fs13071-014-0589-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniel-Mwuambete, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponce-Gordo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrado, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrado, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuesta-Bandera, C.</span></span> <span> </span><span class="NLM_article-title">Effect of two formulations of benzimidazole carbamates on the viability of cysts of Echinococcus granulosus in vivo</span>. <i>Parasite</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1051/parasite/2003104371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1051%2Fparasite%2F2003104371" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=371-373&author=K.+Daniel-Mwuambeteauthor=F.+Ponce-Gordoauthor=J.+Torradoauthor=S.+Torradoauthor=C.+Cuesta-Bandera&title=Effect+of+two+formulations+of+benzimidazole+carbamates+on+the+viability+of+cysts+of+Echinococcus+granulosus+in+vivo&doi=10.1051%2Fparasite%2F2003104371"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1051%2Fparasite%2F2003104371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fparasite%252F2003104371%26sid%3Dliteratum%253Aachs%26aulast%3DDaniel-Mwuambete%26aufirst%3DK.%26aulast%3DPonce-Gordo%26aufirst%3DF.%26aulast%3DTorrado%26aufirst%3DJ.%26aulast%3DTorrado%26aufirst%3DS.%26aulast%3DCuesta-Bandera%26aufirst%3DC.%26atitle%3DEffect%2520of%2520two%2520formulations%2520of%2520benzimidazole%2520carbamates%2520on%2520the%2520viability%2520of%2520cysts%2520of%2520Echinococcus%2520granulosus%2520in%2520vivo%26jtitle%3DParasite%26date%3D2003%26volume%3D10%26spage%3D371%26epage%3D373%26doi%3D10.1051%2Fparasite%2F2003104371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, T. R.</span></span> <span> </span><span class="NLM_article-title">The effect of dose form on the bioavailability of mebendazole in man</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.1985.tb02617.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1111%2Fj.1365-2125.1985.tb02617.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=3978024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaL2MXitV2hsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1985&pages=87-90&author=M.+Dawsonauthor=T.+R.+Watson&title=The+effect+of+dose+form+on+the+bioavailability+of+mebendazole+in+man&doi=10.1111%2Fj.1365-2125.1985.tb02617.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of dose form on the bioavailability of mebendazole in man</span></div><div class="casAuthors">Dawson, M.; Watson, T. R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-90</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">Four dosage forms of mebendazole (I)  [31431-39-7] were administered to human volunteers, and urine was collected and assayed for I and unconjugated metabolites.  Oral administration as an oily suspension enhanced the bioavailability of I slightly as compared with capsules and tablets; however, I was not absorbed following rectal administration.  The major (86%) urinary metabolite of I in humans was 2-amino-5(6)-[α-hydroxybenzyl]benzimidazole  [75501-05-2], not 2-amino-5(6)-benzoylbenzimidazole  [52329-60-9], as previously reported; the latter was present in lesser amts. (∼12%).  The pattern of metabolite excretion was not affected by route of administration.  Metabolites were detd. by extn. with EtOAc and liq. chromatog. on a LiChrosorb RP8 column with a gradient of MeOH-0.01M ammonium phosphate in MeOH-H2O (53:47) and detection at 254 and 280 nm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXxnye76QhcbVg90H21EOLACvtfcHk0lgjOdNaEOXGDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXitV2hsbc%253D&md5=3296c90f4dfe46829341928ec1c64783</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1985.tb02617.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1985.tb02617.x%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DWatson%26aufirst%3DT.%2BR.%26atitle%3DThe%2520effect%2520of%2520dose%2520form%2520on%2520the%2520bioavailability%2520of%2520mebendazole%2520in%2520man%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1985%26volume%3D19%26spage%3D87%26epage%3D90%26doi%3D10.1111%2Fj.1365-2125.1985.tb02617.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iseki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span> <span> </span><span class="NLM_article-title">Improvement of dissolution and bioavailability for mebendazole, an agent for human Echinococcosis, by preparing solid dispersion with polyethylene glycol</span>. <i>Chem. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2158</span>– <span class="NLM_lpage">2160</span>, <span class="refDoi"> DOI: 10.1248/cpb.39.2158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1248%2Fcpb.39.2158" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1991&pages=2158-2160&author=Y.+Chibaauthor=N.+Kohriauthor=K.+Isekiauthor=K.+Miyazaki&title=Improvement+of+dissolution+and+bioavailability+for+mebendazole%2C+an+agent+for+human+Echinococcosis%2C+by+preparing+solid+dispersion+with+polyethylene+glycol&doi=10.1248%2Fcpb.39.2158"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1248%2Fcpb.39.2158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.39.2158%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DY.%26aulast%3DKohri%26aufirst%3DN.%26aulast%3DIseki%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DK.%26atitle%3DImprovement%2520of%2520dissolution%2520and%2520bioavailability%2520for%2520mebendazole%252C%2520an%2520agent%2520for%2520human%2520Echinococcosis%252C%2520by%2520preparing%2520solid%2520dispersion%2520with%2520polyethylene%2520glycol%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1991%26volume%3D39%26spage%3D2158%26epage%3D2160%26doi%3D10.1248%2Fcpb.39.2158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, T. R.</span></span> <span> </span><span class="NLM_article-title">4-Amino-3-(3′-methoxycarbonyl-2′-thioureido)benzophenone, a prodrug of mebendazole</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1007/BF03188765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1007%2FBF03188765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=6673970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaL2cXitVejt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1983&pages=329-334&author=M.+Dawsonauthor=T.+R.+Watson&title=4-Amino-3-%283%E2%80%B2-methoxycarbonyl-2%E2%80%B2-thioureido%29benzophenone%2C+a+prodrug+of+mebendazole&doi=10.1007%2FBF03188765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">4-Amino-3-(3'-methoxycarbonyl-2'-thioureido)benzophenone, a prodrug of mebendazole</span></div><div class="casAuthors">Dawson, Michael; Watson, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-34</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0398-7639</span>.
    </div><div class="casAbstract">4-Amino-3-(3'-methoxycarbonyl-2'-thioureido)benzophenone (I)  [39070-62-7], a prodrug of mebendazole  [31431-39-7], was stable in acid and neutral media and was rapidly hydrolyzed in basic media.  A high-performance liq.-chromatog. assay for mebendazole, the prodrug, and their known or expected metabolites and degrdn. products in aq. media and rat blood was developed.  The prodrug administered orally to rats was rapidly converted to mebendazole.  The area under the blood level vs. time curve of mebendazole, in rats dosed with the prodrug, was more than twice that obtained after giving rats an equimolar amt. of mebendazole.  Only the prodrug, mebendazole, and known metabolites of mebendazole were detected in rats given the prodrug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojBLlTpw0QibVg90H21EOLACvtfcHk0lgjOdNaEOXGDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXitVejt7Y%253D&md5=a9308a598c0aa283446b3e32a984f9d8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2FBF03188765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03188765%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DWatson%26aufirst%3DT.%2BR.%26atitle%3D4-Amino-3-%25283%25E2%2580%25B2-methoxycarbonyl-2%25E2%2580%25B2-thioureido%2529benzophenone%252C%2520a%2520prodrug%2520of%2520mebendazole%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1983%26volume%3D8%26spage%3D329%26epage%3D334%26doi%3D10.1007%2FBF03188765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, L.
S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, H.</span></span> <span> </span><span class="NLM_article-title">N-alkoxycarbonyl prodrugs of mebendazole with increased water solubility</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/0378-5173(94)90060-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2F0378-5173%2894%2990060-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaK2cXhslehtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1994&pages=231-239&author=L.%0AS.+Nielsenauthor=F.+Sloekauthor=H.+Bundgaard&title=N-alkoxycarbonyl+prodrugs+of+mebendazole+with+increased+water+solubility&doi=10.1016%2F0378-5173%2894%2990060-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">N-alkoxycarbonyl prodrugs of mebendazole with increased water solubility</span></div><div class="casAuthors">Nielsen, Lise Sylvest; Sloek, Frank; Bundgaard, Hans</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">231-9</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    </div><div class="casAbstract">Bioreversible derivatization of mebendazole to improve its poor water soly., which is attributed to its low peroral bioavailability, was performed by N-acylation of the benzimidazole moiety with various chloroformates.  The N-alkoxycarbonyl derivs. (I, R = Me, Et or Pr) were readily hydrolyzed to mebendazole in the rabbit liver homogenate and in human and rabbit plasma.  The pH-rate profiles for the hydrolysis of the derivs. were derived at 37°C, and the lipophilicity of the compds. was assessed by partition expts. in octanol-aq. buffer systems.  The water soly. of the N-alkoxycarbonyl derivs. was up to 16-times higher than that of the parent drug.  The results obtained suggest that N-alkoxycarbonyl derivs. of benzimidazole anthelmintics may be useful to improve the peroral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIyKcTfUU55bVg90H21EOLACvtfcHk0lgXBOtt0LYCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhslehtLk%253D&md5=d4df2d6e9122dd904e1b38315d91566c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2F0378-5173%2894%2990060-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-5173%252894%252990060-4%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DL.%2BS.%26aulast%3DSloek%26aufirst%3DF.%26aulast%3DBundgaard%26aufirst%3DH.%26atitle%3DN-alkoxycarbonyl%2520prodrugs%2520of%2520mebendazole%2520with%2520increased%2520water%2520solubility%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D1994%26volume%3D102%26spage%3D231%26epage%3D239%26doi%3D10.1016%2F0378-5173%2894%2990060-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, L. S.</span></span> <span> </span><span class="NLM_article-title">Improved peroral bioavailability of mebendazole in rabbits by administration of various N-alkoxycarbonyl derivatives of mebendazole</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1016/0378-5173(94)90193-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2F0378-5173%2894%2990193-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaK2cXit1Kktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1994&pages=175-179&author=L.+S.+Nielsen&title=Improved+peroral+bioavailability+of+mebendazole+in+rabbits+by+administration+of+various+N-alkoxycarbonyl+derivatives+of+mebendazole&doi=10.1016%2F0378-5173%2894%2990193-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Improved peroroal bioavailability of mebendazole in rabbits by administration of various N-alkoxycarbonyl derivatives of mebendazole</span></div><div class="casAuthors">Nielsen, Lise Sylvest</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-9</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    </div><div class="casAbstract">The absorption of mebendazole, a very poorly sol. benzimidazole carbamate, used in the treatment of hydatid disease, and various N-alkoxycarbonyl prodrugs, was investigated after peroral administration to rabbits.  The compds. were administered in the form of aq. suspensions at pH 5.0.  All prodrugs were rapidly hydrolyzed to mebendazole after absorption.  The bioavailability was improved for all prodrugs.  The highest bioavailability was obtained with the N-methoxycarbonyl deriv. which showed a 13-fold improvement in bioavailability compared to mebendazole.  The improved bioavailability of the prodrugs was ascribed to the increased water solubilities and appropriate lipophilicities.  The N-alkoxycarbonylation of the benzimidazole moiety in mebendazole and in other widely used benzimidazole carbamates may be a promising prodrug approach to enhance poor absorption which follows peroral administration of this type of poorly sol. drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryGbqJlsgPr7Vg90H21EOLACvtfcHk0lgXBOtt0LYCBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXit1Kktrs%253D&md5=2059b42090dc7e6dfa9ee0834d420e3e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2F0378-5173%2894%2990193-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-5173%252894%252990193-7%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DL.%2BS.%26atitle%3DImproved%2520peroral%2520bioavailability%2520of%2520mebendazole%2520in%2520rabbits%2520by%2520administration%2520of%2520various%2520N-alkoxycarbonyl%2520derivatives%2520of%2520mebendazole%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D1994%26volume%3D104%26spage%3D175%26epage%3D179%26doi%3D10.1016%2F0378-5173%2894%2990193-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garbuio, A. Q. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanashiro, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markman, B. E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, F. L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perazzo, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, P. C. P.</span></span> <span> </span><span class="NLM_article-title">Evaluation and study of mebendazole polymorphs present in raw materials and tablets available in the Brazilian pharmaceutical market</span>. <i>J. Appl. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">001</span>– <span class="NLM_lpage">007</span>, <span class="refDoi"> DOI: 10.7324/JAPS.2014.4111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.7324%2FJAPS.2014.4111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=001-007&author=A.+Q.+P.+Garbuioauthor=T.+Hanashiroauthor=B.+E.+O.+Markmanauthor=F.+L.+A.+Fonsecaauthor=F.+F.+Perazzoauthor=P.+C.+P.+Rosa&title=Evaluation+and+study+of+mebendazole+polymorphs+present+in+raw+materials+and+tablets+available+in+the+Brazilian+pharmaceutical+market&doi=10.7324%2FJAPS.2014.4111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.7324%2FJAPS.2014.4111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7324%252FJAPS.2014.4111%26sid%3Dliteratum%253Aachs%26aulast%3DGarbuio%26aufirst%3DA.%2BQ.%2BP.%26aulast%3DHanashiro%26aufirst%3DT.%26aulast%3DMarkman%26aufirst%3DB.%2BE.%2BO.%26aulast%3DFonseca%26aufirst%3DF.%2BL.%2BA.%26aulast%3DPerazzo%26aufirst%3DF.%2BF.%26aulast%3DRosa%26aufirst%3DP.%2BC.%2BP.%26atitle%3DEvaluation%2520and%2520study%2520of%2520mebendazole%2520polymorphs%2520present%2520in%2520raw%2520materials%2520and%2520tablets%2520available%2520in%2520the%2520Brazilian%2520pharmaceutical%2520market%26jtitle%3DJ.%2520Appl.%2520Pharm.%2520Sci.%26date%3D2014%26volume%3D4%26spage%3D001%26epage%3D007%26doi%3D10.7324%2FJAPS.2014.4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jancarik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krecmerova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tichy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenora, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wozniak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally available prodrugs of the glutamate carboxypeptidase II (GCPII) inhibitor 2-Phosphonomethylpentanedioic acid (2-PMPA)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2810</span>– <span class="NLM_lpage">2819</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFaqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2810-2819&author=P.+Majerauthor=A.+Jancarikauthor=M.+Krecmerovaauthor=T.+Tichyauthor=L.+Tenoraauthor=K.+Wozniakauthor=Y.+Wuauthor=E.+Pommierauthor=D.+Ferrarisauthor=R.+Raisauthor=B.+S.+Slusher&title=Discovery+of+orally+available+prodrugs+of+the+glutamate+carboxypeptidase+II+%28GCPII%29+inhibitor+2-Phosphonomethylpentanedioic+acid+%282-PMPA%29&doi=10.1021%2Facs.jmedchem.6b00062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Orally Available Prodrugs of the Glutamate Carboxypeptidase II (GCPII) Inhibitor 2-Phosphonomethylpentanedioic Acid (2-PMPA)</span></div><div class="casAuthors">Majer, Pavel; Jancarik, Andrej; Krecmerova, Marcela; Tichy, Tomas; Tenora, Lukas; Wozniak, Krystyna; Wu, Ying; Pommier, Elie; Ferraris, Dana; Rais, Rana; Slusher, Barbara S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2810-2819</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">2-Phosphonomethylpentanedioic acid (I) (2-PMPA), is a potent inhibitor of glutamate carboxypeptidase II which has demonstrated robust neuroprotective efficacy in many neurol. disease models.  However, I is highly polar contg. a phosphonate and two carboxylates, severely limiting its oral bioavailability.  Our initial strategy was to cover the phosphonate with hydrophobic moieties such as pivaloyloxymethyl (POM) and isopropyloxycarbonyloxymethyl (POC) while keeping the α- and γ-carboxylates unsubstituted.  This attempt was unsuccessful due to the chem. instability of the bis-POC/POM derivs.  Addn. of α,γ-diesters and α-monoesters enhanced chem. stability and provided excellent oral exposure in mice, but these mixed esters were too stable in vivo, resulting in minimal release of I.  By introducing POC groups on both the phosphonate and α-carboxylate, we synthesized Tris-POC-2-PMPA, which afforded excellent release of I following oral administration in both mice and dog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTAKK5dMYGiLVg90H21EOLACvtfcHk0lgw_RTQLbZVNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFaqt7c%253D&md5=3108f3d3bbb360dd7366ed2abea116dc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00062%26sid%3Dliteratum%253Aachs%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DJancarik%26aufirst%3DA.%26aulast%3DKrecmerova%26aufirst%3DM.%26aulast%3DTichy%26aufirst%3DT.%26aulast%3DTenora%26aufirst%3DL.%26aulast%3DWozniak%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DPommier%26aufirst%3DE.%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26atitle%3DDiscovery%2520of%2520orally%2520available%2520prodrugs%2520of%2520the%2520glutamate%2520carboxypeptidase%2520II%2520%2528GCPII%2529%2520inhibitor%25202-Phosphonomethylpentanedioic%2520acid%2520%25282-PMPA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2810%26epage%3D2819%26doi%3D10.1021%2Facs.jmedchem.6b00062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dando, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plosker, G.</span></span> <span> </span><span class="NLM_article-title">Adefovir dipivoxil: a review of its use in chronic hepatitis B</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2215</span>– <span class="NLM_lpage">2234</span>, <span class="refDoi"> DOI: 10.2165/00003495-200363200-00007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.2165%2F00003495-200363200-00007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2215-2234&author=T.+Dandoauthor=G.+Plosker&title=Adefovir+dipivoxil%3A+a+review+of+its+use+in+chronic+hepatitis+B&doi=10.2165%2F00003495-200363200-00007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2165%2F00003495-200363200-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-200363200-00007%26sid%3Dliteratum%253Aachs%26aulast%3DDando%26aufirst%3DT.%26aulast%3DPlosker%26aufirst%3DG.%26atitle%3DAdefovir%2520dipivoxil%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520chronic%2520hepatitis%2520B%26jtitle%3DDrugs%26date%3D2003%26volume%3D63%26spage%3D2215%26epage%3D2234%26doi%3D10.2165%2F00003495-200363200-00007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kearney, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaherty, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, J.</span></span> <span> </span><span class="NLM_article-title">Tenofovir disoproxil fumarate</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.2165/00003088-200443090-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.2165%2F00003088-200443090-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=15217303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=595-612&author=B.+P.+Kearneyauthor=J.+F.+Flahertyauthor=J.+Shah&title=Tenofovir+disoproxil+fumarate&doi=10.2165%2F00003088-200443090-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics</span></div><div class="casAuthors">Kearney, Brian P.; Flaherty, John F.; Shah, Jaymin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">595-612</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Tenofovir disoproxil fumarate (tenofovir DF) is an oral prodrug of tenofovir, a nucleotide (nucleoside monophosphate) analog with activity against retroviruses, including HIV-1, HIV-2 and hepadnaviruses.  Following absorption, tenofovir DF is rapidly converted to tenofovir, which is metabolized intracellularly to its active anabolite tenofovir diphosphate, which is a competitive inhibitor of HIV-1 reverse transcriptase and terminates the growing DNA chain.  Tenofovir exerts antiviral effects in a variety of cell types, including resting cells.  Tenofovir exhibits longer serum (17 h) and intracellular (≥60 h) half-lives than those of nucleoside analogs, which supports a flexible once-daily administration schedule.  The pharmacokinetics of tenofovir are dose-proportional and similar in healthy volunteers and HIV-infected individuals.  The oral bioavailability of tenofovir is enhanced by administration with a high-fat meal, but is similar at steady state when administered with or without a typical meal.  Tenofovir is not a substrate, inducer or inhibitor of human cytochrome P 450 enzymes in vitro or in vivo.  Tenofovir DF has been studied with 15 other antiretroviral and other concomitant medications frequently used in the HIV-1-infected population.  With the exception of didanosine and atazanavir, which require dosage modifications, no clin. significant drug interactions have been obsd. with tenofovir DF.  The recommended oral dosage of tenofovir DF in adults is 300 mg/day.  Tenofovir is eliminated by renal elimination, including tubular secretion; dose-interval adjustments are necessary for tenofovir DF in patients with significant renal impairment.  No dosage adjustment of tenofovir DF is necessary in patients with liver disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh33s_geBBMLVg90H21EOLACvtfcHk0liuthPa7KKO4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVCksLo%253D&md5=90abda8650560aa57a3173cccc289efb</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2165%2F00003088-200443090-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-200443090-00003%26sid%3Dliteratum%253Aachs%26aulast%3DKearney%26aufirst%3DB.%2BP.%26aulast%3DFlaherty%26aufirst%3DJ.%2BF.%26aulast%3DShah%26aufirst%3DJ.%26atitle%3DTenofovir%2520disoproxil%2520fumarate%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2004%26volume%3D43%26spage%3D595%26epage%3D612%26doi%3D10.2165%2F00003088-200443090-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chanteux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Bambeke, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingeot-Leclercq, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulkens, P. M.</span></span> <span> </span><span class="NLM_article-title">Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1279</span>– <span class="NLM_lpage">1288</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.4.1279-1288.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1128%2FAAC.49.4.1279-1288.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=15793098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1Cqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=1279-1288&author=H.+Chanteuxauthor=F.+Van+Bambekeauthor=M.-P.+Mingeot-Leclercqauthor=P.+M.+Tulkens&title=Accumulation+and+oriented+transport+of+ampicillin+in+Caco-2+cells+from+its+pivaloyloxymethylester+prodrug%2C+pivampicillin&doi=10.1128%2FAAC.49.4.1279-1288.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin</span></div><div class="casAuthors">Chanteux, Hugues; Van Bambeke, Francoise; Mingeot-Leclercq, Marie-Paule; Tulkens, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1279-1288</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pivampicillin (PIVA), an acyloxymethylester of ampicillin, is thought to enhance the oral bioavailability of ampicillin because of its greater lipophilicity compared to that of ampicillin.  The fate of PIVA in intestinal cells and the exact location of its conversion into ampicillin have, however, never been unambiguously established.  Polarized Caco-2 cells have been used to examine the handling of PIVA and the release of ampicillin from PIVA by the intestinal epithelium.  Expts. were limited to 3 h.  Cells incubated with PIVA (apical pole) showed a fast accumulation of ampicillin and transport toward the basolateral medium, whereas PIVA itself was only poorly accumulated and transported.  Cells incubated with free ampicillin accumulated and transported only minimal amts. of this drug.  Release of ampicillin from cells incubated with PIVA was unaffected by PEPT1 and OCTN2 inhibitors but was sharply decreased after ATP depletion or addn. of bis(4-nitrophenyl)-phosphate (BNPP; an esterase inhibitor).  PIVA incubated with Caco-2 lysates released free ampicillin, and this release was inhibited by BNPP.  Efflux studies showed that the ampicillin that accumulated in cells after incubation with PIVA was preferentially transported out of the cells through the basolateral pole.  This efflux was decreased by multidrug resistance-assocd. protein (MRP) inhibitors (probenecid, MK-571) and by ATP depletion.  A phthalimidomethylester of ampicillin that resists cellular esterases failed to cause any significant release (cell lysate) or transport (polarized Caco-2 cells) of ampicillin.  These results show that when PIVA is given to Caco-2 cells from their apical pole, ampicillin is released intracellularly and that ampicillin is thereafter preferentially effluxed into the basolateral medium through an MRP-like transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6OLAyYvqg7LVg90H21EOLACvtfcHk0liuthPa7KKO4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Cqu7g%253D&md5=ef1d80e8202cf377ce2bb126a355c902</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.4.1279-1288.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.4.1279-1288.2005%26sid%3Dliteratum%253Aachs%26aulast%3DChanteux%26aufirst%3DH.%26aulast%3DVan%2BBambeke%26aufirst%3DF.%26aulast%3DMingeot-Leclercq%26aufirst%3DM.-P.%26aulast%3DTulkens%26aufirst%3DP.%2BM.%26atitle%3DAccumulation%2520and%2520oriented%2520transport%2520of%2520ampicillin%2520in%2520Caco-2%2520cells%2520from%2520its%2520pivaloyloxymethylester%2520prodrug%252C%2520pivampicillin%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D1279%26epage%3D1288%26doi%3D10.1128%2FAAC.49.4.1279-1288.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hai, L.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3651</span>– <span class="NLM_lpage">3661</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.05.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2Fj.ejmech.2011.05.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3651-3661&author=W.+Fanauthor=Y.+Wuauthor=X.+K.+Liauthor=N.+Yaoauthor=X.+Liauthor=Y.+G.+Yuauthor=L.+Hai&title=Design%2C+synthesis+and+biological+evaluation+of+brain-specific+glucosyl+thiamine+disulfide+prodrugs+of+naproxen&doi=10.1016%2Fj.ejmech.2011.05.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.05.029%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%2BK.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DY.%2BG.%26aulast%3DHai%26aufirst%3DL.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520brain-specific%2520glucosyl%2520thiamine%2520disulfide%2520prodrugs%2520of%2520naproxen%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3651%26epage%3D3661%26doi%3D10.1016%2Fj.ejmech.2011.05.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matiskella, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudyma, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejwani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J. J.</span></span> <span> </span><span class="NLM_article-title">Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological properties</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">3669</span>– <span class="NLM_lpage">3672</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.08.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2Fj.bmcl.2003.08.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3669-3672&author=Y.+Uedaauthor=J.+D.+Matiskellaauthor=J.+Golikauthor=T.+P.+Connollyauthor=T.+W.+Hudymaauthor=S.+Venkateshauthor=M.+Daliauthor=S.+H.+Kangauthor=N.+Barbourauthor=R.+Tejwaniauthor=S.+Variaauthor=J.+Knipeauthor=M.+Zhengauthor=M.+Mathewauthor=K.+Mosureauthor=J.+Clarkauthor=L.+Lambauthor=I.+Medinauthor=Q.+Gaoauthor=S.+Huangauthor=C.+P.+Chenauthor=J.+J.+Bronson&title=Phosphonooxymethyl+prodrugs+of+the+broad+spectrum+antifungal+azole%2C+ravuconazole%3A+synthesis+and+biological+properties&doi=10.1016%2Fj.bmcl.2003.08.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.08.029%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMatiskella%26aufirst%3DJ.%2BD.%26aulast%3DGolik%26aufirst%3DJ.%26aulast%3DConnolly%26aufirst%3DT.%2BP.%26aulast%3DHudyma%26aufirst%3DT.%2BW.%26aulast%3DVenkatesh%26aufirst%3DS.%26aulast%3DDali%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DS.%2BH.%26aulast%3DBarbour%26aufirst%3DN.%26aulast%3DTejwani%26aufirst%3DR.%26aulast%3DVaria%26aufirst%3DS.%26aulast%3DKnipe%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DMathew%26aufirst%3DM.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DLamb%26aufirst%3DL.%26aulast%3DMedin%26aufirst%3DI.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%2BP.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26atitle%3DPhosphonooxymethyl%2520prodrugs%2520of%2520the%2520broad%2520spectrum%2520antifungal%2520azole%252C%2520ravuconazole%253A%2520synthesis%2520and%2520biological%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3669%26epage%3D3672%26doi%3D10.1016%2Fj.bmcl.2003.08.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chassaing, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckeroth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uphoff, M.</span></span> <span> </span><span class="NLM_article-title">Highly water-soluble prodrugs of anthelmintic benzimidazole carbamates: synthesis, pharmacodynamics, and pharmacokinetics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1111</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1021/jm701456r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701456r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVamtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1111-1114&author=C.+Chassaingauthor=M.+Bergerauthor=A.+Heckerothauthor=T.+Ilgauthor=M.+Jaegerauthor=C.+Kernauthor=K.+Schmidauthor=M.+Uphoff&title=Highly+water-soluble+prodrugs+of+anthelmintic+benzimidazole+carbamates%3A+synthesis%2C+pharmacodynamics%2C+and+pharmacokinetics&doi=10.1021%2Fjm701456r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Water-Soluble Prodrugs of Anthelmintic Benzimidazole Carbamates: Synthesis, Pharmacodynamics, and Pharmacokinetics</span></div><div class="casAuthors">Chassaing, C.; Berger, M.; Heckeroth, A.; Ilg, T.; Jaeger, M.; Kern, C.; Schmid, K.; Uphoff, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1111-1114</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Highly water-sol. prodrugs, e.g. I, of anthelmintic benzimidazole carbamates, e.g. II, were synthesized.  These prodrugs combine high aq. soly. and stability with high lability in the presence of alk. phosphatases.  The veterinary utility of I and its regioisomer was shown by a pharmacodynamic and pharmacokinetic study performed in swine.  Comparable anthelmintic efficacy was obsd. with prodrug I and its regioisomer or the parent fenbendazole II.  The pharmacokinetic results showed that II is better absorbed when derived from I and its regioisomer than when applied as such.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_J3-sHxpdQrVg90H21EOLACvtfcHk0liv4aZ3daUvYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVamtb8%253D&md5=3815f9d75c781a5e58bec26439255120</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm701456r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701456r%26sid%3Dliteratum%253Aachs%26aulast%3DChassaing%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DHeckeroth%26aufirst%3DA.%26aulast%3DIlg%26aufirst%3DT.%26aulast%3DJaeger%26aufirst%3DM.%26aulast%3DKern%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DK.%26aulast%3DUphoff%26aufirst%3DM.%26atitle%3DHighly%2520water-soluble%2520prodrugs%2520of%2520anthelmintic%2520benzimidazole%2520carbamates%253A%2520synthesis%252C%2520pharmacodynamics%252C%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1111%26epage%3D1114%26doi%3D10.1021%2Fjm701456r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeGoey, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grampovnik, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flosi, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D. J.</span></span> <span> </span><span class="NLM_article-title">Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavir</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2964</span>– <span class="NLM_lpage">2970</span>, <span class="refDoi"> DOI: 10.1021/jm900080g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900080g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFeltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2964-2970&author=D.+A.+DeGoeyauthor=D.+J.+Grampovnikauthor=W.+J.+Flosiauthor=K.+C.+Marshauthor=X.+C.+Wangauthor=L.+L.+Kleinauthor=K.+F.+McDanielauthor=Y.+Liuauthor=M.+A.+Longauthor=W.+M.+Katiauthor=A.+Mollaauthor=D.+J.+Kempf&title=Water-soluble+prodrugs+of+the+human+immunodeficiency+virus+protease+inhibitors+lopinavir+and+ritonavir&doi=10.1021%2Fjm900080g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Water-Soluble Prodrugs of the Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir</span></div><div class="casAuthors">DeGoey, David A.; Grampovnik, David J.; Flosi, William J.; Marsh, Kennan C.; Wang, Xiu C.; Klein, Larry L.; McDaniel, Keith F.; Liu, Yaya; Long, Michelle A.; Kati, Warren M.; Molla, Akhteruzzaman; Kempf, Dale J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2964-2970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We studied the synthesis, cleavage rates, and oral administration of prodrugs of the HIV protease inhibitors (PIs) lopinavir and ritonavir.  Phosphate esters attached directly to the central hydroxyl groups of these PIs did not demonstrate enzyme-mediated cleavage in vitro and did not provide measurable plasma levels of the parent drugs in vivo.  However, oxymethylphosphate (OMP) and oxyethylphosphate (OEP) prodrugs provided improved rates of cleavage, high levels of aq. soly., and high plasma levels of the parent drugs when dosed orally in rats and dogs.  Dosing unformulated capsules contg. the solid prodrugs led to plasma levels equiv. to those obsd. for dosing formulated solns. of the parent drugs.  A direct synthetic process for the prepn. of OMP and OEP prodrugs was developed, and the improved synthetic method may be applicable to the prepn. of analogous sol. prodrugs of other drug classes with limited soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeiB07ekQMJ7Vg90H21EOLACvtfcHk0lguqLLNkRVi6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFeltLs%253D&md5=6e64ddfeabd5725929cac142bdfe782d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm900080g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900080g%26sid%3Dliteratum%253Aachs%26aulast%3DDeGoey%26aufirst%3DD.%2BA.%26aulast%3DGrampovnik%26aufirst%3DD.%2BJ.%26aulast%3DFlosi%26aufirst%3DW.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DWang%26aufirst%3DX.%2BC.%26aulast%3DKlein%26aufirst%3DL.%2BL.%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLong%26aufirst%3DM.%2BA.%26aulast%3DKati%26aufirst%3DW.%2BM.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26atitle%3DWater-soluble%2520prodrugs%2520of%2520the%2520human%2520immunodeficiency%2520virus%2520protease%2520inhibitors%2520lopinavir%2520and%2520ritonavir%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2964%26epage%3D2970%26doi%3D10.1021%2Fjm900080g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dack, K.</span></span> <span> </span><span class="NLM_article-title">Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">485</span>, <span class="refDoi"> DOI: 10.2174/1389200033489253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.2174%2F1389200033489253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=14683475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpslShtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=461-485&author=K.+Beaumontauthor=R.+Websterauthor=I.+Gardnerauthor=K.+Dack&title=Design+of+ester+prodrugs+to+enhance+oral+absorption+of+poorly+permeable+compounds%3A+challenges+to+the+discovery+scientist&doi=10.2174%2F1389200033489253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist</span></div><div class="casAuthors">Beaumont, Kevin; Webster, Robert; Gardner, Iain; Dack, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">461-485</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review and discussion.  Many drugs are administered at sites that are remote from their site of action.  The most common route of drug delivery is the oral route.  The optimal physicochem. properties to allow high transcellular absorption following oral administration are well established and include a limit on mol. size, hydrogen bonding potential and adequate lipophilicity.  For many drug targets, synthetic strategies can be devised to balance the physicochem. properties required for high transcellular absorption and the SAR for the drug target.  However, there are drug targets where the SAR requires properties at odds with good membrane permeability.  These include a requirement for significant polarity and groups that exhibit high hydrogen bonding potential such as carboxylic acids and alcs.  In such cases, prodrug strategies have been employed.  The rationale behind the prodrug strategy is to introduce lipophilicity and mask hydrogen bonding groups of an active compd. by the addn. of another moiety, most commonly an ester.  An ideal ester prodrug should exhibit the following properties:.  (1) Weak (or no) activity against any pharmacol. target,.  (2) Chem. stability across a pH range,.  (3) High aq. soly.,.  (4) Good transcellular absorption,.  (5) Resistance to hydrolysis during the absorption phase,.  (6) Rapid and quant. breakdown to yield high circulating concns. of the active component post absorption.  This paper will review the literature around marketed prodrugs and det. the most appropriate prodrug characteristics.  In addn., it will examine potential discovery approaches to optimizing prodrug delivery and recommend a strategy for prosecuting an oral prodrug approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJklGnlqCIqbVg90H21EOLACvtfcHk0lguqLLNkRVi6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpslShtLo%253D&md5=442e3b78efc2e601c688c03eeeaa6e54</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2174%2F1389200033489253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200033489253%26sid%3Dliteratum%253Aachs%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DDack%26aufirst%3DK.%26atitle%3DDesign%2520of%2520ester%2520prodrugs%2520to%2520enhance%2520oral%2520absorption%2520of%2520poorly%2520permeable%2520compounds%253A%2520challenges%2520to%2520the%2520discovery%2520scientist%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2003%26volume%3D4%26spage%3D461%26epage%3D485%26doi%3D10.2174%2F1389200033489253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klepser, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marangos, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolau, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintiliani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nightingale, C. H.</span></span> <span> </span><span class="NLM_article-title">Clinical pharmacokinetics of newer cephalosporins</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">361</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.2165/00003088-199528050-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.2165%2F00003088-199528050-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=7614776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADyaK2MXmsV2itb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1995&pages=361-384&author=M.+E.+Klepserauthor=M.+N.+Marangosauthor=K.+B.+Patelauthor=D.+P.+Nicolauauthor=R.+Quintilianiauthor=C.+H.+Nightingale&title=Clinical+pharmacokinetics+of+newer+cephalosporins&doi=10.2165%2F00003088-199528050-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical pharmacokinetics of newer cephalosporins</span></div><div class="casAuthors">Klepser, Michael E.; Marangos, Markos N.; Patel, Kalpana B.; Nicolau, David P.; Quintiliani, Richard; Nightingale, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">361-84</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    </div><div class="casAbstract">A review with 122 refs.  Several new cephalosporins have been developed in recent years.  These agents include several oral and parenteral agents with extended activity against Gramneg. pathogens.  The pharmacokinetic literature for these agents is quite extensive; therefore, we have summarized this information and presented it in tabular form for crit. comparison.  With a few exceptions, the newer cephalosporins share similar pharmacokinetic properties.  Cefixime, cefetamet pivoxil and ceftibuten differ from the others in that they exhibit nonlinear pharmacokinetic properties.  The nonlinear nature of these agents is reflected by decreasing maximal concns. with escalating doses of cefixime and cefetamet pivoxil, decreasing area under the serum concn.-time curve with increasing doses for cefixime, and a reduced bioavailability with large doses of ceftibuten.  Attention to such characteristics aid the clinician in selecting appropriate dosage regimens that will optimize drug absorption.  The majority of agents are primarily renally eliminated; however, renal elimination accounts for only 20% of cefixime elimination.  The pharmacokinetic parameters noted for the newer cephalosporins are not influenced by multiple dose administration, suggesting lack of drug accumulation over time.  The pharmacodynamics of antimicrobials should be considered when extrapolating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLIpb_YKe08rVg90H21EOLACvtfcHk0ljPRUj76NVEMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsV2itb0%253D&md5=53e11c37a3f14bb05015326c538c7962</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2165%2F00003088-199528050-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003088-199528050-00003%26sid%3Dliteratum%253Aachs%26aulast%3DKlepser%26aufirst%3DM.%2BE.%26aulast%3DMarangos%26aufirst%3DM.%2BN.%26aulast%3DPatel%26aufirst%3DK.%2BB.%26aulast%3DNicolau%26aufirst%3DD.%2BP.%26aulast%3DQuintiliani%26aufirst%3DR.%26aulast%3DNightingale%26aufirst%3DC.%2BH.%26atitle%3DClinical%2520pharmacokinetics%2520of%2520newer%2520cephalosporins%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D1995%26volume%3D28%26spage%3D361%26epage%3D384%26doi%3D10.2165%2F00003088-199528050-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">3052</span>– <span class="NLM_lpage">3071</span>, <span class="refDoi"> DOI: 10.1002/jps.20913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1002%2Fjps.20913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=17722003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12jtrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=3052-3071&author=L.+Zhouauthor=L.+Yangauthor=S.+Tiltonauthor=J.+Wang&title=Development+of+a+high+throughput+equilibrium+solubility+assay+using+miniaturized+shake-flask+method+in+early+drug+discovery&doi=10.1002%2Fjps.20913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery</span></div><div class="casAuthors">Zhou, Liping; Yang, Linhong; Tilton, Suzanne; Wang, Jianling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3052-3071</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Increasingly, pharmaceutical and biotech companies have begun to realize the importance of obtaining soly. information in early drug discovery as it is one of the crit. parameters for lead selection and optimization.  This report introduces a high-throughput equil. soly. (HT-Eq sol) assay using a novel miniaturized shake-flask approach and streamlined HPLC anal.  The new HT-Eq sol assay, validated and optimized via a test set of 85 marketed drugs and Novartis internal compds., shows an excellent correlation to the conventional shake-flask thermodn. soly. data generated inhouse and the equil. soly. results reported in literature.  It therefore offers a fast, reliable and cost-effective screening tool for soly. assessment in early drug discovery, allowing for prioritization of drug candidates using aq. soly. in conjunction with other profiling information and efficacy data.  Our work demonstrates that presence of a small amt. of DMSO (0.5-5%) will result in significant overestimation of equil. soly. (up to 6 folds).  In addn., monitoring of drug dissoln. process using the current approach as well as the interplay between equil. soly. data and those from kinetic soly. are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLEKUmI4vDMLVg90H21EOLACvtfcHk0ljPRUj76NVEMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12jtrrO&md5=e04d5b859372d08551b4a6af19e23fb5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjps.20913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20913%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DTilton%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520high%2520throughput%2520equilibrium%2520solubility%2520assay%2520using%2520miniaturized%2520shake-flask%2520method%2520in%2520early%2520drug%2520discovery%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D3052%26epage%3D3071%26doi%3D10.1002%2Fjps.20913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rath, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, A. K.</span></span> <span> </span><span class="NLM_article-title">Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis</span>. <i>Artif. Cells, Nanomed., Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">937</span>– <span class="NLM_lpage">942</span>, <span class="refDoi"> DOI: 10.3109/21691401.2014.1000493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.3109%2F21691401.2014.1000493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=25783855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvVGnsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=937-942&author=S.+Chaudharyauthor=T.+Gargauthor=G.+Rathauthor=R.+R.+Murthyauthor=A.+K.+Goyal&title=Enhancing+the+bioavailability+of+mebendazole+by+integrating+the+principles+solid+dispersion+and+nanocrystal+techniques%2C+for+safe+and+effective+management+of+human+echinococcosis&doi=10.3109%2F21691401.2014.1000493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancing the bioavailability of mebendazole by integrating the principles solid dispersion and nanocrystal techniques, for safe and effective management of human echinococcosis</span></div><div class="casAuthors">Chaudhary, Sushant; Garg, Tarun; Rath, Goutam; Murthy, Rs Rayasa; Goyal, Amit K.</div><div class="citationInfo"><span class="NLM_cas:title">Artificial Cells, Nanomedicine, and Biotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">937-942</span>CODEN:
                <span class="NLM_cas:coden">ACNBCI</span>;
        ISSN:<span class="NLM_cas:issn">2169-141X</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The method based on integrating the principles of solid dispersion and nanocrystal techniques was developed to prep. polymer crystals (PCs) of mebendazole (MBZ) and polyethylene glycol (PEG).  Powder X-Ray diffraction (PXRD) of the PC crystals shows the required integrated cryst. and amorphous regions.  The in vitro soly. studies showed a 32-fold increase in the soly. of the drug.  Tests of dissoln. of the PCs showed that the crystals have an enhanced dissoln. rate in comparison to those in the MF.  The results of the pharmacokinetic study showed a 2.12-fold increase in the bioavailability of the drug.  Thus, the present study has proved the potential in enhancing soly., dissoln., and bioavailability of the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqINAkL-gD7ZbVg90H21EOLACvtfcHk0lg0YS0tatMUJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvVGnsbY%253D&md5=bd5a401ae0ecd4f2a806189c860c224d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3109%2F21691401.2014.1000493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F21691401.2014.1000493%26sid%3Dliteratum%253Aachs%26aulast%3DChaudhary%26aufirst%3DS.%26aulast%3DGarg%26aufirst%3DT.%26aulast%3DRath%26aufirst%3DG.%26aulast%3DMurthy%26aufirst%3DR.%2BR.%26aulast%3DGoyal%26aufirst%3DA.%2BK.%26atitle%3DEnhancing%2520the%2520bioavailability%2520of%2520mebendazole%2520by%2520integrating%2520the%2520principles%2520solid%2520dispersion%2520and%2520nanocrystal%2520techniques%252C%2520for%2520safe%2520and%2520effective%2520management%2520of%2520human%2520echinococcosis%26jtitle%3DArtif.%2520Cells%252C%2520Nanomed.%252C%2520Biotechnol.%26date%3D2016%26volume%3D44%26spage%3D937%26epage%3D942%26doi%3D10.3109%2F21691401.2014.1000493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graves, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledet, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nation, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pramar, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostanian, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, T. K.</span></span> <span> </span><span class="NLM_article-title">Effect of squalane on mebendazole-loaded Compritol(R) nanoparticles</span>. <i>J. Biomater. Sci., Polym. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">868</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1080/09205063.2015.1061351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1080%2F09205063.2015.1061351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=26062393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCktb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=868-880&author=R.+A.+Gravesauthor=G.+A.+Ledetauthor=C.+A.+Nationauthor=Y.+V.+Pramarauthor=L.+A.+Bostanianauthor=T.+K.+Mandal&title=Effect+of+squalane+on+mebendazole-loaded+Compritol%28R%29+nanoparticles&doi=10.1080%2F09205063.2015.1061351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of squalane on mebendazole-loaded Compritol nanoparticles</span></div><div class="casAuthors">Graves, Richard A.; Ledet, Grace A.; Nation, Cedric A.; Pramar, Yashoda V.; Bostanian, Levon A.; Mandal, Tarun K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomaterials Science, Polymer Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">868-880</span>CODEN:
                <span class="NLM_cas:coden">JBSEEA</span>;
        ISSN:<span class="NLM_cas:issn">0920-5063</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The objective of this study was to develop nanostructured lipid formulations of Compritol for the delivery of mebendazole.  The formulations were prepd. with Compritol 888 ATO, squalane, and Pluronic F68.  Nine batches with different amts. of modifier, squalane, and drug were prepd.  The formulations were characterized by evaluating particle size, morphol., and zeta potential.  The thermal properties of the formulations were analyzed by DSC.  The encapsulation efficiency of each formulation and the drug release rates from each formulation were quantified by UPLC.  The particles were spherical and had median particle sizes between 300 and 600 nm.  A linear relationship was obsd. between Compritol/squalane compn. and the m.p. of the mixt.  The DSC scans of the formulations revealed some recrystn. of the drug from the formulations, and the amt. of recrystn. correlated with the amt. of squalane in the formulation.  Approx., 70% efficiency of encapsulation was obsd. in the formulations with 30% (wt./wt.) squalane, and these formulations also had faster dissoln. rates compared to the other formulations.  Overall, the formulations with 30% squalane are the preferred formulation for future testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-rX1hkyq4YbVg90H21EOLACvtfcHk0lg0YS0tatMUJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCktb3N&md5=29c732125eef87b3514fa684a59e7bdf</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F09205063.2015.1061351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F09205063.2015.1061351%26sid%3Dliteratum%253Aachs%26aulast%3DGraves%26aufirst%3DR.%2BA.%26aulast%3DLedet%26aufirst%3DG.%2BA.%26aulast%3DNation%26aufirst%3DC.%2BA.%26aulast%3DPramar%26aufirst%3DY.%2BV.%26aulast%3DBostanian%26aufirst%3DL.%2BA.%26aulast%3DMandal%26aufirst%3DT.%2BK.%26atitle%3DEffect%2520of%2520squalane%2520on%2520mebendazole-loaded%2520Compritol%2528R%2529%2520nanoparticles%26jtitle%3DJ.%2520Biomater.%2520Sci.%252C%2520Polym.%2520Ed.%26date%3D2015%26volume%3D26%26spage%3D868%26epage%3D880%26doi%3D10.1080%2F09205063.2015.1061351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span> <span> </span><span class="NLM_article-title">Evaluation of in vitro models for screening alkaline phosphatase-mediated bioconversion of phosphate ester prodrugs</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1443</span>– <span class="NLM_lpage">1447</span>, <span class="refDoi"> DOI: 10.1124/dmd.108.026245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1124%2Fdmd.108.026245" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1443-1447&author=H.+Yuanauthor=N.+Liauthor=Y.+Lai&title=Evaluation+of+in+vitro+models+for+screening+alkaline+phosphatase-mediated+bioconversion+of+phosphate+ester+prodrugs&doi=10.1124%2Fdmd.108.026245"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.026245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.026245%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLai%26aufirst%3DY.%26atitle%3DEvaluation%2520of%2520in%2520vitro%2520models%2520for%2520screening%2520alkaline%2520phosphatase-mediated%2520bioconversion%2520of%2520phosphate%2520ester%2520prodrugs%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1443%26epage%3D1447%26doi%3D10.1124%2Fdmd.108.026245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ong, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreskin, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locke, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartizal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokocimer, P.</span></span> <span> </span><span class="NLM_article-title">Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1284</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.056697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1124%2Fdmd.113.056697" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=1275-1284&author=V.+Ongauthor=S.+Flanaganauthor=E.+Fangauthor=H.+J.+Dreskinauthor=J.+B.+Lockeauthor=K.+Bartizalauthor=P.+Prokocimer&title=Absorption%2C+distribution%2C+metabolism%2C+and+excretion+of+the+novel+antibacterial+prodrug+tedizolid+phosphate&doi=10.1124%2Fdmd.113.056697"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.056697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.056697%26sid%3Dliteratum%253Aachs%26aulast%3DOng%26aufirst%3DV.%26aulast%3DFlanagan%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DE.%26aulast%3DDreskin%26aufirst%3DH.%2BJ.%26aulast%3DLocke%26aufirst%3DJ.%2BB.%26aulast%3DBartizal%26aufirst%3DK.%26aulast%3DProkocimer%26aufirst%3DP.%26atitle%3DAbsorption%252C%2520distribution%252C%2520metabolism%252C%2520and%2520excretion%2520of%2520the%2520novel%2520antibacterial%2520prodrug%2520tedizolid%2520phosphate%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D1275%26epage%3D1284%26doi%3D10.1124%2Fdmd.113.056697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flores-Ramos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibarra-Velarde, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Campos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera-Montenegro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung-Cook, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canto-Alarcon, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Rivero, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castillo, R.</span></span> <span> </span><span class="NLM_article-title">A highly water soluble benzimidazole derivative useful for the treatment of fasciolosis</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5814</span>– <span class="NLM_lpage">5817</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;key=10.1016%2Fj.bmcl.2014.10.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5814-5817&author=M.+Flores-Ramosauthor=F.+Ibarra-Velardeauthor=A.+Hernandez-Camposauthor=Y.+Vera-Montenegroauthor=H.+Jung-Cookauthor=G.+J.+Canto-Alarconauthor=L.+M.+del+Riveroauthor=R.+Castillo&title=A+highly+water+soluble+benzimidazole+derivative+useful+for+the+treatment+of+fasciolosis&doi=10.1016%2Fj.bmcl.2014.10.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DFlores-Ramos%26aufirst%3DM.%26aulast%3DIbarra-Velarde%26aufirst%3DF.%26aulast%3DHernandez-Campos%26aufirst%3DA.%26aulast%3DVera-Montenegro%26aufirst%3DY.%26aulast%3DJung-Cook%26aufirst%3DH.%26aulast%3DCanto-Alarcon%26aufirst%3DG.%2BJ.%26aulast%3Ddel%2BRivero%26aufirst%3DL.%2BM.%26aulast%3DCastillo%26aufirst%3DR.%26atitle%3DA%2520highly%2520water%2520soluble%2520benzimidazole%2520derivative%2520useful%2520for%2520the%2520treatment%2520of%2520fasciolosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5814%26epage%3D5817%26doi%3D10.1016%2Fj.bmcl.2014.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span>; <span class="NLM_string-name">Kanda, Y.</span>; <span class="NLM_string-name">Yamaguchi, H.</span>; <span class="NLM_string-name">Ashizawa, T.</span>; <span class="NLM_string-name">Murakata, C.</span>; <span class="NLM_string-name">Ikeda, S.-i.</span>; <span class="NLM_string-name">Tamaoki, T.</span></span> <span> </span><span class="NLM_article-title">DC107 Derivatives</span>. U.S. Patent <span class="NLM_patent">5,981,558</span>, Nov 9, <span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=H.+Arai&author=Y.+Kanda&author=H.+Yamaguchi&author=T.+Ashizawa&author=C.+Murakata&author=S.-i.+Ikeda&author=T.+Tamaoki&title=DC107+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DH.%26atitle%3DDC107%2520Derivatives%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01792">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_66424"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01792">10.1021/acs.jmedchem.7b01792</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Structures for previously reported prodrugs (Figure S1), liver homogenate stability of compound <b>11</b> (Figure S2), HPLC traces, <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra, LC–MS parameters (Table S1), structure of losartan internal standard, and molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_001.pdf">jm7b01792_si_001.pdf (1.17 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01792/suppl_file/jm7b01792_si_002.csv">jm7b01792_si_002.csv (0.9 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01792&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-9%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01792%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01792" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ee74bf1c1239","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
